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    The swimbladder is a unique organ in fish for buoyancy regulation. It has been 
postulated as a homolog of the tetrapod lung, but the molecular evidence is scare. In 
this study, I intended to provide evidence on the evolutionary homology from both 
developmental and transcriptomic aspects. I identified homologous expression of Fgf 
signaling ligand and receptor, and discovered both conserved and divergent function 
of Fgf signaling in swimbladder development comparing to lung development. In the 
screening for molecules expressing in developing swimbladder, I found that the 
swimbladder showed much less complex gene expression profile, which might 
explain the simplicity of the swimbladder structure comparing to the lung. I also 
employed RNA-seq technology to study the adult zebrafish swimbladder 
transcriptome, which revealed unique aspects of the swimbladder transcriptome and 
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1.1 Zebrafish as an experimental model 
The zebrafish (Danio rerio), a small tropical freshwater teleost fish originated from 
India, was used as a classical developmental and embryological model as early as the 
1930s. Starting from the 1980s, due to development of zebrafish genetic techniques, 
the zebrafish has become an increasingly popular experimental model. There are 
many advantages that the zebrafish can offer as a model organism. Zebrafish are small 
and hardy fish and easy to breed at a relatively low cost and high density. They can 
reproduce within three months after fertilization, and a healthy pair can provide more 
than two hundred embryos at one time, which makes zebrafish an attractive vertebrate 
model organism suitable for large scale forward genetic mutagenesis screening.  
After three decades of intensive studies, the zebrafish has been developed to a 
model animal for developmental study (Udvadia and Linney, 2003), toxicology 
screening (Hill et al., 2005), tumorgenesis (Stern and Zon, 2003; Stoletov and Klemke, 
2008) and various diseases processes (Lieschke and Currie, 2007). Tremendous 
valuable information has been gained from these studies and contributed to 
biomedical research. 
The large scale genetic screens carried out in the 1990s, which identified thousands 
of early developmental mutants, established the zebrafish as a mainstream model in 
developmental biology (Driever et al., 1996; Haffter and Nusslein-Volhard, 1996). 
The zebrafish has a few unique characters making it a good developmental biology 
model. Firstly, zebrafish embryos develop very fast; gastrulation is completed within 
ten hours after fertilization (Kimmel et al., 1995) and most organs are formed and 
function within the first five days of development. Moreover, the zebrafish embryos 
develop externally and are essentially transparent, facilitating live imaging and 
multiple embryonic manipulations. Morpholino antisense oligonucleotides (MOs) can 




be easily used to study function of any given gene in early development (Eisen and 
Smith, 2008; Nasevicius and Ekker, 2000). Finally, transgenic technique was 
developed and widely used, and different transgenic lines with fluorescent proteins 
labelling essentially every tissue or organ are available (Field et al., 2003b; Lawson 
and Weinstein, 2002). Multiple modifications of the technique have greatly improved 
the transgenic efficiency. The introduction of different transposon systems into 
zebrafish transgenic increases the germline transmission rate from several percents to 
around 50% or even higher (Kawakami, 2005). As a convenient model for 
developmental biology, the zebrafish has been established as a leading tool for studies 
attempted to understand early developmental mechanisms. Developmental studies 
using the zebrafish have contributed a wealth of knowledge about processes 
regulating specification of endoderm, as well as early development of endodermal 
organs such as the thyroid (Porazzi et al., 2009), gut (Trotter et al., 2009), liver (Chu 
and Sadler, 2009) and pancreas (Tiso et al., 2009). 
Phenotypic-driven screenings for zebrafish mutants which mimic human congenital 
genetic diseases have contributed to understanding of molecular pathogenesis of many 
diseases and to identifying novel culprit genes (Bahadori et al., 2006; Bassett et al., 
2003; Paw et al., 2003; Sun et al., 2004). At the same time, the zebrafish has been 
used for studies of acquired diseases, including tumorgenesis, infection and 
inflammation (van der Sar et al., 2004), metabolic and endocrine diseases (Holtta-
Vuori et al., 2010; Sukardi et al., 2010) and psychological and behavioural 
abnormalities (Sison et al., 2006). Among these disease categories, tumorgenesis is an 
extremely complex process which is barely understood. Using chemical 
carcinogenesis approach, the zebrafish can develop a wide variety of neoplasms, 
which are highly similar to human cancers at the level of histopathology (Beckwith et 




al., 2000; Spitsbergen et al., 2000). Several common human tumor types have been 
modelled in zebrafish using transgenesis, confirming the conserved oncogenic 
mechanisms in zebrafish and mammals (Patton et al., 2010; Payne and Look, 2009). 
The zebrafish embryos have been demonstrated feasible for chemical library 
screening for bioactivity and toxicity (Burns et al., 2005; Peterson et al., 2000). In 
contrast to traditional biochemical assays that focus on specific molecular targets, 
using the whole zebrafish animal offers the advantage of identifying novel proteins 
and pathways as drug targets and evaluating toxicity at the level of whole organism 
physiology. Furthermore, by carrying out screens using mutant or transgenic zebrafish 
that manifest unique disease phenotypes, specific disease-suppressing compounds can 
be identified (Peterson et al., 2004; Shepard et al., 2005). In various independent 
studies, the larval zebrafish have been shown to respond to drugs similar to the 
mammalian systems (Elo et al., 2007; Langheinrich, 2003; Milan et al., 2003). 
Therefore, the zebrafish is a promising model to contribute to several aspects of the 
drug development process, including target identification, disease modelling, lead 
discovery and toxicology. 
The zebrafish genome sequencing project was started from February 2001, and the 
ninth assembly of the zebrafish genome (Zv9) was just published in June 2010. The 
estimated genome size of the zebrafish is at around 1.4 Gp and the genome contains 
about 24000 genes. Although annotation is still in process, access to the genome 
sequence enables in silico analysis of many gene orthologs either through a direct 
screening or through comparative bioinformatic analysesof the human, mouse, rat and 
other genome sequences (http://www.ncbi.nlm.nih.gov/genomes/index.html). 
Continued efforts to re-sequence the genome and annotate the genes demonstrate the 




ongoing commitment to fully characterize the zebrafish genome and enhance the 
animal’s use as a genetic model. 
One challenge to the application of functional genomics is the fact that 30-40% of 
the zebrafish genome is tetraploid, arising from a genome duplication event 
(tetraploidization) which happened at around 370 million years ago. It is hypothesized 
that this whole genome duplication facilitated the teleost radiation. For at least 20% of 
human genes, zebrafish has two co-orthologs. On the other hand, the teleost genome 
duplication presents previously unanticipated advantages for the analysis of gene 
function because the subfunction partitioning in teleosts can facilitate the 








1.2 Zebrafish development 
1.2.1 Stages of embryonic development of zebrafish 
Zebrafish embryonic development is rapid compared with other vertebrate models. 
The development of zebrafish can be broadly divided into 4 stages, embryo (0-3 dpf), 
larval (4-29 dpf), juvenile (30-89 dpf) and adult (90 dpf-2 yr). During embryogenesis, 
seven periods can be further defined according to the morphological features, 
including the zygote, cleavage, blastula, gastrula, segmentation, pharyngula, and 
hatching periods.  
  





Figure 1-1. Camera lucida sketches of the zebrafish embryos at selected stages. 
(Reprint from Kimmel et al, 1995) 
 
    A zebrafish embryo completes its first cleavage about 40 minutes after fertilization. 
The chorion swells and surrounds the newly fertilized egg and the cytoplasm starts to 




stream toward the animal pole and this movement is maintained during the early 
cleavage stage (Fig.1-1A) (Kimmel et al., 1995). Early cleavages are meroblastic and 
all cells divide synchronously at a 15-minute interval. As a result, all blastomeres 
connect with each other by cytoplasmic bridges until the 16-cell stage, while the yolk 
is not cleaved. When the embryo enters the eighth cell cycle (2.25 hpf), the blastodisc 
begins to look like a ball which marks the beginning of blastula period (Kimmel et al., 
1995). During this period blastomeres pile up at the animal pole until about 4 hpf, at 
which point the blastodisc begins to thin and moves over the surface of the yolk cell 
(Fig.1-1B-E). The important processes during this period include midblastula 
transition (MBT), formation of the yolk syncytial layer (YSL) and the beginning of 
gastrulation in the form of epiboly. Initially the cells of the blastoderm divide 
synchronously, however, with the onset of MBT the divisions become 
metasynchronous and cell cycle lengthens. The blastomeres at the margin of the 
blastoderm have a unique fate. They lie against the yolk and remain cytoplasmically 
connected to it throughout cleavage (Kimmel et al., 1995). 
Following the blastulation stage, the embryo initiates morphogenetic cell movement 
and generate three primary germ layers: ectoderm, mesoderm and endoderm. This 
movement starts at 50% epiboly in the zebrafish embryo. Epiboly is characterized by 
thinning and spreading of both the YSL and the blastodisc over the yolk cell. 
Eventually the yolk cell is completely engulfed by cells at the end of gastrula. During 
the early stages of epiboly, the blastodisc thins considerably from a high mound of 
cells to a cup shape of multi-layers of cells. Epiboly continues with the morphogenetic 
cell movements of involution, convergence and extension, producing the primary 
germ layers, ectoderm, mesoderm and endoderm and the embryonic axis.  




At 50% epiboly (Fig.1-1F), the blastoderm has advanced over half of the yolk cell 
(Kimmel et al., 1995). Cells at the leading edge, or margin, of the blastula involute, 
moving toward the yolk and then back toward the animal pole under the overlying 
cells (Fig.1-1G). This creates two layers of cells that contribute to the formation of 
embryo proper. The upper layer is epiblast or embryonic ectoderm and the lower layer 
is known as hypoblast or mesendoderm. Epiblast cells at the margin continue to 
involute throughout the gastrulation period. Involuted cells produce mesoderm and 
endoderm whereas cells that remain in the epiblast form epidermis and central 
nervous system (CNS).  
Convergence movement starts shortly after the beginning of involution movement 
and produces a thickened group of cells at the margin at 60% epiboly. This thickening 
is known as the embryonic shield (equivalent to Spemann’s organizer in amphibians) 
and it marks the dorsal side of the embryo. Meanwhile, the cells located at the animal 
pole form the head structures; thus marking the anterior and posterior axis. Shield 
formation indicates the beginning of rapid convergence movements. The cells 
involuting from the shield formed axial hypoblasts. About midway through 
gastrulation, axial hypoblasts become clearly distinct from paraxial hypoblasts, which 
flank the axial hypoblasts on either side. The axial hypoblasts mainly form midline 
structures such as the prechordal plate and notochord, while the paraxial hypoblasts 
mainly generate muscles. The dorsal epiblasts begin to thicken towards the end of 
gastrulation and begin to form the neural plate. Eventually the yolk cell is completely 
engulfed by cells at the end of gastrula. At 10 hpf, by which stage the tail bud forms, 
the epiboly is complete, and the three germ layers are well defined and both 
mesoderm and ectoderm become patterned along the anterior-posterior and 
dorsoventral axis (Fig.1-1H) (Kimmel et al., 1995).  




From 10 hpf to 24 hpf, the embryo experiences a variety of morphogenetic 
movements which give rise to somites, rudiments of primary organs and more 
prominent tail bud (Fig.1-1H-N). From 24 hpf to 48 hpf, the embryo continues to 
elongate the body and lift the head. In addition to these movements, many other 
events occur including development of fins, pigment cells, circulatory system and 
more complex behavior (Fig.1-1O). After 2 dpf (day post fertilization), the embryo 
starts to hatch out from the chorion and morphogenesis of many of the organ 
rudiments is now completed (Fig.1-1P).  
 
1.2.2 Endoderm development in the zebrafish 
Formation of the three germ layers, namely ectoderm, mesoderm and endoderm, is 
one of the earliest events in establishing cell fate during vertebrate development. 
Endoderm is the innermost germ layer and it mainly gives rise to the digestive tract 
and associated organs such as the liver and pancreas (Stainier, 2002).  
 
1.2.2.1  Specification of early endodermal progenitors 
    In the zebrafish, the endoderm progenitors overlap with mesoderm progenitors at 
blastula and early gastrulation stages (Kimmel et al., 1990). Subsequently, these 
endoderm progenitors will be determined and separate from the mesoderm 
progenitors by late gastrulation as they become flattened compared to the rounded 
mesodermal cells (Warga and Nusslein-Volhard, 1999). In the mouse epiblast embryo, 
endoderm progenitors are located in the posterior region. These endoderm progenitors 
overlap with presumptive mesoderm region and this overlap maintains even after the 
primitive streak forms. Similar to mouse embryos, chick embryos contain common 




progenitors of endoderm and mesoderm distributing in the more posterior and medial 
region at early primitive streak stage. In Xenopus, endoderm arises from both vegetal-
most blastomeres and dorsal marginal blastomeres at 32-cell stage. Because the dorsal 
marginal blastomeres also give rise to mesoderm, endoderm and mesoderm fates are 
partially overlapping at this stage (reviewed by Fukuda and Kikuchi, 2005). 
Recently a lot of information on early endoderm development has also been 
acquired in zebrafish. Similar to other models, zebrafish endoderm also arises from 
common precursors of both endoderm and mesoderm at early blastula stage (Kimmel 
et al., 1990). During mid and late blastula stages, most endoderm progenitors are 
located within a 2-cell diameter range of the blastoderm margin and at more dorsal-
lateral area. With the onset of gastrulation, these common precursors became 
restricted in their lineage and endoderm specific progenitors began to appear at the 
marginal zone of the shield stage. At 75% epiboly stage, endoderm precursors acquire 
unique cell morphology and distinguish themselves from mesoderm counterpart 
(Warga and Nusslein-Volhard, 1999). Detailed fate map studies have shown that the 
dorsal-lateral position of endoderm precursors at late blastula stage corresponds to the 
anterior-posterior part of presumptive digestive system (Bally-Cuif et al., 2000; 
Warga and Nusslein-Volhard, 1999).  
In summary, vertebrates endoderm arises from cells with both endoderm and 
mesoderm fate. During blastula and gastrulation stages, these progenitors gradually 
commit to endoderm fate and distinguish themselves from adjacent mesoderm.  
 
1.2.2.2  Formation of the gut tube 
After formation of the endoderm germ layer, these cells further specify and 




differentiate into endoderm organs; among these gut tube formation is usually the first 
step of endoderm organogenesis. In the typical amniotes, gut tube formation begins 
with a sheet in endoderm. The anterior portion of the sheet then proceeds to fold into 
the foregut, followed by posterior folding to generate the hindgut. The two foldings 
eventually join together to make the complete gut tube (Fukuda and Kikuchi, 2005; 
Wells and Melton, 1999). In contrast, the zebrafish gut tube is formed by 
rearrangement of newly polarized cells rather than the folding of endoderm sheet. In 
addition, gut tube formation in zebrafish is relatively late, occurring at mid-somite 
stage, compared to the formation in the early somite stages (1-2 somites) in mammals 
(Wallace and Pack, 2003). Earlier observations suggested that the early endoderm 
forms a thin layer of cells, which move towards the midline to consolidate and form 
an endodermal rod during the early segmentation period. Cells in this rod are 
subsequently rearranged and polarized to form the zebrafish gut tube (Field et al., 
2003b; Horne-Badovinac et al., 2001). Despite these differences, the sequential 
formation of the foregut - hindgut - midgut in both mammals and zebrafish is similar 
and conserved in evolution.  
 
1.3 Lung and swimbladder, the evolutionary homologous organs 
1.3.1 The evolution of respiratory organ 
    Evolutionarily, the lung is characterized by an embryonic origin of ventral 
alimentary canal, an adult ventral position, and the presence of a pulmonary 
circulation. The swimbladder, on the other hand, is originated from the dorsal side of 
the alimentary canal and located ventrally in adult stage, and usually receives blood in 
parallel with the systemic circulation. Furthermore, the lung is a paired organ, while 




the swimbladder is not. The homology of the vertebrate lung and swimbladder was 
established by the British comparative anatomist Richard Owen (1846). But the exact 
evolutionary relationship between the two organs remains a debatable issue. 
    Charles Darwin held the opinion that the swimbladder is ancestral, and through 
natural selection, the swimbladder gave rise to the lung. In the Origin of Species 
(1859), he wrote “The illustration of the swimbladder in fishes is a good one, because 
it shows us clearly the highly important fact that an organ originally constructed for 
one purpose, namely, flotation, may be converted into one for a widely different 
purpose, namely respiration….” This “swimbladder to lung transition” theory was 
challenged by many successors afterwards. 
    Sagemehl (1885) firstly advanced a “lung to swimbladder transition” theory. The 
theory believes that a respiratory lung, perhaps appearing first in early jawed 
vertebrates, was the ancestral organ (Romer, 1966; Liem, 1988). In the lineage 
leading to tetrapods, the primitive lung was gradually modified into the organs found 
in species ranging from lungfish to mammals. By contrast, the fate of the primitive 
lung was different among the actinopterygii, where a gradual transition into a non-
respiratory swimbladder occurred. An intermediate stage example can be found on the 
Australian lungfish (Neoceratodus). Although the single, unpaired lung is dorsally 
located, it is connected to a ventral glottis via an elongated pneumatic duct. 
Comparing to lungs of the African (Protopterus) or South American (Lepidosiren) 
lungfishes, which have paired lung, the lung of Australian lungfish has much more 
reduced surface area. It is consistent with reduced requirements for aerial respiration 
of Australian lungfish, as they are facultative air breathers, and the primary function 
of the single lung is buoyancy. Another intermediate stage might be represented by 
the bowfin (Amia). It retains a pulmonary circulation but has an unpaired, dorsal 




respiratory bladder, and a short pneumatic duct. The final phases of the transition are 
represented in the teleosts, where the pneumatic duct lies closer to the swimbladder (a 
result of alimentary canal rotation) or is absent entirely (physodlistous). Moreover, the 
pulmonary circulation is absent. The major drawback of this hypothesis is that, it 
requires the replacement of one already highly derived state (paired, ventral lungs) by 
another (unpaired, dorsal swimbladder). 
Neumayer (1930) and Wassnetzov (1932) hypothesized that, the swimbladder and 
lung were evolved from the same ancestral organ, namely the respiratory pharynx 
(RP), which is the entire posterior region of the pharynx (Fig. 1-2). The swimbladder 
arises from the dorsal part, while the lung originated from the ventral part. This 
double origin theory is supported by the fact that the lung and swimbladder has 
different origins of blood supply. The bold supply of the entire posterior pharyngeal 
region comes from the 6
th
 branchial artery (BA6). Lobe-finned fish evolved paired 
lungs from the ventral part of the RP, whereas the ancestral statuswas maintained in 
the basal ray-finned fish. In the Polypteriformes the ventral part also formed lungs, 
while all other ray-finned fish developed the dorsal part to form a pulmonoid 
swimbladder (PSB). The PSB and the lungs have a homologous blood supply because 
they originate in the RP, both the dorsal and the ventral parts of which are supplied by 
BA6. There are several evidences supporting this double origin theory, including  the 
presence of a broad dorsal connections of the PSB to the pharynx in Lepisosteus and 
Amia, the ontogenetic origin of the non-respiratory swimbladder in sturgeons from a 
long dorsal pharyngeal ridge, as well as the lack of an attenuated pneumatic in basal 
teleosts. 
Although the homology of the lung and swimbladder has been generally accepted, 
molecular evidence is still lacking. Genetic study of the swimbladder may fill the gap. 






Figure 1-2. Schematic diagram of the ontogeny of the posterior pharyngeal cavity, 
based upon Acipenser. Dramatic remodelling of the posterior three gill pouches 
occurred to form the respiratory pharynx. The dorsal part gives rise to the 
swimbladder and the ventral part to lungs. Numbers denote the pharyngeal pouch, 
beginning at the spiracle (s). Abbreviations: d, dorsal; dl, dorsolateral; dm, 
dorsomedial; v, ventral; vl, ventrolateral. Modified after Wassnetzov (1932).   
 
  




1.3.2 Development of the mammalian lung 
The lung has the most critical functions related to terrestrial living, which is to 
facilitate gas exchange. To fully achieve the function, the lung has gone through 
extensive branching morphogenesis during embryonic development, and has an 
extremely large gas diffusion surface in adulthood. Moreover, a matching vascular 
capillary network develops in close apposition to the alveolar surface. As a vital organ 
as well as a highly venerable organ to infections and various diseases including cancer, 
the lung has been subjected to extensive studies. The early development of lung has 
been extensively studied in the mouse model because of the availability of many 
genetic tools. 
 
1.3.2.1 Stages of the mammalian lung development 
    Mammalian lung formation has been organized into six structural phases that are 
generally conserved, but vary temporally and regionally among diverse species: 
embryonic, pseudoglandular, canalicular, saccular, alveolar and microvascular 
maturation stages (Maeda et al., 2007). Mammalian lung embryonic development 
begins with the ventral budding of the lung primordium from the foregut and the 
trachea septation from the esophagus. During pseudoglandular stage, the lung bud 
forms two mainstream bronchi that undergo dichotomous branching as the 
endodermal tissue invades the surrounding splanchnic mesenchyme. At the same time, 
epithelial cell differentiation and formation of pre-alveolar saccules begins. Pre-
alveolar saccules expand during the canalicular and saccular stages and are further 
subdivided into alveoli by secondary septation. Vascular components in the alveolar 
re-model during the microvascular maturation stage postnatally, producing the 




alveolus and associated capillary structures characteristic of the adult lung. The early 
lung branching pattern does not vary between individuals, indicating that early 
branching patterns are likely to be regulated by a hard-wired genetic program. 
 
1.3.2.2 Endoderm specification 
The earliest known molecular step in the development of the respiratory system (the 
trachea and lungs) is the establishment of a localized domain of expression of Nkx2.1 
in the ventral wall of the anterior foregut (Minoo et al., 1999). Within this domain, the 
lung primordium appears, including the future trachea and two primary lung buds. 
The lung primordium arises at around 9.5 days post coitum (dpc) during mouse 
embryogenesis, which is about the same time with the dorsal pancreatic budding, 
whereas the liver and thyroid budded earlier from the ventral foregut. However, 
deficient of Nkx2.1 does not inhibit lung bud outgrowth. Null mutation of Nkx2.1 
results in neonatal lethal lung defect in association with absence of the thyroid, 
pituitary and parts of the brain (Kimura et al., 1996), as well as failure of septation of 
the esophagotracheal primordium (Minoo et al., 1999). A pair of lung primodia 
directly arises from the sides of the single lumen esophago-trachea, and fails to 
undergo subsequent branching morphogenesis in the mutants (See Fig. 1-4A). 
Lineage tracing showed that the cell fate of the trachea and bronchi were 
established well before formation of the definitive lung buds, suggesting the existence 
of other signals to define the endodermal cell fate (Perl et al., 2002). Recent studies 
show that disruption of Wnt2/2b signal specifically inhibits the specification of 
foregut endodermal cells to lung progenitors while sparing other endodermal organs, 
including the thyroid, esophagus, liver and pancreas. Moreover, activation of 




canonical Wnt/β-catenin signalling can reprogram esophagus and stomach endoderm 
to a lung progenitor fate (Goss et al., 2009). 
 
1.3.2.3 Separation of the trachea from the esophagus 
While much effort has been made to understanding of the process of lung budding, 
the mechanism of trachea-esophageal separation is still unclear. Histology study of 
the foregut suggests that this process is started by the formation of a local constriction 
in the foregut at the site of future separation, just anterior to where the lung buds form 
(Qi and Beasley, 2000; Williams et al., 2003). The walls of the foregut move towards 
the center of the lumen until they make contact in the midline, resulting in the 
formation of two tubes from one.  
By E9.5, folding of the endoderm has generated a uniform foregut tube (Fig. 1-
3A).Later on, mesenchymal signals direct outgrowth of lung buds from the ventral 
side of the foregut at around E9.5. Meanwhile, the trachea derives from ventral 
foregut endoderm and the esophagus from more dorsal endoderm (Fig. 1-3B). As 
development proceeds distinct tracheal and esophageal tubes emerge from the 
localized separation process (Fig. 1-3C). The lung buds actively extend posteriorly in 
response to Fgf10 signals from the overlying distal mesoderm. Normal separation of 
the trachea and esophagus results in two distinct tubes connected at the larynx (Fig. 1-
3D). Defects in the separation process result in human birth defects known as 
esophageal atresia (EA) and tracheoesophageal fistula (TEF) (Fig. 1-3E). In the most 
common form of EA/TEF, a fistula connects the distal esophagus to the trachea, 
placing the stomach in direct connection with the airway. Anteriorly, a blind pouch, 
characteristic of esophageal tissue, is present and termed esophageal atresia. 





Figure 1-3. Schematic representation of mouse lung embryonic development and 
esophageal atresia (EA)/tracheoesophageal fistula (TEF). Abbreviations: Lu, lung 
buds; Tr, trachea; Es, esophagus. Adapted after Que et al. (2006). 
 
In Sonic hedgehog (Shh) null mutant, the trachea fails to separate from the 
esophagus and lung consists of two stunted primary buds arising from both sides of 
the trachea-esphageal tube, indicating Shh is required for the formation of trachea but 
primary and secondary buds induction is activated by a distinct signal (Fig. 1-4A) 
(Pepicelli et al., 1998). However, proximo-distal differentiation of the airway 
epithelium can be observed, indicating that Shh is essential for branching but not for 
proximo-distal epithelial differentiation (Pepicelli et al., 1998). 
In mice, three zinc finger transcription factors, Gli 1, 2 and 3, have been implicated 
in the transduction of Shh signal. During foregut development, all three Gli genes are 
expressed in the splanchinic and lung mesenchyme. Mutant mice lacking Gli2 
function exhibit foregut defects including stenosis of the esophagus and trachea, as 
well as hypoplasia and lobulation defects of the lung. Gli3 null mutant mice have 
shape change and size reduction in pulmonary segmental branches. However, Gli2 




and Gli3 double null mutant mice have completely absent esophagus, trachea and lung 
(Fig. 1-4B). A 50% reduction of Gli3 gene dosage in the Gli2 null mutant background 
resulted in esophageal atresia with trachea-esophageal fistula and a more severe lung 
phenotype. Since compound null mutations of both genes completely abrogated lung 
morphogenesis from early embryonic foregut, it appears that Gli2 and Gli3 have 
specific yet overlapping functions during embryonic foregut development (Motoyama 
et al., 1998). 
As mentioned above, Nkx2.1 mutation can also cause EA/TEF. Morphologically, 
the phenotypes of the Nkx2.1 and Shh null mutants look similar. However, in the 
Nkx2.1 null mutant, epithelial differentiation is arrested before the expression of 
peripheral epithelial markers, while in the Shh null mutant, peripheral lung epithelial 
markers are normally expressed (Fig. 1-4A) (Kimura et al., 1996; Minoo et al., 1999; 
Pepicelli et al., 1998). 
Recent studies show that BMP signaling is also involved in trachea separation. 
Mouse embryos homozygous null for Noggin, which is a BMP antagonist, have 













Figure 1-4. Diagrams of several null mutant phenotypes in early embryonic lung 
morphogenesis. (A) The morphologically similar Nkx2.1 and Shh null mutant 
phenotypes in which the trachea fails to separate dorso-ventrally from the 
esophagus, forming a tracheo-esophageal tube from the sides of which grossly 
hypoplastic and dysplastic epithelial bags arise. (B) The compound null Gli2;Gli3 
mutant phenotype in which the primitive lung anlage completely fails to arise from 
the primitive foregut endoderm. (C) The FGF10 null mutant phenotype in which the 
larynx and trachea form and separate dorso-ventrally from the esophagus; but, the 
primary bronchial branches completely fail to arise from the trachea. Modified after 
Warburton et al., 2006.  
 
1.3.2.4 Branching morphogenesis 
Once the primary lung buds have formed, they extend into the surrounding 
mesenchyme and begin the process of branching morphogenesis. The process 
involves the reciprocal interaction of the epithelium and its surrounding mesenchyme. 
The development of the buds is entirely dependent on the localized expression of 
Fgf10 in the mesoderm overlying the buds and Fgfr2 in the endoderm. No bud 
extension occurs in mutants lacking Fgf10, although the trachea does separate (Min et 
al., 1998; Sekine et al., 1999).  In Fgf10-deficient mice, development of main-stem 
bronchi as well as all subsequent pulmonary branching morphogenesis is completely 
absent although tracheal development is normal, which shows the role of Fgf10 in 
directing the outgrowth of primary buds (Fig. 1-3C) (Min et al., 1998; Sekine et al., 
1999). At 9.75 dpc, mesenchymal Fgf10 expression is detected around the two 
primary buds growing out from the ventral foregut. Later, it is restricted to distal 




mesenchyme of secondary buds generated from the two primary buds (Bellusci et al., 
1997b). Further studies prove that Fgf10 is a chemotactic and proliferation factor for 
the endoderm (Bellusci et al., 1997b; Park et al., 1998).  
During secondary budding, Fgf10 expression are detected at high level in the 
mesenchyme at the very distal tips of the secondary buds. Besides, exogenous FGF10 
provided by bead implantation can induce outgrowth of epithelial buds from isolated 
lungs at a stage when secondary buds are about to form. These results suggest that 
FGF10, in addition to inducing primary bud formation, may also play a key role  
in secondary bud outgrowth. 
While the role of FGF10 appears to be similar in primary and secondary bud 
formation, signalling by Hh and the TGF-b superfamily member Bmp is essential for 
modulating FGF10 activity during secondary bud formation. Thus, temporal and 
spatial differences of Fgf10 signal results in uneven growth of the lung epithelium, 
which is the base of branching morphogenesis. Shh is highly expressed in the distal 
epithelium upon induction of Fgf10, and is responsible to restrict Fgf10 expression 
domain (Bellusci et al., 1997a; Lebeche et al., 1999). Bmp4 is also highly expressed 
in the distal epithelium and can directly antagonize Fgf10-induced proliferation 
(Weaver et al., 2000). And by acting as an Fgf10-dependent inhibitor of Fgfr2b 
activity, Spry2 limits the proliferation or migration of the lung epithelium (Mailleux 
et al., 2001). 
The interaction between Fgf10 and Shh in inducing secondary bud formation has 
been depicted by studying the lungs from Shh mutant mice. Fgf10 expression is 
upregulated and expanded in Shh mutant lungs. In addition, overexpression of Shh in 




the mouse lung leads to reduced Fgf10 expression, consistent with a negative 
regulation of Fgf10 expression by Hh signalling. 
Bmp4 expression is first detected in the ventral mesenchyme of the developing lung 
when the primordial lung buds are emerging from the foregut and  maintained until 
13.5 dpc. Expression of Bmp4 is also detected in the distal endoderm of the 
developing lung bud. The function of Bmps was studied in vitro by showing that 
cultured lung buds failed to grow towards an FGF10-coated bead when exogenous 
BMP4 protein was added to the culture medium. These results suggest that BMP4 
antagonizes the effect of FGF10 in inducing epithelial bud outgrowth. A model has 
been proposed in which Bmp4 functions as an inhibitor of lateral budding based on 
the expression and in vitro studies. Mesenchymal Fgf10 induces Bmp4 expression at 
the tip of the growing lung. In the presence of high level of BMP4, FGF10 fails to 
induce further budding from the growing lung bud, thus ensuring a single extending 
bud, rather than a cluster of buds. Branching only can occur when the Fgf10 
expression domains shift laterally.  
After the secondary buds are specified, the two major modes of branching are 
lateral sprouting and dichotomous branching. Besides the signals described above, 
several other signaling pathways are also involved, including Wnt and TGF-β. 
However, the function of these pathways is not well understood and remains 








1.4 The zebrafish swimbladder 
1.4.1 The teleost swimbladder 
The swimbladder is a specialized organ in teleosts that regulates buoyancy. The 
swimbladder allows the fish to hold vertical positions in the water column with 
minimal energy expenditure (Alexander, 1972). It is a sac filled by several types of 
gas, mainly oxygen and carbon dioxide (Fange, 1983; Pelster, 2004), and is located in 
the dorsal part of the body, between the peritoneum and the vertebral column. The 
volume of gas in the swimbladder is actively regulated to maintain neutral buoyancy 
as fish ascend or descend in the water. The long-term maintenance of internal gas 
pressure and also compensatory inflation and deflation are under reflex autonomic 
control.  
There are, however, large variations among teleosts in swimbladder morphology 
and in the effectors responsible for adjusting the gas content of this organ. Depending 
on whether the swimbladder is connected to the gut through a pneumatic duct, the 
swimbladder can be classified into two groups. Fish species, which maintains a 
connection between the swimbladder and the esophagus are called physostome. On 
the other hand, the fishes in which the swimbladder connection to gut is not retained 
are physoclists.  
In physoclists, regulation of gas secretion into the swimbladder involves a structure 
called the gas gland (Fange, 1983). In addition, there is a vascular rete, termed the rete 
mirabile, in series with the capillary bed of the gas gland, in which a countercurrent 
multiplier helps raise the partial pressure of oxygen in blood afferent to the gland 
(Blaxter and Tytler, 1978). When fishes need to ascend or descent in water, they can 




adjust the volume of gas in the swimbladder either through reabsorption or secretion 
of molecules into or from the blood (Steen and Sund, 1977). 
Cyprinids are a large group of physostome teleosts in which the swimbladder 
commonly consists of two chambers separated by a narrow ductus communicans. The 
anterior chamber is believed to function primarily as an acoustic resonator aiding 
hearing, and the posterior chamber has been proposed to operate as a hydrostatic 
organ (Popper, 1974). In most of physostomes, the effectors for gas transfer to and 
from the bloodstream are generally much reduced and operate less efficiently than 
those in the physoclists. These fish could fulfil most requirements for buoyancy 
adjustment by gulping surface air and forcing it down the pneumatic duct or by 
constricting smooth muscle in the swimbladder to expel air through the duct (the 
“gasspuckreflex” or gas-spitting reflex).  
 
1.4.2 Current status of the study of zebrafish swimbladder developmental study 





] or ET3 expressing GFP in the swimbladder have been 
indentified in Dr. Korzh’s lab (Parinov et al., 2004) and employed to study 
swimbladder development dynamics in vivo. ET33 expresses strong GFP in 
swimbladder epithelium and pneumatic duct starting from 56 hpf and maintained at 
least until 10 dpf, while ET3 expresses GFP mainly in the outer mesothelium of 
swimbladder.  
Several molecular markers have also been selected and carefully examined by 
Winata et al. (2009) to facilitate the observation of swimbladder development in early 
zebrafish embryos, including homeobox HB9 (Wendik et al., 2004), fibroblast growth 




factor 10a, acta2 (Georgijevic et al., 2007), and annexin A5 (Farber et al., 2003). In 
the swimbladder epithelium, the expression of homeobox gene hb9 starts from 36 hpf 
when the swimbladder primordium just forms. The mesenchyme of the swimbladder 
is marked by the expression of two genes, fgf10a and acta2. Expression of fgf10a in 
the swimbladder is initially detected from 48 hpf and maintained at 72 hpf, while 
acta2 expression signifies the initiation of smooth muscle differentiation and is 
initially detected at 65 hpf. It is of particular interest to use acta2 as a marker, as it 
represents the identity of the mesenchymal tissue, which mainly consists of smooth 
muscle. The expression of the fourth marker, annexin A5 begins only after 60 hpf in 
outer mesothelium layer. Taken together, the four marker genes enable the analysis of 
all three distinct layers of cells in the swimbladder. 
Previous studies by Winata et al. (2009) have focused on the function of Hedgehog 
signaling in swimbladder. During swimbladder development, Hedgehog signaling 
ligands (shha and ihha) are expressed in the epithelium and receptors (ptc1 and ptc2) 
are expressed in the mesenchyme, which is homologous to those in early lung 
development. It is also demonstrated that Hedgehog signaling has a conserved role in 
swimbladder development, particularly in its requirement for epithelial and 
mesenchymal growth and smooth muscle differentiation. 
 
  




1.5 RNA-seq as an emerging technology for transcriptome analysis 
    The transcriptome is the complete set of RNA molecules, including mRNAs, non-
coding RNAs and small RNAs, in one cell or a population of cells, transcribed for a 
specific developmental stage or physiological condition. Studying the transcriptome, 
both descriptive and quantitative, is essential for interpreting the functional elements 
of the genome and revealing the molecular constituents of cells and tissues, and also 
for understanding development and disease.  
    Diverse technologies have been developed and applied to study the transcriptome, 
including hybridization- and sequence-based approaches. Microarray is one of the 
hybridization-based approaches which are commonly used for transcriptome study. 
The microarray technique uses fluorescent-labeled cDNA to hybridize with short 
oligonucleotide or cDNA probes attached on a microchip, commercial available or 
custom-made. The hybridization produces fluorescent signals of different intensity, 
which are subsequently converted to gene expression level using various algorithms. 
The technique is high throughput and relatively inexpensive (Reviewed by Schena et 
al., 1998; Lipshutz et al., 1999; Wolber et al., 2006). However, it also has several 
major limitations. The microarray completely relies on existing genomic sequence 
knowledge, which makes it impossible to apply on non-model organisms. Besides, the 
cross-hybridization usually results in high background level (Okoniewski and Miller, 
2006; Royce et al., 2007) and it always requires several technical replications. 
Moreover, comparison of expression levels across different experiments is often 
difficult and can require complicated normalization methods (Curtis et al., 2009). 
Different from microarray methods, sequence-based approaches directly determine 
the cDNA sequence. EST (Expressed Sequence Tag) libraries were firstly used.  ESTs 
are small pieces of cDNA sequence (usually 500 to 800 nucleotides long) which are 




generated by sequencing either one or both ends of an expressed gene (Boguski et al., 
1994; Parkinson and Blaxter, 2009). They were extremely useful to discover new 
genes and identify gene transcript variations, and are still being used, e.g. Baxendale 
et al., 2009 and Lo et al., 2008. To construct a cDNA library, mRNAs are reverse-
transcribed to cDNAs, which are subsequently cloned into plasmid vectors. The 
cDNA library was sequenced using the state-of-art Sanger sequencing, which is still 
the only technique capable achieving long and accurate readings. But the EST 
approach is relatively low throughput and expensive, and can only reach to a semi-
quantitative level even if a significant effort was invested. 
    Recently, the development of novel high-throughput DNA sequencing methods, 
termed RNA-seq (RNA sequencing) has provided a revolutionary method for 
transcriptome analysis employing the recently developed deep-sequencing 
technologies. In general, a population of RNA (total or fractionated, such as poly(A)+) 
is converted to a library of cDNA fragments with adaptors attached to one or both 
ends. Each fragment, with or without amplification, is  sequenced in a high-
throughput manner to obtain short sequences from one end (single-end sequencing) or 
both ends (pair-end sequencing). Depending on the DNA-sequencing technology used, 
the reads are typically 30-400 bp. Several deep sequencing technologies are available 
on the market, including the Illumina Genome Analyzer (GA) (Nagalakshmi et al., 
2008; Wilhelm et al., 2008; Lister et al., 2008),  Applied Biosystems SOLiD 
(Cloonan et al., 2008) and Roche 454 Life Science systems (Barbazuk et al., 2007; 
Vera et al., 2008).  
    Since the illumina GA is employed in this study. A more detailed explanation of its 
technology will be provided. The Illumina approach uses solid-phase bridge PCR 
amplification of DNA template attached on a single-molecule array, or flowcell. In 




the amplification step, more than 40 million clusters are formed in a flowcell, each of 
which consist approximately 1000 copies of a single template molecule. The 
sequencing is conducted in a massively parallel fashion using a sequencing-by-
synthesis approach, which employs reversible terminators with removable fluorescent 
moieties. The latest version of the Genome Analyzer is capable of generating 100 bp 
reads and one pair-end sequencing experiment can be finished within 10 days. 
Illumina has just published its new sequencing system HiSeq
TM
 2000 in this year, 
from which up to 25 Gb of data can be retrieved per day. 
Although RNA-seq is still a technology under active development, it offers 
several key advantages over existing technologies. First, unlike hybridization-based 
approaches, RNA-seq is not limited to detecting transcripts that correspond to existing 
genomic sequence (Vera et al., 2008), and novel transcripts and splicing variations 
can be detected easily. It’s especially valuable for people working on non-model 
organisms whose genome sequences are completely or partially unavailable, and it is 
even possible to do de novo sequencing and assembly of genomes with the assistance 
of powerful bioinformatic tools. A second advantage of RNA-seq relative to DNA 
microarrays is that RNA-seq has very low background signal because DNA sequences 
can be unambiguously mapped to unique regions of the genome. The results of RNA-
seq also show high levels of reproducibility for both technical and biological 
replicates, and the experiment requires much less amount of RNA sample. Moreover, 
this method can offer single-base resolution for annotation at the genome level. 
Although RNA-seq is still more expensive than DNA microarray, considering the 
incomparable amount and depth of information which could be retrieved from single 
experiment, this method is very cost-effective comparing to large scale Sanger EST 
sequencing. Finally, RNA-seq protocol can be easily modified to fulfill the needs of 




different research purposes, including small RNAs (Marson et al., 2008) and ncRNAs 
(Guttman et al., 2009) discovery, sense and antisense transcript survey (He et al., 
2008), and epigenomic study. To date, RNA-seq has been applied in different 
epigenomic areas, including the characterization of DNA methylation patterns (Cokus 
et al., 2008; Taylor et al., 2007) and posttranslational modifications of histones 
(Barski et al., 2007; Mikkelsen et al., 2007). Taking all of these advantages into 
account, RNA-seq is the first sequencing-based method that allows the entire 
transcriptome to be analyzed in a very high-throughput and quantitative manner.  
 
  





In the current study, in order to provide molecular evidence of the evolutionary 
relationship between the mammalian lung and fish swimbladder, we attempted to 
pursue the following objectives: 
1. To investigate the molecular mechanism regulating the development of 
swimbladder by focusing on the Fgf pathway due to its critical role in lung branching 
morphogenesis:  
a. To characterize the expression pattern of Fgf genes and their receptors in the 
zebrafish swimbladder.  
b. To perform functional analysis through mutants and morpholino gene knockdown.  
c. To investigate the role of other genes whose homologues have been known to 
interact with the Fgf pathway in lung development, such as the Hh and Bmp signaling 
pathways. 
2. To characterize the zebrafish swimbladder transcriptome  
a. To describe the general features of the swimbladder transcriptome 
b. To identify unique elements of the swimbladder transcriptome by comparing to 
other zebrafish organs for better understanding of the swimbladder function. 
c. To perform comparative transcriptome analyses between the mammalian lung and 
the zebrafish swimbladder in order to provide novel insights into the evolutionary 
relationship of two organs. 
 
 










Developmental study of the zebrafish swimbladder 
  




2.1 Materials and Methods 
2.1.1 Zebrafish 
2.1.1.1 Fish maintenance 
    Wild-type zebrafish (Danio rerio) were purchased from local fish farms. The fish 
were maintained basically according to the method described by Westerfield (2000) 
and in compliance with Institutional Animal Care and Use Committee (IACUC) 
guidelines. Normally, fish were fed twice per day with flakes (Aquori). During the 
spawning period, the fish were fed with brine shrimps (World Aquafeeds) and were 
kept under the natural photoperiod cycle about 12 hours of day (light) and 12 hours of 
night (dark).  
 
2.1.1.2 Obtaining embryos 
    Embryos were obtained from spawning pairs placed in a two-tank breeding system, 
using an inner breeding tank with mesh bottom and an outer tank. Adult male and 
female to be crossed were placed in the inner tank and separated by a plastic divider 
on the day before spawning. Plastic divider was removed in the morning of the 
spawning day allowing fishes to breed. Embryos fell through the inner mesh and were 
subsequently collected using a sieve, reared in egg water medium (1.5 mL sea salts 
stock added to 1 L distilled water to 60 μg/mL final concentration), and kept in an 
incubator at 28°C. Embryos were staged by hours (h) or days (d) post-fertilization 
according to Kimmel et al. (1995). 
 
 




2.1.1.3 Zebrafish mutant and transgenic lines 
Zebrafish transgenic LiPan [Tg(elastase:GFP); Tg(lfabp:dsRed)] line was generated 
by Gong lab and maintained in the zebrafish facility at Department of Biological 





syu as follow) (Schauerte et al., 1998), slow-muscle omitted (smu
b641
, smu 




as follow) (Norton et al., 
2005) were maintained as heterozygous adults as described above, in the zebrafish 
facility at Department of Biological Sciences, NUS and the Institute of Molecular and 
Cell Biology, Singapore. The embryos from the mutant lines of fishes were collected 
in the same way as that of the wildtype. Homozygous syu
t4
 mutant embryos were 
identified as early as 30 hpf by defects in somite patterning and absence of blood flow 
in the posterior trunk (Schauerte et al., 1998). Homozygous smu
b641
 embryos were 
identified as early as 24 hpf due to curled-down tail phenotype and U-shaped somites 
(Barresi et al., 2000). Homozygous dae
tbvbo
 was identified due to absence of pectoral 
fin at 60 hpf (Norton et al., 2005). 
 
2.1.1.4 Live imaging of zebrafish embryos 
    To facilitate visualization zebrafish embryos in whole-mount preparations, 
pigmentation of skin was inhibited by raising embryos and larvae in egg water 
containing 0.2 mM PTU (1-phenyl-2-thiourea) (Sigma). Microscopic observations 
and photography of live embryos were performed using a compound microscope 
(Zeiss Axioscope 2, Zeiss). For embryos older than 20 hpf, twitch movements may 
affect imaging quality. These embryos were treated with anaesthetic before imaging 
to prevent movement. For this purpose, phenoxyethanol was diluted in egg water to a 




final concentration at 0.1%. Embryos are transferred into this anesthetic solution prior 
to observation. After a few seconds the embryo under anesthetic influence can be 
transferred into 4% methyl cellulose in egg water for soft mounting and viewed under 
the microscope. 
 
2.1.2 Gene amplification and DNA recombination 
2.1.2.1 Isolation of total RNA from zebrafish embryos and adult tissues 
Total RNAs from zebrafish embryos and different adult tissues were extracted 
using TRIzol reagent (Invitrogen). Briefly, about 200 embryos or 100 mg of tissues 
were quickly frozen in liquid nitrogen and homogenized in 1 mL of TRIzol® reagent. 
The homogenate was incubated at room temperature for 5 minutes to allow 
nucleoproteins to dissociate before 200 µL of chloroform was added. The mixture was 
shaken by hand vigorously for 15 seconds and incubated at room temperature for 3 
minutes, followed by centrifugation at 14,000 rpm for 15 minutes at 4 °C to separate 
aqueous and organic phase. 300 µL of supernatant was then transferred to a new tube 
and an equal volume of isopropanol was added. After incubation in ice bath for 30 
minutes, RNA was pelleted by centrifugation at 14,000 rpm for 10 minutes at 4 °C 
and washed with 1 mL of cold 70% ethanol. After drying pellet at room temperature 
completely, the RNA pellet was then dissolved in DEPC (Diethyl pyrocarbonate)-
treated water and stored in -80°C. RNA was quantified and qualified using 








2.1.2.2 cDNA synthesis  
cDNA synthesis was conducted using SuperScript
TM
 II First-Strand Synthesis 
System (Invitrogen). For a 20 µL reaction system, up to 2 µg of total RNA, 2 µM of 
oligo dT primer, 1 µL of 10 mM dNTP mix was mixed in a 0.5-mL tube. DEPC-
treated water was added up to 10 µL. The mixture was incubated at 65 °C for 5 
minutes, and placed on ice for at least 1 minute. Subsequently, 2 µL of 10× first-
strand buffer (50 mM Tris-HCl, pH 8.3; 75 mM KCl; 3 mM MgCl2 and 10 mM DTT), 
1 µL of RNaseOUT (40 U/µL) and 1 µL of SuperScript® Reverse Transcriptase (200 
U/µL) was added in the indicated order. After incubating at 42 °C for 50 minutes, the 
reaction was inactivated by heating at 70°C for 15 minutes. The cDNA synthesis 
reaction was diluted for 10 times and used as template for PCR immediately or stored 
at -20 °C for further use. 
 
2.1.2.3 Standard polymerase chain reaction (PCR) 
    Standard PCR was performed in a 50 µL reaction using the DNA Thermal Cycler 
Model 480 or 9600 (Perkin Elmer). Each reaction included 5 µL of 10× PCR buffer 
(0.5 M KCl; 0.1 M Tris-HCl, pH 8.8; 15 mM MgCl2; 1% Triton X-100), 2.5 µL of 2 
mM dNTP, 1 µL of 10 µg/µL sense primer, 1 µL of 10 µg/µL antisense primer, 1 µL 
of 5 U/µL Taq polymerase and 1 µL template DNA. A typical program was as 
follows: denaturation at 94 °C for 5 minutes, followed by 35 cycles of denaturation at 
94 °C for 30 seconds, annealing at 56-60 °C for 30 seconds and extension at 72 °C for 
certain minutes based on 1 min/kb and final extension at 72 °C for 10 minutes.  
 
 




2.1.2.4 DNA electrophoresis 
    Typical DNA electrophoresis was performed in 1% agarose gel unless particular 
requirements are indicated. The agarose powder was melt in 1×TAE (0.04 M 
Trisacetate; 0.001 M EDTA) by heating in a microwave oven. After the solution was 
cooled to 60 °C, SYBR Safe (Invitrogen) was added to a final concentration of 0.1 
µg/mL before the agarose gel was casted. DNA samples were mixed with loading dye 
and loaded to the wells of the gel submerged in 1XTAE. Voltage of 1-5 v/cm was 
applied during the electrophoresis.  
 
2.1.2.5 Purification of PCR products 
    Suitable PCR products were directly purified from the PCR mixture. The purified 
products were used for various applications including cloning and ligation. QIAquick 
PCR purification kit (QIAGEN) was used to purify the PCR product. Generally, 5× 
volume of Buffer PB (Binding Buffer) was added to 1× volume of PCR sample. 
QIAquick spin column was placed in a collection tube. The buffer and PCR sample 
mix were placed in the spin column and centrifuged for 1 minute. The flow through 
was discarded. 0.75 mL of Buffer PE (Washing Buffer) was added to the spin column 
and centrifuged for 1 minute. The flow through was discarded and centrifuged for 
additional 1 minute. The purified PCR product was then eluted with 20-30 L of 
sterile water or TE buffer by incubating for 1 minute and centrifuging for 1 minute. 








2.1.2.6 Plasmid vector: pGEM®-T Easy 
    The recovered PCR products were cloned into the pGEM
＠
-T Easy (Fig. 2-2). The 
pGEM®-T Easy Vector (Promega) is a convenient system for cloning of PCR 
products. The pGEM
＠
-T Easy vector was prepared by cutting vector with EcoRV and 
adding a 3’ terminal thymidine to both ends by the manufacturer. These single 3’-T 
overhangs at the insertion site greatly improved the efficiency of ligation of PCR 
products into the plasmid because the Taq DNA polymerase generated a 3’ adenine 
overhang in the PCR products. In addition, the system with the convenient EcoRI and 
NotI restriction enzyme sites flanking the insertion site, providing the options for 
removal of insert DNA with a single restriction digestion.  
 
Figure 2-1. pGEM＠-T Easy Vector map and sequence reference points. 
 
2.1.2.7 Ligation 
    DNA ligation reaction was carried out typically in 10 µL of volume, containing 1 
µL of 10× ligation buffer (0.3 M Tris-HCl, pH 7.8; 0.1 M MgCl2; 0.1 M DTT and 5 
mM ATP), insert DNA, vector DNA and 1 unit of T4 DNA ligase (Promega or New 




England Biolabs). The molar ratio of insert-to-vector DNA was usually 3:1 or 4:1. 
Ligation reaction was incubated at 4 °C overnight or 16 °C for 4 hours.  
 
2.1.2.8 Transformation 
2.1.2.8.1 Preparation of competent cells 
    For successful cloning, normally the competent cells should be well prepared with 
a high efficiency of transformation (>10
7
 colonies/μg of supercoided plasmid). For the 
preparation of competent bacteria cells, 2 mL of LB broth was incubated with a single 
fresh colony of Escherichia coli strain DH5α at 37°C with 250 rpm shaking overnight. 
In the following morning, 0.5 mL of the culture was re-inoculated into a 250 mL flask 
containing 50 mL of LB broth and shaken at 250 rpm at 37 °C until OD600 reached 
around 0.5. The culture was chilled on ice for 15 minutes after being transferred into 
50 mL Falcon tubes. Cells were pelleted by centrifugation at 1,000 g at 4 °C for 15 
minutes. The cell pellets were drained thoroughly and resuspended in RF1 (100 mM 
RbCl; 50 mM MnCl2; 30 mM Potassium acetate; 10 mM CaCl2 and 15% glycerol) 
with 1/3 volume of the original bacteria culture. After incubation on ice for 15 
minutes, the cells were spun down and resuspended in 1/12.5 of the original volume 
of RF2 (10 mM MOPS; 10 mM RbCl; 75 mM CaCl2; 15% glycerol). After another 15 
minute-incubation on ice, the competent cells were transferred into 1.5-mL 
microcentrifuge tubes in aliquot (100 µL) and fast-frozen in liquid nitrogen. These 









    The aliquotted competent cells were thawed on ice and the 5 µL out of 10 µL of 
ligation reaction was added and mixed by gentle pipetting. This mixture was then 
incubated on ice for 30 minutes. After being heated at 42 °C for 90 seconds, the tube 
was cooled immediately on ice for 2 minutes. 900 µL of LB medium was then added 
into the mixture. After being incubated at 37 °C for 45 minutes with shaking at 200 
rpm, 1/10 and 9/10 of the transformation reaction mixture was spread onto two 
separate LB plates supplemented with appropriate antibiotics in order to produce 
proper density of transformant colonies. The plates were incubated at 37 °C overnight.  
 
2.1.2.9 Colony screening 
PCR was applied to screen for correct recombinant DNA directly using the bacteria 
colonies, as DNA was effectively released from bacteria cells under the repeated high 
temperature during PCR. A pair of primers on the vector was used to amplify the 
insert by a PCR reaction. 
For PCR screening, colonies to be examined were marked in numerical order. A 
toothpick was used to pick up the colony and the attached bacteria were spread to the 
bottom of a PCR tube, which was preloaded with 30 µL of PCR mixture, containing 
0.6 units of Taq DNA polymerase, 3 µL of 10X PCR buffer, 1.5 µL of 2 mM dNTP 
mix and 0.3 μg of each sense and antisense primers. PCR program includes initial 
denaturation at 94 °C for 5 minutes, followed by 30 cycles of denaturation at 94 °C 
for 30 seconds, annealing at 50 °C for 45 seconds and elongation at 72 °C for 10 
minutes. PCR product was examined in 1-1.5% agarose gel. Colonies that yielded 
PCR products with expected size were inoculated for plasmid DNA preparation. 





2.1.2.10 Isolation and purification of plasmid DNA 
Small-scale preparation of plasmid DNA was carried out using Wizard Miniprep kit 
(Promega), with the processing of alkaline lysis followed by the binding of plasmid 
DNA to a positive charged silica-based resin. DNA was then re-dissolved and eluted 
in low salt buffer or water. Normally, around 10 μg of high copy number plasmid 
DNA can be isolated from 5 mL of overnight bacteria culture in Luria-Bertani (LB) 
medium. 
Firstly, the bacteria in LB liquid medium with appropriate antibiotics were 
harvested by centrifugation at 5,000 rpm for 3 minute using the 5417C centrifuge 
(Eppendorf). The bacterial pellet was then re-suspended in 250 µL of Cell 
Resuspension Solution (100 mg/mL RNase A; 10mM EDTA; 25 mM Tris-HCl, pH 
7.5). 250 µL of Cell Lysis Solution (0.2 M NaOH; 1% SDS) and 10 L of alkaline 
protease solution were added to the bacterial suspension and mixed by gently 
inverting the tube for several times.  
After 5 minutes incubation at room temperature, this mixture was then neutralized 
by adding 350 µL of Neutralization Buffer (1.32 M KOAc, pH 4.8). After being 
centrifuged in a microcentrifuge tube at 14,000 rpm for 10 minutes, the supernatant 
was transferred into a fresh mini-column provided in the kit and was centrifuged at 
14,000 rpm for 1 min. The flow-through was discarded. After adding 750 µL of 
Column Wash Solution (200 mM NaCl; 5 mM EDTA; 20 mM Tris-HCl, pH 7.5; 75% 
EtOH), the minicolumn was centrifuged at 14,000 rpm for 1 minute. Then the flow-
through was discarded and 250 µL of Column Wash Solution was added. The 
minicolumn was centrifuge at 14,000 rpm for 2 minutes. Then the minicolumn was 




transferred to a new microcentrifuge tube. To elute plasmid DNA, 30-50 µL water 
was added into the minicolumn for 2 minutes incubation at room temperature, 
followed by centrifugation at 14,000 rpm for 2 minutes. 
 
2.1.2.11 DNA sequencing reaction 
Automated sequencing reactions were carried out using the ABI 
PRISM™BigDye™ Terminator Cycle Sequencing Ready Reaction Kit (Perkin 
Elmer). The kit contained a sequencing enzyme AmpliTaq® DNA polymerase called 
FS and a set of dye labeled terminators for fluorescent cycle sequencing of lager 
fragments with high accuracy.  
Each sequencing reaction (5 L) contains 2 L of BigDye Terminator Ready 
Reaction Mix, 40-200 ng of DNA, and 1 L of primer (0.2 g/L). PCR was 
performed on the DNA thermal cycler Model 480 or 9600 (Perkin Elmer) with 25 
cycles of 96 °C for 10 seconds, 50 °C for 5 seconds, and 60 °C  for 4 minutes, and 
finally hold at 4 °C. Ethanol precipitation was carried out to purify the extension 
products. 2 L of 3 M NaOAc (pH4.6) and 80 L of 95% ethanol was mixed with the 
20 L of reaction mix, and incubated at room temperature for 15 minutes. The tube 
was spun for 15 minutes at the maximum speed at 4 °C. The pellet was rinsed with 
500 L of 70% ethanol for two times, and air-dried prior to loading into the DNA 








2.1.3 Gene Expression analyses 
2.1.3.1 One-step RT-PCR 
QIAGEN OneStep RT-PCR kit (QIAGEN) was applied to perform one step 
reaction by performing cDNA synthesis and following PCR together in one PCR tube. 
If the same amount of starting RNA was used, this method can serve as a semi-
quantitative measurement for RNA expression level. The RT-PCR primers were 
designed to span an intron/exon boundary in order to avoid amplifying genomic DNA, 
or designed to flank an intron to distinguish genomic amplification (large fragment) 
from cDNA amplification (small fragment).  
The reaction mix was set up in 25 µL volume, 5 µL of 5× RT-PCR buffer, 1 µL of 
dNTP mix (containing 10 mM of each dNTP), forward primer 0.3 μM (final 
concentration), reverse primer 0.3 μM (final concentration), 1 µL of one-step RT-PCR 
enzyme mix, and 0.5-1 µL of template RNA (1μg/µL). The reaction mix was kept on 
ice till the thermal cycler reached 50 °C. The PCR program was cDNA synthesis at 
50 °C for 30 mins; denaturation at 94 °C for 15 minute for 1 cycle followed by 25-35 
cycles of 94 °C for 45 seconds, 55-60 °C for 45 seconds and 72 °C for 1 minute and 
final extension at 72 °C for 10 minutes. The annealing temperature and extension time 
were adjusted according to the primer design and the length of the final PCR products.  
 
2.1.3.2 Real-time PCR 
    First-strand cDNA was synthesed using SuperScript™ II Reverse Transcriptase 
(Invitrogen) as described in section 2.2.2 and real-time PCR was conducted using 
LightCycler DNA amplification kit SYBR Green I (Roche Applied Science) 
according to the manufacturer’s instruction manual with minor modifications. Prior to 




quantification, the optimal concentrations of template, primers, and magnesium were 
determined. Each real-time PCR reaction mix was prepared to a final volume of 10 
µL, containing 0.2 µL Taq DNA polymerase, 0.5 µL of each of 10 uM primer, 1.2 µL 
of 25 mM Mg
2+
, 1.8 µL of 5× reaction mixture (dNTP mix and SYBR Green I dye), 
and 60 ng of total RNA in a well of LightCycler microplate. PCR was performed for 
40 cycles with denaturation at 95°C, anealing at 57°C (variable), and extension at 
72°C, followed by a melting curve analysis as described in the manufacturer’s 
protocol. Each run consisted of a set of 5-fold serial dilution of positive control RNA 
for construction of a standard curve. 
 
 
2.1.3.3 Whole mount in situ hybridization 
2.1.3.3.1 Synthesis of antisense probe 
2.1.3.3.1.1 Linearization of plasmid DNA by restriction endonuclease digestion 
    5 μg of plasmid DNA was linearized at the 5’ end of the cDNA insert with a proper 
restriction enzyme (RE) at 37 °C for 2 hours Completion of linearization was 
confirmed by running the digestion product on 1% agarose gel. After confirmation, 
the linearized fragment was purified by phenol: chloroform precipitation. The total 
volume of digestion mix was made up to 100 µL and equal volume of 1:1 
phenol:chloroform was added. This was followed by centrifugation at 14,000 rpm for 
5 minutes at room temperature. The top layer was transferred to a fresh tube and 
1/10th 1M Sodium acetate and 2× volume of cold absolute ethanol was added. This 
mix was incubated on ice for 30-45 minutes and centrifuged for 30-45 minutes. The 
supernatant was carefully discarded without disturbing the pellet. The pellet was 




washed with 75% ethanol and spun for 5 minutes at 14,000 rpm. The pellet was then 
resuspended in 50-100 µL of sterile water or TE buffer for further use. If necessary, 
the purified DNA might be further visualized by running on a 1% agarose gel and 
quantitated by spectrophotometry. 
 
2.1.3.3.1.2 Recovery of DNA fragments from agarose gel 
    QIAquick Gel Extraction Kit (QIAGEN) was used to recover or purify DNA 
fragments ranging from 100 bp to 10 kb from agarose gel according to manufacturer’s 
instruction. The DNA fragment could be PCR products, plasmids or DNA after RE 
digestion. Briefly, the gel slice containing the DNA band of interest was cut from the 
gel and transferred into Buffer QG (Binding Buffer) (3 mL for every g of gel slice), 
melted at 50 °C for 10 minutes and then loaded into a QIAquick spin column. The 
column was centrifuged at 14,000 rpm for 1 minute, washed by adding 0.75 mL of 
Buffer PE (Washing Buffer) and spun again. The residual Buffer PE was removed by 
spinning at 14,000 rpm for another 1 minute. 30 µL of H2O was added to the column 
and incubated at room temperature for 2 minutes. DNA fragment was eluted into a 1.5 
mL centrifuge tube by centrifugation at 14,000 rpm for 1 minute.  
 
2.1.3.3.1.3 Probe incubation and precipitation 
    1 μg of linearized DNA was used to synthesize the DIG-labeled probe. The reaction 
was performed at 37 °C for 2 hours in a total volume of 20 µL containing 2 µL of 10× 
transcription buffer, 2 µL of DIG-NTP mix (10 mM ATP, 10 mM CTP, 10 mM GTP, 
6.5 mM UTP and 3.5 mM DIG-UTP), 1 µL of RNase inhibitor (40 U/µL) (Promega) 
and 1 µL of proper RNA polymerase (50 U/µL) (Roche Applied Science). Following 




the reaction, 2 µL of RNase-free DNase I was used to digest the DNA template at 
37°C for 15 minutes. 1 µL of 0.5 M EDTA (pH 8.0) was used to stop the restriction 
digestion. Subsequently, 2.5 µL of 4 M LiCl and 75 µL of cold pure ethanol were 
added to precipitate the RNA. After washing with 75% ethanol, the RNA probe was 
resuspended in 60 µL of DEPC treated water and stored at -80 °C. 
 
2.1.3.3.2 Preparation of zebrafish embryos 
2.1.3.3.2.1 Embryo collection and fixation 
    Staged zebrafish embryos were fixed in 4% paraformaldehyde (PFA)/PBS (0.8% 
NaCl; 0.02% KCl; 0.0144% Na2HPO4; 0.024% KH2PO4, pH 7.4) for 12 to 24 hours at 
room temperature or 4 °C. Embryos younger than 16 hpf were fixed before 
dechorionization and the chorion was removed afterwards. Embryos older than 16 hpf 
were dechorionated before fixation. Older embryos with tails were hibernated on ice 
before fixation to prevent the curling of tails. After fixation, the embryos were washed 
in PBST (0.1% Tween20 in PBS) twice for 1 minute each, followed by four times for 
20 minutes each on a nutator (CLAY ADAMS® Brand, Becton Dockinson) at room 
temperature.  
 
2.1.3.3.2.2 Proteinase K treatment 
This step is especially necessary for embryos older than 14 somites (>16 hpf). 
Embryos were treated with 10 μg/mL of proteinase K in PBST at room temperature. 
The time of exposure depended upon age of embryos and the specific activity of 
proteinase K, which varied from batch to batch. For most cases, the conditions used 
are as below.  




16 - 24 hpf 5 minutes 
24 - 32 hpf 10 minutes 
32 - 48 hpf 20 minutes 
48 - 60 hpf 25 minutes 
60 - 72 hpf 30 minutes 
Older than 72 hpf 45 - 50 minutes 
To stop the reaction, the proteinase K solution was removed completely, and the 
embryos were fixed again in 4% PFA/PBS for 20 minutes at room temperature. 




    Prehybridization was performed by replacing half the volume of washing solution 
with hybridization buffer [50% formamide; 5× SSC; 50 μg/mL Heparine; 500 μg/mL 
tRNA; 0.1% Tween20, pH6.0 (adjusted by citric acid)] and incubated at room 
temperature for 1 hour. This solution was removed and replaced with hybridization 
buffer; embryos were incubated at 68 °C for 5-10 hours.  
 
2.1.3.3.3 Hybridization 
    1-2 µL of DIG-labeled probe was diluted in 200 µL of hybridization buffer. The 
probe was denatured by heating at 80°C for 5 minutes followed by 2 minutes of ice 
bath. Embryos of different stages or treatments were selected and placed in one tube 




or separate tubes depending on the experimental conditions. The original buffer was 
replaced with the denatured probe dissolved in hybridization buffer. Hybridization 
was performed at 68 °C in a circulating water bath overnight. 
 
2.1.3.3.4 Post-hybridization washes 
    On the next day, the probe was removed and replaced with pre-warmed 100% 
hybridization wash solution (hybridization buffer without tRNA and heparine) for 15 
minutes. The embryos were then washed in the following order of wash solutions, 15-
20 minutes each: 75% hybridization wash solution, 25% 2× SSCT (SSC with 0.1% 
Tween-20); 50% hybridization wash solution, 50% 2× SSCT; 25% hybridization 
wash solution, 75% 2× SSCT. This was followed by 2× SSCT wash twice for 30-45 
minutes each and 0.2× SSCT wash twice for 30-45 minutes each. Subsequently, the 
embryos were washed twice with PBST (PBS with 0.1% Tween-20) at room 
temperature for 5 minutes each. 
 
2.1.3.3.5 Antibody incubation 
2.1.3.3.5.1 Preparation of pre-absorbed DIG 
    Commercial DIG-AP antibody (Roche Applied Science) should be pre-incubated 
with biological tissues, preferably of the same origin as the sample used for 
hybridization, in order to reduce the staining background and increase signal-to-noise 
ratio. Thus, anti-DIG-AP was diluted to 1:500 in maleic acid buffer (0.15 M Maleic 
acid; 0.1 M NaCl, pH 7.5)/4% Blocking Reagent (Roche Applied Sciences) 
respectively and incubated with 50 zebrafish embryos of any stages on a nutator at 
4 °C overnight. After that, the antibody solution was transferred to a new tube and 




diluted to 1:5000 with maleic acid buffer/4% blocking reagent. 10 µL of 0.5 M EDTA 
(pH 8.0) and 5 µL of 10% sodium azide were added to prevent bacterial growth. The 
pre-absorbed antibody was stored at 4 °C and can be used for many times. 
 
2.1.3.3.5.2 Incubation with pre-absorbed antibodies 
    The embryos after hybridization and post hybridization washes were incubated in 
maleic acid buffer/4% blocking reagent for 2 hours at room temperature to block non-
specific binding sites for antibody. After removing the blocking solution, the embryos 
were incubated with preabsorbed anti-DIG-AP antibody at 4 °C overnight. 
 
2.1.3.3.6 Color development 
Embryos were washed in PBST twice for 1 minute each, and 4 times for 15-20 
minutes each on a nutator at room temperature followed by washing in buffer 9.5 
(0.1M Tris-HCl, pH9.5; 50 mM MgCl2; 10 mM NaCl and 0.1% Tween.20) once for 
30 seconds and twice for 10 minutes each. 4.5 µL of NBT (Nitroblue tetrazolium, 
Boehringer Mannheim, 50 mg/mL in 70% dimethyl formamide) and 3.5 µL of BCIP 
(5-bromo, 4-chloro, 3-indodyl phosphate salt, Boehringer Mannheim, 50 mg/mL in 
H2O) was added into 1 mL of Buffer 9.5 (100 mM NaCl; 50 mM MgCl2; 100 mM 
Tris, pH9.5 and 0.1% Tween-20) with embryos and mixed thoroughly. Embryos were 
kept in dark at room temperature for few minutes to several hours, and the progress of 
staining was monitored from time to time under a Leica MZ12 microscope (Leica). 
To stop the reaction, staining solution was removed and the embryos were washed in 
1X PBST twice for 10 minutes each. Embryos can be preserved in 4% PFA/PBS at 
4°C.  





2.1.3.3.7 Mounting and photography 
    Selected embryos were washed with PBST twice for 10 minutes each and 
transferred to 50 % glycerol in PBS solution. After incubation for at least 3 hours at 
4 °C, embryos can be preceded for imaging. A viewing chamber was made by 
stacking together 3-5 small cover glasses on both sides of a 25.4 × 76.2 mm 
microscope slide using a drop of nail polish between each. A selected embryo in a 
drop of 50% glycerol in PBS was placed on the slide between the two cover glass 
stack and orientated using a needle. Alternatively, for observation of internal organs, 
yolk could be removed from the embryo using needles prior to mounting. A 22 × 44 
mm cover glass was superimposed on the embryo, care was taken not to introduce air 
bubbles, and this could be used to adjust the orientation of embryo by gentle sliding. 
Photograph was taken using a camera mounted to an Olympus AX-70 microscope 
(Olympus) or Zeiss Axioplan 2 (Zeiss). 
 
2.1.4 Genotyping of dae heterozygous embryos and adult fish 
As dae heterozygous embryos or adults cannot be distinguished from the wildtype 
embryos or adults, genotyping has to be performed to identify the heterozygous. For 
embryos, the tails are cut from PFA (paraformaldehyde)-fixed embryos. For adult fish, 
a small triangle-shaped tail fin is cut from each anesthetized fish. The cut tissues are 
digested in genome DNA extraction buffer (1X PCR Buffer, 200 µg/mL Proteinase K) 
for 1-3 hr at 65 °C with votex occasionally. The digestion is stopped when no 
remaining tissue is observed in the eppendorf tube. The mixture was directly used as 
template for PCR reaction after incubation at 95°C for 5 min. Genomic DNA was 




amplified with the PCR primers 
GCTCTTCCCAGTTTTCCGAGCTCCAGGACAATGTGCAAATCG (forward) and  
TCCGTTCTTATCGATCCTGAG (reverse) in a 25 µL reaction volume as described 
in section 2.2.3. The PCR product was purified using QIAquick PCR purification kit 
(QIAGEN) as described in section 2.2.5. Taqa1 (NEB) was used to identify the SNP 
in dae heterozygous embryos and adults. The RE digestion was performed for 2 hr at 
65°C as described in section 2.3.3.1.1. Wildtype embryos or adults generated a band 
of 260 bp. dae mutant embryos were not digested by Taqa1 and produced a band of 
300 bp; heterozygous embryos were identified as having two bands (300 bp and 260 
bp) following electrophoresis on a 2% agarose gel as described. The residual 40 bp 
band formed by digestion of wildtype or heterozygous embryos was run off the gel. 
 
2.1.5 Histological techniques 
2.1.5.1 Cryosection 
2.1.5.1.1 Mounting of embryos in agarose 
    Prior to cryosectioning, embryos were fixed in 4% PFA/PBS at room temperature 
overnight and embedded in a desired orientation in 1.5% Bacto-Agar medium 
containing 5% sucrose in a detached eppendorf tube cap. The agarose block was then 
trimmed such that a flat base and slanting top was achieved for proper positioning. 









    A layer of tissue freezing medium (Reichert-Jung, Germany) was frozen on the 
surface of the prechilled tissue holder. The agarose block was placed on top of the 
tissue holder and coated with one drop of tissue freezing medium. It was frozen in 
liquid nitrogen until the block has solidified completely. The frozen blocks were 
equilibrated in the cryostat chamber (Leica CM1900, Leica) at -28°C for at least 30 
minutes prior to sectioning. Sections (10-15 μm thickness) were made and placed onto 
a poly-L-lysine coated microscope slide (Menzel-Glaser). Slides were dried on a 
38 °C hot plate for a few hours. Sections were subsequently fixed in 4% PFA/PBS for 
30 minutes, washed gently with PBS 3 times for 15 minutes each. Sections were 
embedded with 50% glycerol in PBS solution and covered with cover glass for 
photography. 
 
2.1.5.2 Paraffin section 
2.1.5.2.1 Embedding 
    Embryos were fixed in 4% PFA/PBS at room temperature overnight and washed in 
PBS several times. The embryos were subsequently dehydrated in ethanol of 
gradually increased concentration, and transferred to Histoclear (National Diagnostics) 
for clearing. The embryos were then embedded in paraffin in desired position. 
 
2.1.5.2.2 Section 
Sectioning (5 um in thickness) was performed on microtome (Leica). Each embryo 
was cross-sectioned from head to tail. Sections were collected on poly-L-lysine coated 
microscope slide (Menzel-Glaser) and allowed to dry on a hot plate at 37 °C overnight.  





2.1.5.3 Haematoxylin and Eosin staining 
    Sectioned samples were stained with Haematoxylin and Eosin for viewing tissue 
structures. Paraffin embedded tissue sections were deparaffinized and rehydrated by 
immersing the slides sequentially in Histoclear, ethanol of decreasing concentrations 
and water.  The slides were then subjected to Ehrlich’s Acid Haematoxylin (Sigma) 
for 30 minutes, followed by a brief rinse in Acid Alcohol (1 % HCl in 70 % ethanol).  
The slides were washed in running tap water until the desired color was fully 
developed. This is followed by washing in distilled water for 3 minutes and 
sequentially immersing in increasing concentrations of ethanol for 3 minutes each 
starting from 50%. After dehydration in 90 % ethanol, the slides were subjected to 
Eosin (1 % Eosin dissolved in 90 % ethanol) staining for 3 minutes, and proceeded 
back to 90 % ethanol for 3 minutes to wash out excess staining. The slides were then 
immersed in 100 % ethanol twice for 10 minutes each to ensure that the sections are 
completely dehydrated before treating with fresh Histoclear twice for 10 minutes each. 
After incubation in Histoclear, the slides were mounted in DPX (Sigma) and viewed 
and subjected to photography with Zeiss Axioplan 2 (Zeiss). 
 
2.1.6 Immunofluorescent staining 
2.1.6.1 Proliferation assay 
    We used PCNA antibody to label proliferating cells in the swimbladder. PCNA is a 
processivity factor for DNA polymerase δ in eukaryotic cells. The protein is 
exclusively expressed in the nuclei of cells during the DNA synthesis phase of the cell 




cycle (Leonardi et al., 1992); therefore, it has been commonly used as a marker for 
cell proliferation. 
 
2.1.6.1.1 Primary antibody incubation 
Sections were deparaffinized and hydrated by immersing the slides sequentially in 
Histoclear, ethanol of decreasing concentrations and water.  Slides were brought to 
boil in 10 mM sodium citrate buffer (pH 6.0) then maintained at a sub-boiling 
temperature for 10 min to unmask antigen. The slides were allowed to cool on bench 
for 30 min before further processing. Slides were equilibrated in PBST. To block non-
specific sites, slides were incubated in 5% goat serum/PBST for 2 hours at room 
temperature. The embryos were then incubated with 1:200 dilution of PCNA antibody 
(Santa Cruz Biotechnology) in 5% goat serum/PBST at 4 °C overnight.  
 
2.1.6.1.2 Secondary antibody incubation 
    After removing the primary antibody, embryos were washed in PBST briefly for 2 
times and additional 4 times for 30 minutes each. The embryos were then incubated 
with Alexa Fluor 488 F(ab')2 fragment of goat anti-mouse IgG or Alexa Fluor 594 
F(ab')2 fragment of goat anti-mouse IgG (Invitrogen) secondary antibodies (1:500) for 
2-3 hours at room temperature (avoiding light). Nuclei were counter-stained with 









To detect the signal of secondary antibody labeled with fluorescent Alexa Fluor dye, 
the embryos were monitored under a fluorescence dissection microscope. Alexa Fluor 
488 was observed under a blue filter (450-490 nm), and Alexa Fluor 594 was 
observed under a yellow filter (546 nm). To stop the reaction, embryos were washed 
in PBST for 3-4 times 10 minutes each and then mounted in 50% glycerol/PBS. 
Number of total cells and PCNA positive cells were counted in each sections of the 
swimbladder under a Zeiss Axioplan 2 microscope (Zeiss). Imagings were taken using 
a confocal microscope (Zeiss LSM510, Zeiss). Raw image collection and processing 
were performed using the LSM510 software (Zeiss). Combined images were made on 
Adobe® Photoshop CS4.  
 
 
2.1.6.2 TUNEL assay 
    Cleavage of genomic DNA during apoptosis may yield double-stranded, low 
molecular weight DNA fragments as well as single strand breaks in high molecular 
weight DNA. Those DNA strand breaks can be identified by labeling free 3’-OH 
termini with modified nucleotides. Terminal deoxynucleotidyl transferase (TdT) 
catalyzes polymerization of labeled nucleotides in a template-independent manner. 









2.1.6.2.1 Preparation of tissue sections 
Tissue sections were deparaffinized and hydrated by immersing the slides 
sequentially in Histoclear, ethanol of decreasing concentrations and water.  Slides 
were brought to boil in 10 mM sodium citrate buffer (pH 6.0) then maintained at a 
sub-boiling temperature for 10 minutes to unmask antigen. The slides were allowed to 
cool on bench for 30 minutes before further processing. Slides were then equilibrated 
in PBST twice. The slides were immersed in 0.1 M Tris-HCl  buffer (pH 7.5), 
containing 3% BSA (bovine serum albumin) and 20% normal bovine serum at room 
temperature for 30 minutes. Slides were subsequently rinsed in PBST twice. Positive 
control section can be obtained by DNase I recombinant incubation for 10 minutes at 
room temperature to induce DNA strand breaks. 
 
2.1.6.2.2 Labeling of tissue sections 
    Immediately before use, prepare the TUNEL reaction mixture by mixing Enzyme 
Solution (Terminal deoxynucleotidyl transferase in storage buffer, 10× concentration) 
and Label Solution (Nucleotide mixture in reaction buffer, 1× concentration) in a 1:9 
ratio. 50 µL of the reaction mixture was added to each section, and the sections were 
incubated for 60 minutes at 37 °C in a humidified atmosphere in the dark. The slides 
were rinsed in PBST three times for 5 minutes each to stop the reaction. Nuclei were 
counter-stained with Hoechst 33258 pentahydrate (bis-benzimide) (Invitrogen). The 








2.1.7 Functional analyses 
2.1.7.1 Anti-sense morpholino design 
Anti-sense oligos or morpholinos have become an attractive method to specifically 
block gene function (Nasevicius and Ekker, 2000; Summerton and Weller 1997). 
Morpholino oligos are short chains of Morpholino subunits comprised of a nucleic 
acid base, a morpholine ring and a non-ionic phosphorodiamidate intersubunit 
linkage. Morpholinos act via a steric block mechanism (RNAse H-independent) and 
with their high mRNA binding affinity and exquisite specificity they yield reliable 
and predictable results. Design of an efficient antisense Morpholino requires careful 
consideration of several criteria as follows.  
1) Select a target sequence in the post-spliced mRNA in the region from the 5' cap 
to 25 bases 3' to the AUG translational start site. 
2) It is important to ensure that the selected sequence has little or no self-
complementarity. Preferably the selected Morpholino oligo should form no more than 
4 contiguous intrastrand base pairs. In some cases, 4 contiguous base-pairs can be 
detrimental to achieving good antisense inhibition if the resulting pairing is between 
all G and C residues. 
3) The antisense oligonucleotide may show reduced water solubility if it contains 
more than 7 total guanines or more than 3 contiguous guanines in a 25-mer oligo. 
4) 25-mers (the longest commercially available) are recommended for most 
applications. This is because efficacy increases substantially with increasing length 
and because long oligos best assure access to a single-stranded region in the target 
RNA, as is required for nucleation of pairing by the oligo. 




5) In terms of composition and sequence motifs, an optimal splice-blocking oligo 
has the same properties described above for a translation-blocking oligo. However, 
splice-blocking oligos have additional target-specific requirements, the most 
important of which is a defined pre-mRNA sequence with a minimum of 3 exons and 
explicitly known exon-intron and intron-exon boundaries. 
    Morpholinos (MOs) were resuspended from lyophilized powder and then diluted to 
1 mM stock in 1× Danieau’s solution. The MOs were diluted to the appropriate 
concentration before they were injected into embryos. 
 





Sequence Targeted region 
Fgf10a Spl-MO 5’ GAAAATGATGCTCACCGCCCCGTAG 3’ Exon 2-Intron 2 
Fgf10b ATG-MO 5’ TCATGGGACATGCTGCTCAACCAAT 3’ 5’ UTR 




The samples for injection were prepared to different concentrations in respective 
buffers. Morpholino antisense RNAs were prepared in 1× Danieau solution (58 mM 
NaCl; 0.7 mM KCl; 0.4 mM MgSO4; 0.6 mM Ca(NO3)2; 5.0 mM pH 7.6 HEPES). 
Sense RNAs were prepared in sterile filtered water to required concentrations. The 
needles used for the microinjection were prepared using optimized conditions of heat 
and pull time for different purposes using the Sutter Micropipette puller P-97 (Sutter 
Instruments Co.). The conditions for normal injections into 1-2 cell embryos used 
were Pressure-500, heat-500/550, pull-150/150, velocity-100/100 and time-150/150. 




Antisense oligos were injected into the cytoplasm of 1-2 cell stage zebrafish embryos 
using FemtoJet® (Eppendorf) by placing the embryos under a dissection microscope 
(Olympus SZX12). Each embryo received a specific volume of the samples 
depending on the concentration of the sample. The injected embryos were reared in 
egg water at 28 °C. 
 
2.1.7.3 SU5402 treatment 
    Embryos were grown in embryo medium and kept in 28 °C until initiation of 
treatment. Before treatment, chorions were partly torn using needles, and 10-15 
embryos were placed in a well of 6-well cell culture plate with 5 mL embryo medium. 
A 10mM stock of SU5402 was prepared in DMSO (dimethyl sulfoxide) and diluted to 
1 μM in embryo medium. Embryos were kept in dark for the entire treatment, and 
embryo medium with SU5402 was changed every day. Two groups of controls were 
set up, one group was reared in embryo medium containing matching amount of 
DMSO (final concentration was 0.1%), and another group was reared in embryo 
medium only. The two groups of control did not show any difference in morphology 
or behavior, eliminating the possibilities of DMSO toxicity in treated groups. 
  




2.1 Results  
2.1.1 Role of fibroblast growth factor pathway in swimbladder development 
2.1.1.1 Fibroblast growth factor receptor expression 
In our previous study, fgf10a has been found to express in the swimbladder 
mesenchyme from 48 hpf (Winata et al., 2009). Fgf receptors (Fgfr) are required to 
transduce Fgf signal to downstream responding molecules. There are four members in 
the zebrafish Fgfr family, namely fgfr1-4. The early expression patterns of these genes 
have been characterized during zebrafish embryogenesis (Sleptsova-Friedrich et al., 
2001; Thisse et al., 1995; Tonou-Fujimori et al., 2002), but there is no information 
whether any of these genes is expressed in the swimbladder. We generated probes for 
these four genes and examined their expression in the swimbladder. We found that 
only fgfr2 was expressed in the swimbladder. Fgfr2 mRNA was detected in the 
swimbladder as early as 48 hpf, and maintained up to 72 hpf (Fig.2-2C, E). Cross 
section further confirmed that the expression was uniformly in the epithelium layer 











Figure 2-2. Expression of fgfr2 during embryonic development. (A-C) Fgfr2 
expression in the gut at 36 hpf. Cross section shows fgfr2 expression in the gut 
endoderm at 36 hpf. (D-F) Fgfr2 expression in the gut and swimbladder at 48 hpf. 
Cross section shows fgfr2 expression in both the gut epithelium and mesenchyme at 
48 hpf. (G) Fgfr2 expression in the pneumatic duct, the posterior chamber and the 
anterior chamber primordium of the swimbladder at 72 hpf, as well as in the gut. 
Cross sections shows fgfr2 is expressed in the swimbladder epithelium and gut 
mesenchyme at 72 hpf. Additional domains of expression were observed in the 
spinal cord, the dorsal aorta and mesoderm of the gut. Red arrow indicates the 
position of the swimbladder primordium. B, E and H are cross sections of the 
embryos in A, D and G at the position of black line, respectively. C, F, I are the 
enlarged view of the square box in B, E and H. Abbreviations: d, dorsal aorta; e, gut 
endoderm; g, gut; s, spinal cord; sb, swimbladder. Scale bars: 250 µm in whole 
mount, 200 µm in B, E, H, and 50 µm in C, F, I. 
 
  




We also examined fgfr2 expression in the alimentary tract at different 
developmental stages. At 36 hpf, fgfr2 was expressed in the gut endoderm (Fig. 2-2A-
C), which is consistent with the earlier report on fgfr2 expression at 24 hpf (Tonou-
Fujimori et al., 2002). However, at 48 hpf, fgfr2 was expressed in both epithelium and 
mesenchyme of the gut (Fig.2-2D). Particularly, fgfr2 was only expressed in the 
proximal side of the gut epithelium, indicating polarization of epithelial cells. In 
contrast to the epithelial expression of fgfr2 in the swimbladder, fgfr2 was strongly 
expressed in the outer layer of the developing gut at 72 hpf, which is the mesenchyme 
layer (Fig.2-2F). We further examined the expression of fgfr2 in the alimentary tract 
on series of cross sections along the anterior-posterior axis. In the pharynx, fgfr2 was 
expressed in the mesenchyme (Fig. 2-3B). At the position where the pneumatic duct is 
connected to the esophagus, both the pneumatic duct and the esophagus express fgfr2 
in the mesenchyme (Fig. 2-3C). As the pneumatic duct elongates posteriorly, a 
transition of fgfr2 expression domain from the mesenchyme to the epithelium 
occurred (Fig. 2-3D). At the very posterior end of the pneumatic directly connecting 
to the posterior chamber of the swimbladder, the fgfr2 expression domain was 
restricted to the epithelium (Fig. 2-3E, F). However, in the gut,  fgfr2 expression was 
constantly observed in mesenchyme (Fig. 2-3D-F).  
 













Figure 2-3. Expression of fgfr2 in wildtype embryos at 72 hpf. fgfr2 is expressed 
along the alimentary tract and in the swimbladder. As shown in cross sections, fgfr2 
is expressed in the mesenchyme of the pharynx (B), esophagus (C) and gut (D, E, F), 
while in the swimbladder, fgfr2 is expressed in the epithelial layer, including the 
posterior part of the pneumatic duct, the anterior and posterior chambers. Black 
lines in A indicate the position of cross sections in B, D, F, H and J. C, E, G, I, K are the 
enlarged view of the square box in B, D, F, H, J. Dotted red circles indicated the outer 
boundary of pharynx, esophagus, pneumatic duct, swimbladder or gut in different 
panels. and yellow circles indicated epithelium. Abbreviations: p, pharynx; pd, 
pneumatic duct; e, esophagus; g, gut; ac, primordium of anterior chamber; sb, 
swimbladder. Scale bars: 250 µm in whole mount, 200 µm in B, D, F, H, J, and 100 µm 
in C, E, G, I, K. 
 
  




2.2.1.2 Effect of Fgf10a signal disruption on swimbladder development 
2.2.1.2.1 Lack of swimbladder phenotype in fgf10a mutants and morphants 
As fgf10a has been found to express in swimbladder mesenchyme, which is similar 
to its mesenchymal expression in lung (Bellusci et al., 1997b), it is of interest to 
further characterize its function in swimbladder development. We examined the 
phenotype of zebrafish fgf10a null mutant, dae (Norton et al., 2005). The mutants 
show no apparent defects except that their pectrol fins are severely truncated, which is 
used to distinguish the mutant embryos at 3 dpf.  
    Contrary to our expectation, the phenotype of the swimbladder at 3 dpf appeared to 
be normal. All our markers, including annxA5 (mesothelium), fgf10a (mesenchyme), 
acta2 (smooth muscle), hb9 (epithelium), were expressed normally in dae mutants 
(Fig. 2-4B, E, G, J). Particularly, the presence of acta2 expression revealed normal 
smooth muscle differentiation. The expression of fgfr2 indicated that the expression of 
fgfr2 in developing swimbladder of dae mutants but the expression level was lower 
than that in the wildtype embryos, suggesting that fgf10a may have a positive 
feedback effect on fgfr2 expression level (Fig. 2-4L, M). These results were further 
confirmed using morpholino knockdown as previously described (Norton et al., 2005) 
(Fig. 2-4C, H, K). Morphants with severely truncated pectrol fins were selected for in 
situ hybridization analysis.  The presence and proper organization of hb9, acta2 and 
annxa5 expression domain showed the normal specification and differentiation of the 
three layers in the swimbladder. Furthermore, histology on 5 dpf mutants showed that 























Figure 2-4. Phenotype of fgf10a mutants and morphants. (A, D, F, I) Expression 
pattern of annxA5, fgf10a, acta2, hb9 in swimbladder of wildtype (WT) embryos at 3 
dpf. (B, E, G, J) Expression of annxA5 in mesothelium (B), fgf10a (E) and acta2 (G) in 
mesenchyme and hb9 in epithelium (J) is normal and organized in swimbladder of 
dae mutants, indicating that the swimbladder has no obvious morphological defect 
in dae mutants. (C, H, K) Normal expression of annxA5 (C), acta2 (H), and hb9 (K) in 
swimbladder of fgf10a morphants injected with 4-8 ng of fgf10a splice blocking 
morpholino confirms results from dae mutants. (L-N) Fgfr2 expression in 
swimbladder of dae mutants (M) and fgf10a morphants (N) is normal compared with 
that in swimbladder of wildtype embryos (L). (O, P) Cross section and H&E staining of 
swimbladder at 5 dpf. (O) Swimbladder is histologically normal in dae mutant at 5 
dpf. Mesothelium and epithelium layers are complete, and smooth muscle is 
morphologically normal. (P) Normally inflated swimbladder in dae siblings at 5 dpf. 








2.2.1.2.2 Decreased epithelial proliferation in the swimbladder of dae mutants 
    To decipher the function of fgf10a in swimbladder development, we examined the 
proliferation profile along the anterior –posterior axis of swimbladder in dae 
homozygous mutant and heterozygous sibling embryos, as well as in wildtype 
embryos. 
Firstly, we determined that there was no difference between the proliferation 
profiles of dae heterozygous embryos and wildtype siblings (Fig. 2-5). In the 
swimbladder of heterozygous embryos at 60 hpf, the percentage of proliferating cells 
at the anterior part of epithelial layer was slightly lower than 50%. The percentage 
increased rapidly towards the posterior part of the swimbladder, and at the very 
posterior end of the swimbladder, the percentage of proliferating cells was as high as 
75%. At the same time, the mesoderm including the mesenchymal and mesothelial 
layers had less proliferating cells. The percentage of proliferating cells in the anterior 
part of mesenchyme and mesothelium was only around 30%, and it gradually 
increases to 45% at the posterior end of the swimbladder.  
At this stage, the percentage of proliferating epithelial cells was higher than that of 
the mesenchyme and mesothelium, which might represent the needs of rapid epithelial 
growth prior to swimbladder inflation. Along the anterior-posterior axis, the 
proliferation showed a constant increasing trend for all the three tissue layers, 
correlating with the observation that the swimbladder extends posteriorly and expands 
laterally during development. 
 
  









Figure 2-5. Proliferation profiles of the swimbladder tissue layers in wildtype and 
dae heterozygous embryos at 60 hpf. Swimbladder sections were processed for 
immunocytochemistry using an anti-PCNA antibody. Labelled epithelial and 
mesodermal cells were counted and compared to the total number of epithelial and 
mesodermal cells in the same section. Vertical axis represents the percentage of 
proliferating cells in the respective tissue layers. Mesenchymal and mesothelial 
layers are considered together as the mesoderm. Horizontal axis shows the relative 
positions from the anterior end to the posterior end of the swimbladder with each 
data point representing one tissue section. 
  









Figure 2-6. Immunofluoresence staining of proliferating cells in dae heterozygous 
siblings and homozygous mutants at 60 hpf. (A-C) Proliferating cells in dae 
heterozygous sibling embryos. (D-F) Proliferating cells in dae homozygous mutant 
embryos. Proliferation is severely decreased in the swimbladder of the dae 
homozygous mutant embryos. PCNA antibody (red) specifically marks the 
proliferating cells (A, D), while Hoechst (blue) labels all nucleus in the tissue section 













Figure 2-7. Proliferation profiles of the swimbladder tissue layers in dae 
heterozygous and homozygous embryos at 60 hpf. Swimbladder sections were 
processed for immunocytochemistry using an anti-PCNA antibody. Labelled epithelial 
and mesodermal cells were counted and compared to the total number of epithelial 
and mesodermal cells in the same section. Vertical axis represents the percentage of 
proliferating cells  inthe respective tissue layers. Mesenchymal and mesothelial 
layers are considered together as the mesoderm. Horizontal axis shows the relative 
positions from the anterior end to the posterior end of the swimbladder with each 
data point representing one tissue section. The length of swimbladder in dae 
homozygous embryo is shorter than dae heterozygous, therefore there are less data 
points for homozygous embryos. 
 
  





In the swimbladder of dae homozygous mutants, the percentage of proliferating 
epithelial cells was dramatically decreased (Fig. 2-6 and Fig. 2-7). The percentage of 
proliferating cells was reduced to 30% in the anterior part, and the percentage for the 
entire epithelium was never higher than 40%. More significantly, we observed that the 
percentage of proliferating cells declined for 73% at the posterior end of the 
swimbladder. On the contrary, the proliferation of mesenchyme and mesothelium was 
largely unaffected, and proliferation reduction was observed only in the last several 
sections. As a result of decreased proliferation in the dae homozygous mutant, the 
length of the swimbladder was 22.4% shorter (average of three embryos) comparing 
to that in the heterozygous embryos, and the diameter of epithelial layer was 18.5% 
smaller.  
We also examined the apoptosis profile in dae homozygous mutant and 
heterozygous sibling embryos. At 60 hpf, there was no apoptosis in the swimbladder 
of dae homozygous mutant or heterozygous siblings (figure not shown), indicating 









2.2.1.2.3 Summary of fgf10a function in swimbladder development 
    We showed that in the dae mutants, all molecular markers for different layers were 
normally expressed. However, as previously reported (Norton et al., 2005), the mutant 
embryos failed to inflate their swimbladders.  
    As the inflation of swimbladder is controlled by the autonomic nervous system 
targeting muscle and blood vessels, the failure to inflate swimbladder in dae mutant 
could be caused by failure of smooth muscle maturation, vasculogenesis, and/or 
innervations. However, it is also possible that failure to inflate swimbladder in dae 
mutants is due to severe defect of pectrol fins, as it has been demonstrated that 
swimbladder inflation in zebrafish larvae can be prevented by blocking them to reach 
to the water surface (Goolish and Okutake, 1999). Consistent with this, we observed 
that dae mutants spent most time at the bottom of the petri dish although they could 
rush to the water surface and stay for about one second upon stimulation. This 
possibility was further supported by the observation that around 13% (20/159) of the 
dae mutants can inflate their swimbladder at 8 dpf (Fig. 2-8), implying that the failure 
to inflate swimbladder in dae mutants is not due to any developmental defects caused 
by disruption of fgf10a signal. The delay of swimbladder inflation in dae mutants 
might also be caused by the severely reduced epithelial proliferation, thus the larvae 
needed a longer time before their swimbladder epithelium reach to an inflation size.  
    In summary, although fgf10a is not required for the swimbladder budding, growth 
and differentiation, it functions in the swimbladder as a mitogen in a paracrine manner 














Figure 2-8. Different swimbladder inflation conditions in dae mutants at 8 dpf. (A) 
Normally inflated swimbladder in all wildtype larvae. (B-D) Different inflation status 
of the swimbladder in dae mutants. The swimbladders in dae mutants can be fully 
inflated (13%, 20/159) (B), partially inflated (1%, 2/159) (C) or completely non-
inflated (86%, 137/159) (D). Red arrows point the swimbladders. Blue arrows 
indicate the normal pectrol fins in wildtype larvae, which are severely truncated in 
dae mutants. Scale bars: 1 mm. 
 
  




2.2.1.3 Disruption of swimbladder development by Fgf signal inhibition by 
SU5402 
    To further investigate the requirement for Fgf signal in zebrafish swimbladder 
development, we exposed developing embryos to SU5402 starting at different 
developmental time points and assessed whether such exposure inhibited the 
formation of swimbladder. 
    The reagent SU5402 has been shown to bind to and inhibit signaling via Fgfr1, but 
its exact specificity relative to other Fgf receptors remains untested (Mohammadi et 
al., 1997). As SU5402 blocks Fgfr1 activity by binding to a region that is conserved in 
all four Fgfrs (Johnson and Williams, 1993), it has been suggested that the reagent 
likely inhibits all Fgf receptors (Furthauer et al., 2001). Despite this broad specificity, 
SU5402 represents a useful means of assessing requirements for Fgf signaling in 
developmental processes. Not only can it be applied late in development leaving early 
Fgf-dependent processes unperturbed, but also it can potentially uncover Fgf 
requirements that might not be revealed by knocking down specific Fgf ligands or 
receptors because of functional redundancy. 
     The dosage effect of SU5402 was determined by treating ET3 embryos starting 
from 10 hpf to 3 dpf. A concentration of 1 µM was chosen because it was the lowest 
concentration sufficient to inhibit swimbladder development as judged by missing of 
EGFP expression in the swimbladder and to allow embryos to survive to 3 dpf with 
very mild general toxicity defects. 
 
  




2.2.1.3.1 Requirement of Fgf signal for epithelium specification 
We investigated the effects of temporal Fgf signal inhibition on swimbladder 
development. Using hb9 as a marker for epithelium, Fgf inhibition starting before 13 
hpf resulted in the absence of epithelium (Fig. 2-9B). Treatment starting from 15 hpf 
or later did not block the specification of epithelium, but the size of swimbladder 
epithelium was significantly reduced (Fig. 2-9C, D).  
 
 
Figure 2-9. Effect of inhibition of Fgf signaling on swimbladder epithelium and 
mesenchyme. (A-D) Expression of hb9 in the swimbladder epithelium treated with 
SU5402 starting at 13 hpf (B), 15 hpf (C) and 19 hpf (D). Adding SU5402 at 13 hpf 
completely disrupt epithelium formation, while adding SU5402 at 15 hpf and 
afterwards allows swimbladder epithelium development, and treatment starting 
later results larger epithelium. (E-H) Expression of fgf10a in the swimbladder 
mesenchyme treated with SU5402 starting at 11 hpf (F), 13 hpf (G) and 17 hpf (H). 
Inhibition of fgf signal from 11 hpf destroys mesenchyme formation, and inhibiton 
starting from 13 hpf allows formation of an underdeveloped mesenchyme, while a 
mesenchyme with normal pocket-shape can be formed in embryos treated starting 
from 17 hpf. All the embryos were fixed at 3 dpf. All pictures are in lateral view, 
except F is in ventral view. Scale bars: 250 µm. 
 
  




2.2.1.3.2 Requirement of Fgf signal for mesenchyme specification and 
differentiation 
Adding SU5402 to embryos starting from 11 hpf resulted in the absence of 
mesenchymal fgf10a expression (Fig. 2-9F), while treatment starting from 13 hpf did 
not inhibit fgf10a expression, but the size of mesenchyme was reduced (Fig. 2-9G). 
Furthermore, the pocket-like shape of fgf10a expression domain can only be observed 
in embryos treated starting from 17 hpf (Fig. 2-9H). Moreover, treatment starting as 
late as 25 hpf inhibited differentiation of mesenchyme to smooth muscle, as acta2 
expression was absent (data not shown).  
 
2.2.1.3.3 Requirement of Fgf signal for mesothelium organization 
Different from epithelial and mesenchymal layers, only organization but not 
specification of outer mesothelium layer was disrupted by Fgf signal inhibition. 
WISH of annxA5 on treated embryos showed clusters of disorganized positive-stained 
cells around the location of swimbladder, and these cells were usually located 
bilaterally across the midline (Fig. 2-10A, B). There was a trend that these cells were 
increasingly large and organized as the treatment start point delayed (Fig. 2-10C-F). 
In embryos treated from 25 hpf, the outer mesothelium cells were already migrated to 
form a roughly round shape but still lacked the proper spherical organization at 3 dpf 
(Fig. 2-10H). 
 





Figure 2-10. Effect of inhibition of Fgf signaling on swimbladder mesothelium. 
Expression of annxa5 in the swimbladder mesothelium treated with SU5402 starting 
at 11 hpf (A), 13 hpf (B), 15 hpf (C), 17 hpf (D), 19 hpf (E), 21 hpf (F), and 25 hpf (G). 
WISH of annxA5 on SU5402-treated 3 dpf embryos shows that disorganized 
mesothelial cells. The starting stages (hpf) of SU5402 treatment are indicated in each 
panel. A-D, G, dorsal view; E, F, H, ventral view with yolk removed. Scale bars: 250 
µm. 
 
2.2.1.3.4 Summary of early Fgf signal requirement in swimbladder 
development 
Our data suggest that Fgf signal is required for the specification of swimbladder 
primodium, and it seems that the specification of mesenchyme is earlier than that of 
epithelium. Furthermore, proper Fgf signal is important for smooth muscle 
differentiation, and the commitment of mesenchymal cells to smooth muscle cell fate 
happens after 25 hpf. Interestingly, the specification of mesothelium is unaffected by 
Fgf signal disruption, but the organization and movement is severely affected, which 
suggests that the specification of mesothelial cells is regulated by a distinct signal and 
independent of swimbladder development, while the subsequent organization and 
movement needs proper guidance from the epithelial and mesenchymal layers. 
 
  




2.2.1.4 Screening for redundant Fgf ligand in swimbladder development 
    SU5402 treatment revealed a critical role of Fgf signal in swimbladder 
development, but analysis of dae mutants shows that fgf10a deficiency does not have 
significant effect on swimbladder, which raised the possibility of the presence of 
redundant Fgf signal during swimbladder development. As there is no information on 
any other Fgf ligands expressing in the swimbladder, we conducted a screening to 
identify the candidate. The Fgf family contains at least 27 members in the zebrafish 
(Itoh and Konishi, 2007) and more than 10 members have not yet been characterized.  
18 members of the zebrafish Fgf family were cloned and examined for their 
expression at various developmental stages (4-15 somites, 36 hpf, 48 hpf, and 3 dpf), 
and none of them showed expression in the swimbladder (Table 2-2). But several 
genes were expressed in the adjacent regions of the future swimbladder. For example, 
fgf7 and fgf14 are expressed in the notochord, and fgf17 and fgf18a are expressed in 
the somites (Fig. 2-11). These results may suggest that there might be two stages of 
Fgf signal requirement during swimbladder development: early Fgf signal during 
segmentation stage is required for swimbladder specification and fgf10a functions 
during swimbladder growth to promote proliferation. 
  








4-15 somites 36 hpf 48 hpf 3 dpf 3 dpf dae 
fgf1 negative negative Retina retina retina 
(Songhet et al., 2007; 
Thisse and Thisse, 2004) 

















(Yamauchi et al., 2009) 
fgf5* negative negative Brain brain brain  
fgf6a notochord negative negative negative negative 
(Thisse and Thisse, 
2005) 
fgf7* notochord negative negative negative negative  
fgf8a brain, somites brain, eye, etc.  brain, pectrol fin bud Brain brain 
(Lun and Brand, 1998; 
Thisse and Thisse, 2004) 
fgf10b* whole organism whole organism 
liver, pancreas, gut, 
brain 
liver, pancreas, gut, 
brain 
liver, pancreas, gut, 
brain 
 
fgf13 brain brain, spinal cord brain, spinal cord Brain brain  
(Thisse and Thisse, 
2004) 
fgf14* anterior notochord negative negative Brain brain  
fgf16 otic vesicle pectrol fin bud negative negative  negative (Nomura et al., 2006) 
fgf17 somites heart, myotome pharyngeal arch Brain brain 
(Thisse and Thisse, 
2004) 












whole organism  whole organism 
(Jovelin et al., 2010) 
fgf20a negative Negative negative negative negative (Bouzaffour et al., 2009) 




fgf20b brain mesoderm Negative negative negative negative  
fgf22*  negative Negative Brain whole organsism whole organism  
fgf24  mesoderm pectrol fin bud 
 pectrol fin bud, 
pancreas 
 pectrol fin  pectrol fin 
(Thisse and Thisse, 
2005) 
*Genes only been studied in this thesis.









Figure 2-11. Expression of Fgf ligands during segmentation stage. (A) Fgf7 
expression in the notochord. (B) Weak fgf14 expression in the anterior notochord 
(region between the two red arrows). (C) Fgf17 expression in the somites and pre-









2.2.1.5 Crosstalk between Fgf and Hedgehog signaling  
Previously we have demonstrated that the Hedgehog signaling is required for 
zebrafish swimbladder development (Winata et al., 2009). To uncover the potential 
crosstalk between Fgf and Hedgehog signaling, we examined fgfr2 expression in 
mutants or morphants of Hedgehog signaling. In both syu mutant and ihha morphant 
embryos, fgfr2 mRNA was present in both the swimbladder and the gut (Fig. 2-12A, 
B). However, the expression in the swimbladder was severely reduced compared to 
wildtype embryos at 72 hpf (Fig. 2-12D). In smu mutants, in which the Hh signal is 
completely disrupted, the fgfr2 expression was absent in the swimbladder as well as in 
the gut (Fig. 2-12C). This is in consistent with the fact that the epithelium layer is 
absent in smu mutants (Winata et al., 2009). 
 
 
Figure 2-12. Expression of fgfr2 in the swimbladder in syu, ihha morphants, smu, 
and wildtype backgrounds at 3 dpf. (A, B) Reduced expression of fgfr2 in syu 
mutants (A) and ihha morphants (B), respectively. (C) Absent expression of fgfr2 in 
the swimbladder and the gut in smu mutants. (D) Expression of fgfr2 in the 
swimbladder and the gut in wildype embryos. All embryos are in lateral view. 
Swimbladder is indicated by red dashed-line circles and red arrows. Numbers are 
used to mark the position of somite 1-5. Scale bars: 100 µm. 





2.2.2 Expression and function of Fgf regulators in swimbladder development 
2.2.2.1 Screening for signaling molecules expressing in the swimbladder 
During lung morphogenesis, Fgf signal is under tight special restriction to create 
the distinct pattern of branching buds. We would like to explore the expression and 
potential function of these regulatory genes during swimbladder development. A 
panel of candidature genes involved in lung morphogenesis was screened for 
expression in swimbladder development (Table 2-3). Nkx2.1 was selected as it is the 
earliest marker for lung specification. Besides, we focused on genes which are 
negative regulators of Fgf10 in lung development.  
Table 2-3 Genes screened for expression in the zebrafish swimbladder and the 
function of their mammalian homologs in lung development 
Gene(s) Function in lung References 
nkx2.1 
Separation of trachea from 
esophagus, epithelial differentiation   
(Kimura et al., 1996; Minoo et 
al., 1999) 
spry2 
Direct antagonization Fgf10 signal 
by inhibiting activation of Ras 
(Kim and Bar-Sagi, 2004; 
Mailleux et al., 2001) 
bmp4 
Inhibition of Fgf10–induced distal 
proliferation 
(Weaver et al., 2000) 
tgfb1/2/3 Inhibition of Fgf10 expression 
(Alejandre-Alcazar et al., 2008; 
Liu et al., 2000) 
wnt2 Not clear 









2.2.2.1.1 Lack of expression in developing swimbladder for nkx2.1, spry2 and 
tgf1/2/3 
It turned out that nkx2.1, spry2 and tgf1/2/3 were not expressed in developing 
swimbladder. The observation is basically in accordance with our hypothesis that 
difference of gene expression pattern, especially those involved in lung branching 
morphogenesis, is likely one of the reasons that contribute to the morphological and 
functional differences between the swimbladder and the lung. 
 
2.2.2.1.2 Bmp4 expression during swimbladder development 
   Bmp4 expression was detected in the swimbladder as early as 38 hpf (Fig. 2-13A), 
and the expression is persistent to at least 72 hpf (Fig. 2-13B-D). Cross section at 72 
hpf showed that bmp4 is expressed in the mesothelium layer (Fig. 2-13E-G). The 
expression pattern of bmp4 indicated that it may be an even earlier marker for 
developing mesothelium than elovl1a as previously identified (Yin et al., 2011). 
During lung development, Bmp4 expression is first in the ventral mesenchyme of the 
primordial lung buds, and later in the distal endoderm of developing secondary lung 
buds (Minoo et al., 1999; Weaver et al., 2000). This nonconserved expression domain 
between zebrafish swimbladder and mammalian lung indicates that the regulation and 
function of Bmp4 signaling might also be different.   
  








Figure 2-13. Expression of bmp4 in developing swimbladder. (A-D) Expression of 
bmp4 in the swimbladder at 38 hpf (A), 48 hpf (B), 65 hpf (C), and 72 hpf (D). Bmp4 
expression can be detected in the swimbladder as early as 38 hpf (A), and the 
expression is persistent to at least 72 hpf (B-D). (E) Cross section confirmation of 
bmp4 expression in the mesothelium layer at 72 hpf. (F, G) Bmp4 expression along 
the alimentary duct shown by sagittal section. Enlarged view shows that bmp4 is 
expressed around the pneumatic duct and the swimbladder (F). Red arrows indicate 
the position of swimbladder. E is the section of the embryo in D at the position 
marked by the black line. G is the enlarged view of the framed box in F. 
Abbreviations: sb, swimbladder; g, gut; h, heart; pd, pneumatic duct. Scale bars: 100 
µm in A-D and F, 250 µm in E and G. (Korzh, unpublished data) 
 
  




2.2.2.1.3 Wnt2 expression during swimbladder development 
    In our screening for genes expressing in the swimbladder, wnt2 was found to have a 
very interesting expression pattern. Wnt2 expression was clearly detected in 
developing swimbladder at 48 hpf (Fig. 2-14A). At 60 hpf, wnt2 was only expressed 
at the right side of swimbladder from dorsal view (Fig. 2-14B). At 72 hpf, high level 
of wnt2 expression was further restricted to the right and distal part of swimbladder 
with a decreasing gradient to other parts and no clear border (Fig. 2-14C). Cross 
section indicated that wnt2 was specifically expressed in the mesenchyme layer of 
swimbladder (Fig. 2-14I). Since there is no obvious sign that the swimbladder is an 
asymmetric organ itself in terms of smooth muscle differentiation (Georgijevic et al., 
2007), angiogenesis (Isogai et al., 2001), or neuromuscular development (Robertson 
et al., 2007), we suspect that the asymmetric expression of wnt2 in swimbladder 
mesenchyme might be involved in regulating its relative position with other organs, 
such as the developing gut. 
    In order to uncover the potential regulatory mechanism of wnt2 expression, we also 
examined expression pattern of wnt2 in some mutants affecting swimbladder 
development. In syu
t4
 mutants, in which sonic hedgehog signaling is disrupted and 
epithelium and mesenchyme layers are disorganized (Schauerte et al., 1998; Winata et 
al., 2009), wnt2 expression was present but highly disorganized (Fig. 2-14D-F). In 
smu
b641
 mutants, in which hedgehog pathway is completely blocked and both 
epithelium and mesenchyme layers are missing (Barresi et al., 2000; Winata et al., 
2009), wnt2 expression was not detected (Fig. 2-14G). These results suggest that wnt2 
might act downstream of hedgehog pathway. Furthermore, in dae mutants, which are 
fgf10a null mutants, we found that wnt2 expression was completely normal (Fig. 2-
14H).  








Figure 2-14. Expression of wnt2 in the swimbladder during embryogenesis and in 
mutant lines. (A-C) Wnt2 expression in the swimbladder at 48 hpf (A), 60 hpf (B) and 
72 hpf (C). Wnt2 can be detected in the swimbladder at 48 hpf; as early as 60 hpf, 
wnt2 expression shows an asymmetrical pattern, and its expression is further 
restricted to right and distal part of swimbladder at 3 dpf. (D-F) Disorganized 
expression of wnt2 in syu mutants. (G) Absence of wnt2 expression in smu mutant. 
(H) Normal wnt2 expression in dae mutant. (I) Cross section confirmation of wnt2 
expression in the mesenchymal layer of the swimbladder. All embryos are ventral 
view with heads to the left except the last one. Scale bars: 100 µm for whole mount 
and 50 µm for cross section. 
 
  




2.2.2.2 Role of bone morphogenetic protein signal in swimbladder development 
In our screening for signaling molecules expressing in the developing swimbladder, 
bmp4 is expressed in the mesothelium layer. It has been reported that a Bmp 
antagonist, the protein related to Dan and Cerberus (prdc), is expressed in the 
swimbladder mesenchyme as early as 32 hpf (Muller et al., 2006). In zebrafish, prdc 
is expressed initially around 17 hpf in the developing eyes and the first two 
pharyngeal arches, and it is also transiently expressed in the ventral somites between 
20 and 36 hpf. Prdc is a secreted glycoprotein, which belongs to the DAN subfamily 
of Bmp antagonists. Since Bmp signaling plays a critical role for lung development, 
and the expression of prdc is conserved between the zebrafish swimbladder and the 
mammalian lung (Lu et al., 2001), it is of interest to further study the function of 
bmp4 and prdc in swimbladder development. 
 
2.2.2.3 Effect of bmp4 signal disruption to swimbladder development 
A bmp4 morpholino was used to block bmp4 activity (Leung et al., 2005) (Korzh, 
unpublished data). As shown by GFP expression in various enhancer trap lines, all 
three tissue layers in the swimbladder, including the epithelium, mesenchyme and 
mesothelium, are present although reduced in bmp4 morphants (Fig. 2-15). 











Figure 2-15. Phenotype of swimbladder in bmp4 morphants at 72 hpf. All tissue 
layers of the swimbladder is present but reduced in bmp4 morphants, including 
epithelium (A-B, marked by ET33), mesenchyme (C-D, marked by ET33-E20) and 
mesothelium (E-F, marked by ET65A-7). The swimbladder part is enlarged and shown 








2.2.2.2.1 Effect of prdc knockdown on swimbladder development 
    A translational blocking morpholino was designed to specifically knockdown 
prdc expression level. The embryos injected with prdc morpholino showed yolk 
elongation defects and cardioedema. Furthermore, all morphants had defects in 
somitogenesis, especially in the region posterior to the 10th somite (Fig. 2-16), which 
is in consistent with prdc expression pattern in the somites. Prdc is transiently 
expressed in the ventral somatic mesoderm between 20 and 36 hpf, which is the stage 
when cells of sclerotome, as well as the slow and fast muscle fibers, proliferate, 
migrate, and differentiate. 
 
Figure 2-16. Embryonic development defects caused by prdc knockdown. All 
morphants show yolk elongation defects and cardioedema. B, D and F are the 
enlargement of regions marked by the dashed square in A, C and F, respectively. Red 
arrows mark the regions with most severe somitogenesis defects. All embryos are 
observed at 72 hpf. Scale bars: 250 µm for A, C and E, 100 µm for B, D and F. 
 




We further examined the effect of prdc knockdown on swimbladder development 
using various molecular markers. At 48 hpf, hb9 expression is normally identified in 
the swimbladder in prdc morphants, although the expression domain is smaller than 
that in wildtype embryos (Fig. 2-17A, B). Furthermore, the presence of swimbladder 
epithelium is confirmed by using a foxa3 probe (Fig. 2-17C-F).  
Bmp4 expression was not disrupted or even upregulated by prdc knockdown (Fig. 
2-18A, B). At 72 hpf, epithelial markers, including hb9 and ihha, are expressed in the 
prdc morphants (Fig. 2-18E-H). The mesencymal marker, fgf10a, is also present (Fig. 
2-18I, J). These together represent the normal specification of epithelium and 
mesenchyme. However, acta2 expression is undetected, indicating smooth muscle 
differentiation is impaired in prdc morphants (Fig. 2-18K, L). The mesothelial layer is 
disorganized as shown by the dispatched expression of annxa5 (Fig. 2-18C, D). 
Moreover, expression of wnt2 is expanded in the morphants (Fig. 2-18M, N).  
The results suggest that prdc is not required for the initial specification of 
epithelium and mesenchyme of the swimbladder, but the disruption of prdc function 
















Figure 2-17. Decreased expression of molecular markers in prdc morphants at 48 
hpf. (A, B) Expression of hb9 in prdc morphants (A) and controls (B). (C-F) Expression 
of foxa3 in prdc morphants (C, E) and controls (D, F). A, B, E and F are in side view, 
and C and D are in ventral view. Red arrows are used to indicate swimbladder. 
















Figure 2-18. Expression of molecular markers in prdc morphants at 72 hpf. (A, B) 
Undisrupted Bmp4 expression in prdc morphants. (C, D) Reduced and disorganized 
expression of annxa5 in prdc morphants. (E-J) Significantly decreased expression of 
hb9 (E, F), ihha (G, H) and fgf10a (I, J) in prdc morphants. (K, L) Absent expression of 
acta2 in the swimbladder of prdc morphants. (M, N) Expanded expression of wnt2 in 
the swimbladder in prdc morphants. Red arrows and dashed circle are used to 
indicate swimbladder. Numbers are used to mark the position of somite1-4. A-L are 
in lateral view, while M-N are in ventral view. Scale bars: 250 µm. 
 
  




2.2.3 Effect of fgf10b signal disruption to endoderm development 
In mouse embryos, Fgf10 is expressed in endodermal organs including the lung, 
liver, pancreas and gut. However, in the zebrafish, Fgf10 has two orthologs due to the 
genome duplication in teleosts, fgf10a and fgf10b. The two paralogs have 55.22% 
identity in protein sequence (Fig. 2-19). To date, fgf10b has not been subjected to any 
experimental studies. We examined the expression and function of fgf10b during 
endodermal organ development.  
 
 
Figure 2-19. Alignment of fgf10a and fgf10b protein sequences. Similar amino acids 
are shaded in light blue and identical amino acids are shaded in dark blue. Amino 
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2.2.3.1 Temporal and spatial expression of fgf10b  
2.2.3.1.1 Temporal expression of fgf10b during development 
    We first examined the transcript level of fgf10b at different developmental stages 
by semi-quantitative RT-PCR. Fgf10b mRNA showed maternal expression, and the 
expression level was maintained at a stable level to at least 120 hpf (Fig. 2-20). 
Generally, fgf10b was not expressed at a high level, since 35 cycles were required in 
RT-PCR in order to amplify the transcript to a visible level. 
 
 
Figure 2-20. Expression of fgf10b at different developmental stages by RT-PCR. 
Fgf10b was maternally transcribed, and the transcription level was stable from 2 hpf 
to 120 hpf. Gapdh was used as a loading control.  
 
  




2.2.3.1.2 Fgf10b expression in developing endoderm 
    To further investigate the expression pattern of fgf10b in zebrafish embryos, whole 
mount in situ hybridization (WISH) was carried out. Fgf10b was ubiquitously 
expressed in the whole embryo at a low level. At 48 hpf,  fgf10b expression was 
detected in several endodermal organs, including the liver, exocrine pancreas and gut. 
The expression became clearer and more prominent at 72 hpf (Fig. 2-21), but no 
fgf10b expression was observed in the swimbladder. 
 
Figure 2-21. Expression of fgf10b in endodermal organs at 72 hpf by WISH.  Fgf10b 
is expressed in the liver, exocrine pancreas and gut at 72 hpf. Abbreviations: L, liver; 
P, exocrine pancreas; G, gut. Scale bars: 250 µm. 
 
  




2.2.3.2 Disruption of liver and pancreas development by fgf10b knockdown 
  In order to reveal the potential function of fgf10b during zebrafish embryonic 
development, we used a translational blocking morpholino to knock down fgf10b 
expression. 4-12 ng of morpholino was injected into 1-cell stage embryos. The 
morpholino did not produce any obvious early effect up to gastrulation. Dose 
dependent developmental delay was observed in the morphants. 24 hours after 
injection, 1-2 hour delay was observed in morphants injected with 4-8 ng of 
morpholino, and 3-4 hour delay was observed in morphants injected with 12 ng of 
morpholino. 
  
2.2.3.2.1 Reduction in the size of liver and pancreas by fgf10b knockdown 
Using LiPan line as a live marker, we found that the size of liver and exocrine 
pancreas was obviously reduced in fgf10b morphants, and the effect is dose-dependent.  
In the zebrafish, the liver is in the growth phase between 50 and 96 hpf. During this 
phase, the size of liver increases fast (Field et al., 2003b). At 4 dpf, the liver can be 
seen touching the pericardial cavity and resting on top of the remaining yolk from the 
left lateral view (Fig. 2-22A, B). As shown in Fig. 3-18, in the fgf10b morphants, the 
liver growth was impaired. From the left lateral view, it can be seen that the anterior 
end of the liver touched the pericardial cavity, but the liver failed to extend posteriorly 
along the yolk. The liver size was more reduced as the morpholino amount increases 
(Fig. 2-22C-H). 
At 4 dpf, the exocrine pancreas in the zebrafish has an enlarged anterior head region 
and a posterior tail elongated to the position of the 6th somite (Fig. 2-23A, B) (Field 
et al., 2003a). In the fgf10b morphants, the position of the anterior head were not 




shifted, indicating the initial budding and migration of the pancreas primordium was 
not affected. But the posterior elongation of the exocrine pancreas was severely 
decreased. Injection of fgf10b morpholino as little as 8 ng shortened the pancreas by 1 
somite (Fig. 2-23C, D), and larger amount (12 ng) of the morpholino resulted in 
completely failure of posterior elongation (Fig. 2-23E, F). 
  








Figure 2-22. Reduction of liver size in fgf10b morphants at 4 dpf. (A, B) Normal liver 
size in LiPan embryos at 4 dpf. (C-H) Reduced liver size in fgf10b morphants injected 
with 4 ng (C, D), 8 ng (E, F) and 12 ng (G, H) of fgf10b morpholino. The same larvae is 
taken photo under 488 nm fluorescent filter (A, C, E, G) and bright field (BF) (B, D, F, 











Figure 2-23. Shortening of exocrine pancreas size in fgf10b morphants at 4 dpf. (A, 
B) Normal pancreas size in LiPan embryos at 4 dpf. (C-F) Reduced pancreas size in 
fgf10b morphants injected with 8 ng (C, D) and 12 ng (E, F) of fgf10b morpholino. The 
same larvae is taken photo under 488 nm fluorescent filter (A, C, E) and bright field 
(BF) (B, D, F) respectively. All embryos are left lateral view with heads to the left. 
Scale bars: 250 µm. 
 
  




2.2.3.3 Disruption of correct organ position by fgf10b knockdown 
The liver and pancreas are originated from the left and right side of the gut tube, 
respectively. At 4 dpf, liver growth has resulted in a medial expansion so that it 
extends from the left side of the embryo all the way across the midline ventral to the 
esophagus, but the majority of the tissue is still at the left side of the midline (Field et 
al., 2003b; Korzh et al., 2008). At the same time, the posterior tail of the pancreas, 
which rests solely at the right side of the larva, has also elongated to the position of 
the 6th somite (Fig. 2-25E, F) (Field et al., 2003a; Korzh et al., 2008). In the fgf10b 
morphants, we observed that the liver and pancreas showed various abnormalities in 
morphants with respect to their positions in control, including inversed left-right 
position of liver and pancreas, doubled liver and pancreas, etc.. The percentage of 
morphants showing the positional defects increased from 10% to more than 30% as 
the amount of fgf10b morpholino injected increased (Fig. 2-24). 
 
 
Figure 2-24. Dose-dependent abnormalities of liver and pancreas in fgf10b 
morphants. The percentage of abnormal phenotypes increases from 10% to more 
than 30% when the injected morpholino is gradually increased from 4 ng to 12 ng. 
Error bars represent standard derivations calculated by three individual experiments. 
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The positions of the liver and the pancreas showed various defects in fgf10b 
morphants. The most common defect was the switched lateral positions of the liver 
and the pancreas, which constitutes more than 70% of the abnormalities (Fig. 2-21). 
In this type of morphants, most of them had smaller liver and pancreas than control 
larvae (Fig. 2-21A, B). However, some morphants had almost normally sized liver 
and pancreas (Fig. 2-21C, D), indicating the positional defect was not necessarily 




Figure 2-25. Left-right inverse of liver and pancreas position in some fgf10b 
morphants. In wildtype larvae, the liver is on the left side and the pancreas is on the 
right side (E, F). In some fgf10b morphants, the position of the liver and pancreas is 
switched (A-D). This positional defect is not definitely associated with the reduction 
of liver and pancreas size, as almost normal sized liver and pancreas is observed in 
some morphants (C, D). The same larva is taken photo under 488 nm fluorescent 
filter (A, C, E) and bright field (BF) (B, D, F) respectively. All embryos are dorsal view 
with heads to the left. Scale bars: 250 µm. 




    Some morphants had two separated liver buds, and one or two pancreas buds. 
Around 25% of the morphants had this type of defects. The two liver buds were 
usually not symmetrically separated by the midline (Fig. 2-26A-D). Moreover, the 
pancreas specification seemed independent from the liver, as some morphants showed 
completely normal pancreas position and shape (Fig. 2-26C, D).  
Occasionally, morphants showed defects in which the liver and the pancreas were 
originated from the same side of the gut tube. In wildtype larvae, the liver and 
pancreas showed no direct contact with each other at this stage, which was different 
from the morphology in adulthood (Fig. 2-27G-J). In some fgf10b morphants, the 
liver and pancreas were both located near the midline of the larvae (Fig. 2-27A, B). 
Further observation from the lateral view shows that the two organs were imbedded in 
each other (Fig. 2-27C, D). In other fgf10b morphants, they had the liver and pancreas 
originated from the same side of the larvae (Fig. 2-27E, F). 
  





Figure 2-26. Two separated liver buds are observed in some fgf10b morphants. In 
wildtype larvae, single liver and pancreas bud was originated from the left and right 
side of the gut tube, respectively (E, F). In some fgf10b morphants, two separated 
livers buds are originated from two sides of the midline, and one or two pancreas 
buds are observed (A-D). The same larva is taken photo under 488 nm fluorescent 
filter (A, C, E) and bright field (BF) (B, D, F) respectively. All embryos are dorsal view 
with heads to the left. Scale bars: 250 µm. 
 





Figure 2-27. Randomized liver and pancreas position in some fgf10b morphants. In 
wildtype larvae, single liver and pancreas bud was originated from the left and right 
side of the gut tube, respectively (G, H), and the liver and pancreas show no direct 
contact with each other (I, J). In some fgf10b morphants, the liver and pancreas are 
both located near the midline of the larvae and are imbedded in each other (A-D). 
And some morphants have the liver and pancreas originated from the same side of 
the larvae (E, F). The same larvae is taken photo under 488 nm fluorescent filter (A, 
C, E, G, I) and bright field (BF) (B, D, F, H, J) respectively. Embryos C, D, I, J are left 
lateral view with heads to the left, and embryos A, B, E-H are dorsal view with heads 
to the left. Scale bars: 250 µm. 
  





2.3.1 The conservation of Fgf ligand and receptor expression pattern in the 
swimbladder and lung provides molecular evidence for the evolutionary 
homology of the two organs  
FGFs are essential components of the regulatory networks between epithelium and 
mesenchyme in the embryonic lung. Fgf10 signaling is mediated by Fgfr2 (Xu et al., 
1998). At early stages of lung development, Fgf10 is dynamically expressed at early 
stages of lung development in the distal mesenchyme, at sites where prospective 
epithelial buds will appear. On the contrary, Fgfr2 is expressed at high levels along 
the entire proximal-distal axis of the respiratory tract epithelium (Cardoso et al., 1997). 
This even distribution of Fgfr2 expression suggests that the spatial control of 
branching morphogenesis is mostly likely determined by mesenchymal expression of 
an Fgf ligand. 
The critical role of Fgf signaling in lung development was first depicted by the 
severe disruption of branching morphogenesis observed in lungs of transgenic mice 
expressing dominant negative forms of FGFR2 (Celli et al., 1998; Peters et al., 1994). 
Expression of a dominant negative FGFR2 in the primitive respiratory epithelium of 
transgenic mice under the control of the SP-C promoter/enhancer resulted in 
completely pulmonary aplasia. In these mice, tracheal cell lineages are normally 
expressed, but peripheral epithelial cell lineages marked by SP-C expression as well 
as the vasculature are not. Similarly, the respiratory tract in Fgf10 null mice consists 
of a blunt ended tracheal tube, truncated at the level of the thymus.  
We showed that fgfr2 is highly expressed in the epithelium of the pneumatic duct, 
the posterior chamber and the future anterior chamber. And fgf10a is expressed in the 




mesenchyme surrounding these structures. We demonstrated the presence of an Fgf 
ligand-receptor expression pattern during swimbladder development. Thus, the 
conserved expression domains of the Fgf ligand and receptor provides molecular 
evidence of the homology between fish swimbladder and mammalian lung in their 
early development in terms of epithelial-mesenchymal interactions. 
 
2.3.2 Early Fgf signal is required for the induction of swimbladder bud 
Although fate mapping studies enable us trace the precursors of different 
endodermal organs since as early as late blastula (Bally-Cuif et al., 2000; Warga and 
Nusslein-Volhard, 1999), the early mechanism regulating fate specification of these 
cells have been largely unexplored. It has been suggested that the endoderm is likely 
regionalized as early as gastrulation (Biemar et al., 2001; Roy et al., 2001). Several 
studies have also identified the crucial time windows of Fgf signaling for endodermal 
organ development, and it has been shown that Fgf signaling after 18 hpf is essential 
for hepatoblast specification (Shin et al., 2007). Requirement of Fgf signaling for 
ventral pancreatic bud induction was found to be between 26 and 29 hpf (Manfroid et 
al., 2007). Nevertheless, our SU5402 treatment experiment suggested that the 
presence of Fgf activity up to 15 hpf is not sufficient to induce a swimbladder bud 
from the gut, which is consistent with our previous study on Hedgehog signaling 
(Winata et al., 2009). It has been postulated that Hh signal from the notochord is 
required for the specification of swimbladder progenitor cells (Winata et al., 2009). 
In our experiments with SU5402 treatment, the mesenchyme could be specified in 
the absence of epithelium, and the mesenchyme seems to require early Fgf signal for 
its specification. As SU5402 blocks Fgfr1 activity by binding to a region that is 




conserved in all four Fgfrs (Johnson and Williams, 1993), it has been suggested that 
the reagent likely inhibits all Fgf receptors (Furthauer et al., 2001). The expression 
patterns of the four fgfrs during segmentation stage have been carefully characterized 
in the zebrafish. During the segmentation stage, high level of fgfr1 expression is 
detected in the forebrain, the midbrain-hindbrain boundary, presomitic mesoderm and 
somites; weak expression is also present at this stage in the ventral mesoderm 
(Scholpp et al., 2004). Fgfr2 is expressed in the somitic mesoderm from early stages 
of segmentation to 15-somite stage, while expression in the underlying mesenchyme 
persists at the late somitogenesis stage (Thisse et al., 1995). Fgfr3 is expressed in the 
axial mesoderm at the level of the midbrain and hindbrain between 6 and 10 hpf, and 
later in the hindbrain at 24 hpf (Sleptsova-Friedrich et al., 2001). Fgfr4 is transiently 
expressed in the notochord and segmental plate mesoderm, as well as in the lateral 
plate mesoderm (Tonou-Fujimori et al., 2002). Therefore, the combinative expression 
domain of the four fgfrs in the zebrafish includes broad domains such as the 
notochord, lateral plate mesoderm, and somites, which makes it hard to determine the 
source of Fgf signal required for swimbladder development. Possibilities remain that 
in SU5402 treatment, Fgf signal from the notochord was disrupted therefore 
interrupting swimbladder mesenchymal progenitors specification, or inhibition of 
fgfrs directly blocked the specification of swimbladder mesenchymal progenitors.  
 
  




2.3.3 Mesoderm to endoderm Fgf signaling promotes epithelial proliferation in 
the swimbladder 
    In vitro tissue culture of lung explants experiments show that Fgf10 promotes both 
proximal and distal endoderm proliferation and migration, and has no effect on lung 
mesoderm (Weaver et al., 2000). Interestingly, in whole lung cultures, the 
chemotactic effect seems to be specific for distal lung buds. We showed that fgf10a 
functions in a paracrine manner to promote epithelial proliferation in the swimbladder, 
which is consistent with its function in lung development. Moreover, the expression 
domain of fgf10a in the developing swimbladder mesenchyme forms a sac posteriorly 
embracing the epithelial bud. Correlating with the expression domain, we observed 
epithelial proliferation is more active in the posterior part of the swimbladder than in 
the anterior part. The swimbladder bud extends posteriorly during growth, possibly 
under direction of fgf10a-expressing mesenchyme. The result also provides 
supporting evidence that fgf10a functions as a chemoattractant during swimbladder 
development.  
Similarly, Shh functions in a paracrine manner to promote mesenchymal 
proliferation during lung development. In Shh-null mutant mice, the lung 
mesenchyme shows enhanced cell death and decreased cell proliferation (Litingtung 
et al., 1998). Overexpression of Shh in the distal epithelium caused increased 
mesenchymal cell proliferation (Bellusci et al., 1997a). Previous studies showed that 
inhibition of Hedgehog signaling in the swimbladder by cyclopamine significantly 
reduced mesenchymal and outer mesothelial proliferation, while the proliferation rate 
of epithelium was slightly affected (Winata et al., 2009). Taken together, Fgf and 
Hedgehog signals work on the epithelial and mesodermal layers separately to promote 
swimbladder growth. 




2.3.4 Conserved and divergent elements of Fgf pathway in the early 
development of swimbladder and lung 
The lack of fgf10a function in zebrafish swimbladder budding provides another 
piece of evidence for the conservation between swimbladder and early lung 
development. Even though mouse deficient for Fgf10 possess severe lung phenotype, 
in which the lung fail to form, resulting in the absence of lower trachea, bronchi, and 
lung parenchyma, their lung buds were formed, and only subsequent growth and 
differentiation was impaired (Min et al., 1998; Sekine et al., 1999). Fgf10 functions as 
a stimulator for epithelial cell proliferation and acts as a chemoattractant for 
directional lung bud growth (Bellusci et al., 1997; Park et al., 1998). Furthermore, 
Fgf10 does not seem to interfere with early epithelial cell differentiation.  The 
swimbladder could therefore be viewed as a structure which is homologous to the 
early lung, and as a result, disruption of fgf10a does not affect it. Expression of Shh 
along the trachea of Fgf10 
-/-
 mice (Sekine et al., 1999), and shha along the length of 
the dae mutant swimbladder epithelium, provides a further supporting evidence for 
this hypothesis. Therefore, it seems that while earlier events during swimbladder and 
lung development remain conserved, novel developmental mechanisms arose during 
evolution in tetrapod lungs, which allowed tetrapods to adjust the function of their 
lungs for air breathing through the formation of an extensively branched morphology 
at later stages of development. 
 
  




2.3.5 Differential expression of negative regulatory genes in the swimbladder 
correlates with the unbranched swimbladder organ 
The most important morphological difference between the fish swimbladder and the 
mammalian lung is the lack of branching morphogenesis in the swimbladder. This 
could be contributed to the differences in gene expression program during early 
development. 
In lung development, Fgf10 signal is the major mitogen and chemoattractant to 
induce epithelial proliferation and migration, and its signal is under tight spatial 
control by multiple negative regulators, including genes from the Hh, Bmp, Tgfb and 
Wnt families. These negative regulators have temporally and spatially dynamic 
expression patterns. They coordinate to down-regulate Fgf10 expression in the 
existing distal buds and Fgf10 expression domains were forced to move laterally to 
induce new buddings. However, in the zebrafish swimbladder, we found that several 
important negative regulators of lung branching morphogenesis (spry2, tgfb1/2/3) 
were not expressed during early development. The absence of negative regulatory 
gene expression during swimbladder development may provide one reason that the 
swimbladder and the lung are morphologically different. On the other hand, several 
negative regulatory genes, including shh and bmp4, are homogeneously expressed in 
developing swimbladder. The homogeneous expressions of genes result in the even 
growth of swimbladder, and subsequently the sac-like shape of the organ.  
 
  




2.3.6 Preliminary analysis of Bmp signaling in swimbladder development 
During lung development, Bmp4 expression has two distinct domains at different 
stages. Bmp4 expression is first detected in the ventral mesenchyme of the developing 
lung when the primordial lung buds are emerging from the foregut (Que et al., 2006). 
Later the expression of Bmp4 is also detected in the distal endoderm in the developing 
lung bud (Bellusci et al., 1996). Bmp4 inhibits epithelial proliferation in vitro 
(Weaver et al., 2000) and in vivo (Bellusci et al., 1996). Therefore, it is thought to be 
involved in lateral inhibition during branching morphogenesis (Hogan, 1999). Prdc is 
a secreted protein that directly bind to Bmp4 and blocks ligand signaling induced by 
Bmp4 (Sudo et al., 2004). During lung development, expression of Prdc is observed 
in the mesenchymal cells immediatedly adjacent to the proximal airway epithelium, 
which overlaps with the expression of SM22a (Lu et al., 2001). This pattern of 
expression suggests that Prdc may regulate Bmp signaling events between the 
endodermal and mesodermal components of the lung and may play a role in bronchial 
smooth musle development.  
    During swimbladder development, bmp4 is expressed in the mesenchyme and later 
in the mesothelium, which is not conserved with the lung. Nevertheless, prdc is 
expressed in the mesenchyme during swimbladder development, which is consistent 
with its expression in the lung. The conserved expression of Prdc in the two organs 
may suggest a similar role of Bmp signaling in lung and swimbladder development.  
Indeed in our morpholino knockdown experiment, prdc had no effect on early 
specification of swimbladder, and disruption of prdc signal impaired smooth muscle 
differentiation. This phenotype is consistent with the speculated function of Prdc 
during lung development.  
 




2.3.7 Subfunctionalization of Fgf10 signal 
It is well established that zebrafish often has two orthologs of human genes. Genetic 
mapping studies showed that zebrafish co-orthologs of human genes generally occupy 
duplicated segments on different zebrafish chromosomes. For at least 20% of human 
genes, zebrafish has two co-orthologs (Postlethwait et al., 2004). On the other hand, 
the teleost genome duplication presents previously unanticipated advantages for the 
analysis of gene function, because the subfunction partitioning in teleosts can 
facilitate the identification of gene functions obscured in mammals by either 
pleiotropy or haploinsufficiency.  
Previous chromosome study showed that conserved gene order was observed at the 
human FGF10 and zebrafish fgf10a loci, indicating that fgf10a is a zebrafish ortholog 
of human FGF10 (Itoh and Konishi, 2007). In contrast, no conserved gene order was 
observed at the fgf10b locus, indicating that fgf10b is a paralog of fgf10a potentially 
generated from fgf10a by gene duplication and translocation. During mice 
embryogenesis, Fgf10 is expressed in endodermal organs, including the lung, liver, 
pancreas and gut. We showed that the expression of fgf10a and fgf10b is 
complementary to each other in the endodermal organs, which provides a good 
example of spatial separation of gene function due to the genome duplication. 
 Furthermore, in Fgf10-deficient mice, limb and lung development are severely 
impaired, while minor defects are observed in the formation of teeth, kidneys, hair 
follicles and digestive organs (Ohuchi et al., 2000). In Fgf10-deficient mouse 
embryonic pancreases, the evagination of the epithelium and the initial formation of 
the dorsal and ventral buds appear normal. However, the subsequent growth, 
differentiation and branching morphogenesis of the pancreatic epithelium are arrested; 
this is primarily due to a dramatic reduction in the proliferation of the epithelial 




progenitor cells marked by the production of the homeobox protein PDX1 (Bhushan 
et al., 2001). Similarly, Fgf10-deficient mouse embryonic livers are smaller due do 
diminished proliferation of hepatoblasts (Berg et al., 2007). We observed similar 
growth defect on zebrafish liver and pancreas after fgf10b knockdown. Therefore, the 
co-orthologs of Fgf10 in the zebrafish together maintained the similar functions as the 
Fgf10 in mammals does. 
 
  





In this chapter, I have studied the early development of the zebrafish swimbladder 
focusing on the Fgf signaling pathway and its regulators in comparison with lung 
development. The main findings of this chapter include the following: 
1. The expression of fgfr2 in the swimbladder was characterized. Compared to 
lung development, a conserved expression pattern of ligand-receptor of Fgf 
signaling was found in the swimbladder.  
2. Analysis of the zebrafish fgf10a mutants reveals that fgf10a is not required for 
the swimbladder specification and differentiation, but impaired Fgf10a signal 
reduces epithelial proliferation. 
3. Functional analysis of the Fgf pathway has revealed the requirement of Fgf 
signalling in two phases of swimbladder development: firstly, in the initial 
specification of the epithelium and mesenchyme, and secondly, in later events 
of growth of the epithelium.  
4. Screening of Fgf signal regulators in swimbladder development revealed that 
there are two major gene expression pattern differences between the 
swimbladder and the lung which may contribute to the morphological 
differences of the two organs: some regulatory genes are not expressed in the 
swimbladder, and the genes present in the swimbladder are homogenously 
expressed.  
5. Fgf10b, an fgf10a paralog, was first analysed for its expression and function 
during endodermal development, providing an example for 
subfunctionalization of co-orthologs in the zebrafish due to partial genome 
duplication.  












Transcriptomic study of the zebrafish swimbladder 
  




3.1 Materials and Methods 
3.1.1 Preparation of RNA samples for RNA-seq 
3.1.1.1 Isolation of total RNA from zebrafish embryos and adult tissues 
    45 female and 45 male Singapore wildtype adult zebrafish (around 6 months old) 
were sacrificed. Swimbladder, brain, heart and headkidney were isolated and pooled 
together. Total RNA extraction was performed using TRIzol® Reagent (Invitrogen) 
as described in section 2.1.2.1. 
 
3.1.1.2 Purification of mRNA 
    mRNA was purified using DynaBeads® Oligo(dT)25 (Invitrogen) according to the 
manufacture’s protocol. Briefly, the volume of 75 µg of total RNA was adjusted to 
100 µL, and equal volume of binding buffer (20 mM Tris-HCl, pH 7.5; 1.0 M LiCl; 2 
mM EDTA) was added. The mixture was heated to 65 °C for 2 minutes and 
immediately chilled on ice to allow the mRNA binding to the beads. mRNA was 
isolated using magnetic separation by placing the tube on the magnet. The beads were 
washed twice by washing buffer (10 mM Tris-HCl, pH 7.5; 0.15 M LiCl; 1 mM 
EDTA). Purified mRNA was eluted by 10 mM Tris-HCl (pH 7.5). The RNA samples 
were subsequently incubated at 37 °C with DNaseI (New England Biolabs) for 30 
minutes to remove residual genomic DNA and subjected to another round of mRNA 
purification. The resulted mRNA sample was qualified and quantified on NanoDrop® 








3.1.1.3 Hydrolysis of mRNA 
Prior to cDNA synthesis, mRNAs were hydrolyzed by RNA Fragmentation 
Reagent (Ambion), which is designed to fragment RNA to sizes between 60-200 
nucleotides. The mRNA sample was hydrolyzed at 70 °C for 1 minute in 1× 
Fragmentation Buffer (a buffered zinc solution), and stopped by Stop Solutions (200 
mM EDTA, pH 8.0). 
 
3.1.1.4 cDNA library construction and sequencing 
    Paired-ends sequencing was performed according to Sanger-modified Illumina’s 
protocol (Bentley et al., 2008; Quail et al., 2008).  
 
3.1.2 Primary data processing and transcript annotation 
3.1.2.1 Mapping 
    We used MAQ (Mapping and Assembly with Qualities) to align the sequence tags 
to transcriptome database (Li et al., 2008). MAQ assign each alignment a phred-
scaled quality score (Qs), which measures the probability that the true alignment is 
not the one found by MAQ. The data have been submitted to the European 
Bioinformatics Institute (EBI) database (Accession number: ERP000447 ). ZGC 
(Zebrafish Gene Collection) database (retrieved on Jan 28, 2011) was used in this 
study, which contains 16,739 ORFs (Open Reading Frames).  
 
  




3.1.2.2 Normalization  
    The mapped sequence tags for each transcript entry were normalized into RPKM 
(reads per kilobase of exon model per million mapped reads) (Mortazavi et al., 2008). 
The RPKM reflects the transcript concentration by normalizing for RNA length and 
for the total read number, which facilitates transparent comparison of transcript levels 
both within and between samples.  
     
                                         




    To facilitate functional implications of zebrafish transcriptome, all zebrafish genes 
were mapped to annotated human and mouse genes in order to use existing online 
software developed in human genes. Thus, Unigene annotation of zebrafish transcript 
entries (GenBank accession ID) and human and mouse homology mapping of 
zebrafish Unigene clusters were retrieved from the Genome Institute of Singapore 
Zebrafish Annotation Database (http://giscompute.gis.a-star.edu.sg/~govind 
/unigene_db/) as previously described (Lam et al., 2006). In this study, the transcript 
entries of the ZGC database (containing 11,478 zebrafish Unigene clusters) were 
mapped to 6392 unique human Unigene clusters and 6793 unique mouse Unigene 
clusters. Some zebrafish Unigene clusters were mapped to more than one human or 
mouse Unigene clusters, which usually came from the same gene family. To remove 
redundancy and avoid causing bias in functional analyses, only the first human or 
mouse Unigene cluster in the list was selected to represent the zebrafish Unigene 
clusters. For Unigene clusters mapped by more than one transcript entries, the highest 




RPKM was used to represent the expression level of the Unigene cluster (van Ruissen 
et al., 2005). Functional characterization of human and mouse Unigenes clusters was 
based on Gene Ontology and can be obtained from Stanford’s SOURCE database 
(Diehn et al., 2003) . 
 
3.1.2.4 Conversion to transcript counts per cell 
    Absolute transcript counts per cell (TPC) was estimated based on RPKM and 
information on cellular RNA content. We estimated that 3.3 RPKM corresponds to 
about one TPC, based on report that human cells contain approximately 300,000 
mRNA molecules per cell (Velculescu et al., 1999), which has been used in most 
RNA-seq studies (Matkovich et al., 2010; Mortazavi et al., 2008).  
 
3.1.3 Functional analysis methods 
3.1.3.1 Gene Ontology (GO) Slim classification 
    Gene Ontology Slims are cut-down versions of the gene ontologies containing a 
subset of the terms in the whole GO (Ashburner et al., 2000). They give a broad 
overview of the ontology content without the detail of the specific fine grained terms. 
GO Slims are particularly useful for a summary of the results of GO annotation of a 
transcriptome when broad classification of gene product function is required. Gene 
ontology slim classification was performed using the total zebrafish swimbladder 
transcriptome (4,489 zebrafish Unigene clusters recognized in the database) against 
the total ZGC database (9,530 zebrafish Unigene clusters recognized). WebGestalt 
(WEB-based GEne SeT AnaLysis Toolkit, available at: 




http://bioinfo.vanderbilt.edu/webgestalt/) was used for this analysis (Duncan et al., 
2010; Zhang et al., 2005), which incorporates information from public resources and 
provides an easy way to analyze large datasets. The significance level of enrichment 
was indicated by false discovery rate (FDR) –corrected p-value from hypergeometric 
test. The cutoff is FDR<0.01. 
 
3.1.3.2 Gene Ontology enrichment analysis 
    Gene ontology enrichment analysis was performed using DAVID (The Database 
for Annotation, Visualization and Integrated Discovery) (Huang da et al., 2009) with 
the total zebrafish genome information as the background, with p-values representing 
a modified Fisher’s exact t-test. Gene Ontology Fat categories were used for this 
analysis. GO Fat is a term that the DAVID team used to describe a subset of the GO 
term set. It is coined after GO slim which serves as a subset of the broadest GO terms. 
In contrast, the GO Fat attempts to filter out the broadest terms so that they will not 
overshadow the more specific terms. FDR score was also provided as a multiple 
testing correction method.  
 
3.1.3.3 KEGG pathway enrichment analysis 
    KEGG (Kyoto Encyclopedia of Genes and Genomes) pathway is a collection of 
manually drawn pathway maps representing current knowledge on the molecular 
interaction and reaction networks for metabolism, cellular process, signaling pathway 
and diseases (Kanehisa and Goto, 2000; Kanehisa et al., 2010). KEGG pathway 
enrichment analysis was performed using DAVID. Signaling molecules identified by 




GO annotation in the swimbladder with an expression level higher than 10 RPKM 
were used as input. 365 transcript entries were included. Fold enrichment was 
calculated by dividing the observed number of transcript entries by the expected 
number of transcript entries in each pathway. P-values represent a modified Fisher’s 
exact t-test and benjamini score was provided as a multiple testing correction method. 
The cutoff is p-value < 0.01 and benjamini < 0.05. 
 
3.1.3.4 Analysis of whole transcriptomics profile using GSEA pre-ranked 
analysis 
    GSEA Pre-ranked option was used to analyze the whole transcriptome. Briefly, the 
gene symbols of human homologs of the zebrafish Unigene clusters with RPKM>10 
were ranked using logarithm transformed RPKM (base 10). The number of 
permutation used was 1000. Pathways with nominal p-value (NP) < 0.05 and false 
discovery rate (FDR) < 0.25 were considered statistically significant. Positive and 
negative values of NESs (normalized enrichment scores) indicate the activities of 
pathways that are up- and down-regulated, respectively.  
 
3.1.3.5 Biological insight inference via Ingenuity Pathways knowledge-based data 
mining 
    The human homologues of the zebrafish swimbladder transcripts were used to mine 
the human database via Ingenuity Pathways Knowledge Base software 
(www.ingenuity.com). The ‘physiological system development and function’ and 
‘molecular and cellular function’ analysis was performed against the whole 




swimbladder transcriptome (RPKM > 10) to identify biological functions and systems 
that were significantly associated with the gene set. Fisher’s exact t-test was used to 
calculate p-values in determining the probability that each biological function 
assigned to that data set is due to chance alone. P-value<0.05 is considered significant 
by the algorithm.  
 
3.1.4 Zebrafish organ-specific enriched gene selection by t-test 
    While gene ontology analysis can provide a general picture of the swimbladder 
transcriptome, the unique features of the swimbladder may only be unmasked by 
removing those housekeeping genes which are commonly expressed in all organs. 
Therefore, one sample t-test was conducted to select enriched genes in the 
swimbladder and other zebrafish organs. Maximum RPKM value from each zebrafish 
Unigene cluster was used to represent the expression of the Unigene cluster. One 
sample t-test was performed according to the standard method implemented in 
MATLAB. The p value is the probability, under the null hypothesis, of observing a 






where  ̅ is the sample mean or RPKM values of a transcript in the swimbladder, µ is 
the population mean or mean RKPM values of the same transcript in the other three 
comparing tissues, s is the sample standard deviation calculated from population 
means in the three comparing tissues, and n is the sample size and the value is 3 here.  
Gene clusters with p-value smaller than 0.025 are defined as enriched genes. At the 
same time, a second threshold of RPKM>10 and RPKM>average RPKM of the 4 




zebrafish organs is added to ensure that the selected genes are relatively abundant and 
physiologically relevant. The list of enriched zebrafish Unigene clusters was 
subsequently converted into homologous human Unigene clusters. The resulted lists 
for the zebrafish swimbladder, brain, heart and head kidney organs contain 888, 1,732, 
535 and 684 human Unigene clusters respectively. 
 
3.1.5 Cross species and platforms analysis 
3.1.5.1 Processing of human and mouse microarray data 
    Two sets of transcriptome data for healthy human and mouse organs (GSE2361 and 
GSE97) were obtained from GEO (Gene Expression Omnibus). Probes with A (absent) 
or M (marginal) calls were pre-excluded from the analysis. Annotation information 
was retrieved from the Genome Institute of Singapore Annotation Database 
(http://giscompute.gis.a-star.edu.sg/~govind/unigene_db/). For multiple probes which 
can be mapped to one Unigene cluster, the maximum signal intensity was selected to 
represent the expression level of the Unigene cluster. In order to qualify as enriched 
genes for each of human or mouse organ, the genes must be significantly 
differentially expressed (p<0.001) by t-test, and the signal intensity must be higher 
than the average and 50 at the same time.  
 
3.1.5.2 Establish of correlation between zebrafish and mammalian organs by 
Gene Set Enrichment Analysis (GSEA)  
    We used GSEA to establish the relationship between zebrafish and mammalian 
organs. GSEA is a computational method that determines whether a priori defined set 




of genes shows statistically significant, concordant differences between two biological 
samples; it calculates an enrichment score using a running-sum statistic through a 
ranked list of gene expression data set (Subramanian et al., 2005). The zebrafish 
swimbladder, brain, heart and head kidney transcriptome lists were converted into 
human and mouse homolog Unigene clusters. The enriched gene list of each tissue 
was used to represent its transcriptome. The statistical significance of the enrichment 
score was estimated by using an empirical phenotype-based permutation test 
procedure. An FDR value was provided by introducing adjustment of multiple 
hypothesis testing.  
 
  





3.2.1 Overview of RNA-seq data 
    The swimbladders, brains, hearts and head kidneys were isolated from 90 adult 
zebrafish and pooled to make representatives for deep sequencing analysis. One 
cDNA library was constructed and sequenced for each organ. 34 to 43 million of read 
pairs were generated for each organ, which is comparable to several recently 
published data using the Illumina Genome Analyzer (Hegedus et al., 2009; 
Rosenkranz et al., 2008).  
    All sequence tags were mapped to known transcripts in ZGC (Zebrafish Gene 
Collection) in order to reveal the molecular characteristics of the zebrafish 
transcriptome. In each organ, the number of mapped transcript entries ranges from 
less than 8,000 to more than 9,000 (Table 3-1). A total of 11,323 transcript entries 
were identified with as few as one mapped read pairs, constituting 67.64% of total 
known zebrafish transcript entries in the ZGC database. 
    As shown from previous studies, RNA-seq can be readily used to determine gene 
expression level across a broad dynamic range (Mortazavi et al., 2008; Wang et al., 
2009b). For example, the expression level of genes in the swimbladders ranges from 
0.54 to 11,178 RPKM, showing a dynamic range of more than five orders of 
magnitude.  
    Real-time PCR was carried out to verify relative abundance of several selected 
transcripts estimated by RNA-seq. For comparison between real-time PCR and RNA-
seq results, Cp and RPKM values for each gene were normalized against Cp and 
RPKM of ef1a (Dr.31797).The result indicated a good correlation of the two methods 
(Figure 3-1).  




The presence of transcripts with low RPKMs could be due to leaky expression; 
therefore, we implemented a primary cutoff at 3.3 RPKM (=1 TPC) (Mortazavi et al., 
2008). 10,287 transcript entries have been identified to be expressed in at least one 
organ at levels as low as one TPC, representing more than 60% of the ZGC 
transcriptome database. In each organ, the identified transcript entries range from 47% 
to 56% of the ZGC database (Table 3-1). Surprisingly, the swimbladder transcriptome 
shows the highest diversity among the 4 organs by having almost 8,000 transcript 
entries mapped. 
 
Table 3-1 Summary of sequencing results for the 4 zebrafish organs 
Organ Total tag reads Total transcript 
entries mapped 
Transcript entries 
higher than 1TPC 
Swimbladder 34,026,474 9,315 7,999 
Brain 38,938,626 8,825 7,640 
Heart 42,820,495 7,889 6,431 
Head kidney 37,039,047 8,910 7,335 
 
 
Figure 3-1. Real-time PCRvalidation of RNA-seq data. The relative expression level 
of the genes selected was shown in log2 fold change as compared with a 
housekeeping gene, ef1a (10680.1 RKPM). 




3.2.2 Description of the zebrafish swimbladder transcriptome 
3.2.2.1 General features of the zebrafish transcriptome 
    As shown in Figure 3-2, the distribution of transcript entries and total counts over 
different transcript abundance categories showed very similar tendencies for all four 
organs. It also shows a relatively continuous distribution of gene expression levels. 
Similar to previous RNA-seq studies in other tissues (Hegedus et al., 2009), there are 
only a few transcripts which have high expression level, while most transcripts are 
expressed at very low level. More than 60% of the transcript body consists of the 
highest expressed transcripts which count for less than 10% of the transcript entries, 
while the lowest expressed 60% of the transcript entries only contribute for less than 
10% of the total transcript counts. The heart represents the most extreme case with the 
top 0.7% transcribed transcript entries constitute more than 50% of the transcriptome 
body.  
 






Figure 3-2. Distribution of transcript entries and total transcript counts over different tag abundance categories in the transcriptome 
of the 4 zebrafish organs. Categories of transcript abundance were assigned by setting the lower limit of the count number that 
includes the transcript as a category member. The percentages of total transcript counts and number of different transcript entries per 
category are plotted on a logarithmic scale (base 10). 




3.2.2.2 Representation of transcript entries and Unigene clusters in the 4 organs 
   To further select only the physiologically relevant transcripts, we implemented a 
more stringent cutoff at 10 RPKM (=3.3 TPC) for all functional analyses. Finally, 
5,758 transcript entries remained after the cutoff will be used to represent the total 
swimbladder transcriptome, which accounts for 61.8% of the total mapped transcript 
entries in the swimbladder transcriptome (Table 3-2). 
    To facilitate transcriptome analyses, transcript entries were converted to Unigene 
clusters, which remove the sequence redundancy and produce an organized view of 
the transcriptome (Pontius et al., 2003). For Unigene clusters mapped by multiple 
transcript entries, the highest RPKM was used to represent the expression level of the 
Unigene cluster. The percentage of Unigene clusters present in each organ is higher 
than the percentage of transcript entries (Table 3-3), which could be explained by one 
Unigene cluster correlating with more than one transcript entries. For the multiple 
transcript entries correlating with one Unigene clusters, there might be only one 
transcript expressing in one organ type.  
 
  












than 10 RPKM  
Percentage 
(%)  
Swimbladder  9,315 55.65 5,758 34.40 
Brain 8,825 52.72 5,587 33.38 
Heart  7,889 47.13 4,180 24.97 
Head kidney  8,910 53.23 4,863 29.05 
 
 











Swimbladder  8,512 74.16 5,506 47.97 
Brain 8,129 70.82 5,354 46.65 
Heart  7,252 63.18 4,008 34.92 
Head kidney  8,220 71.62 4,662 40.62 
The 16,739 transcript entries in ZGC database were mapped to 11,478 zebrafish 
Unigene clusters.  




3.2.2.3 Gene ontology classification of the zebrafish transcriptome 
    Gene ontology slim analysis of the whole transcriptome revealed that all the 4 
organs had very similar distribution of gene ontology categories (Figure 3-3). In terms 
of biological processes, genes involved in metabolism are the most abundant in all 4 
organs, demonstrating that the majority of the transcriptome is participating basic 
metabolic processes to maintain the normal physiology of the organ. Membrane and 
nucleus are two most abundant cellular component categories. However, this result 
might be due to the incomplete gene ontology database, as more than 60% of the 
transcripts have no localization information. Moreover, many gene products are part 
of various macromolecular complexes to fulfill their functions. 
    The results show that most gene ontology categories have similar distributions in 
the 4 organs, which demonstrate that even the 4 organs have different primary 
functions, a full set of transcripts have to be present to serve all aspects of the organ’s 
physiology. The variations of transcript expression levels may contribute more to the 
differential constitutions and functions of each organ.  
    The brain has significantly higher percentages of transcripts located in the 
membrane, which is in coincidence with the massive amount of neurons in the brain. 
Transcripts with nucleotide binding function and structural molecule activity are 
enriched in the heart, which reflects the muscular nature of the organ. In the 
swimbladder transcriptome, there are more transcripts involved in cellular component 
organization and cytoskeleton constitution, which may indicate the organ has more 
complex tissue constitution. Transcripts located in the endoplasmic reticulum and 
Golgi complex are also enriched in the swimbladder, suggesting that the active protein 
modification and transportation. 












Figure 3-3. Gene ontology slim category classification of the zebrafish 
transcriptome under Biological Process, Molecular Function and Cellular 
Component classifications. Slim classifications of the brain, heart, head kidney and 
swimbladder transcriptome are represented by blue, red, green and purple bars, 
respectively. Astrid is used to label significantly enriched categories in the organ 
against other organs (FDR<0.01).




3.2.3.4 Energy distribution of the zebrafish organs 
    As we suspected, the variations of transcript expression level are the key factors 
contributing to the differences of organs, we continue to examine the energy 
distribution of each organ by combining the transcript classifications and the 
expression levels. Energy distribution describes how a given tissue distributes its 
transcriptional energy based on relative abundance of total transcripts in different GO 
groups, thus yielding information on the main function of the tissue (Zeng and Gong, 
2002). Significant differences are observed among the organs (Figure 3-4). 
    Within the biological process domain, genes related to cell communication and 
multicellular organismal process constitute small amounts of the energy expenditure 
in all organs, although these two categories show very diversified gene expression 
profiles as shown by gene ontology classification. These categories contain most 
signaling molecules and receptors. The fact of diversified expression profiles and low 
energy expenditure for these two categories fits the scenario that most genes in 
signaling cascades are expressed at a relatively low level. Among cellular component 
categories, genes located in membrane, nucleus and macromolecular complex are the 
most abundant groups, identical with gene ontology classification results. 
    Generally speaking, the brain has the most even energy distribution among the 4 
organs. However, the brain shows lower level of transcripts involved in ‘response to 
stimulus’, which could be explained by the relatively lower expression of genes with 
immune response function. In terms of cellular component, the brain has higher 
transcript levels of ribosomal genes, which represents the high demanding of new 
protein synthesis. 




    In contrast, the heart shows extremely high energy investment in several GO 
categories, such as biological regulation, developmental process and cellular 
component organization. The bias is caused by the high expression of myosin in the 
heart, which is involved in cardiac muscle development, organization, and regulation. 
And the fulfillment of its function requires calcium binding, which is reflected by the 
fact that transcripts with ‘calcium binding’ function are extraordinarily abundant. 
    The similar uneven energy distribution is also observed in the head kidney. The 
head kidney shows more transcripts with nucleic acid and nucleotide binding function 
and hydrolase activity. A detailed examination of its transcriptome shows that the top 
transcribed gene is ddx54, which is an RNA helicase localized in the nucleus. The 
gene interacts with estrogen receptor and other nuclear receptors in a hormone-
dependent manner to represses their transcriptional activities (Rajendran et al., 2003). 
It is thought to function in transcriptional regulation, but there is no evidence of its 
function in the kidney.  
    The swimbladder shows much higher energy expenditure on transcripts involved in 
protein binding and lipid binding than the other 3 organs, which reflects the 
abundance of membrane proteins in the swimbladder. More transcripts constituting 
the cytoskeleton are present in the swimbladder. And transcripts located in the 
extracellular matrix and Golgi apparatus are also abundant, which might indicate the 
active synthesis and secretion of extracellular proteins. Furthermore, the swimbladder 
shows the highest energy expenditure on transcription factors, and it is contributed by 
the high expression of hoxC genes, which will be further depicted in section 3.2.4.3 
and discussed in section 3.3.3. 
 











Figure 3-4. Energy distribution of the zebrafish transcriptome under Biological 
Process, Molecular Function and Cellular Component classifications. Slim 
classifications of the swimbladder, brain, heart and head kidney transcriptome are 
represented by blue, red, green and purple bars, respectively. The median average of 
each category is shown by the hollow square. The significant different organ in each 
category is marked by asterisk. **: very significant (p<0.01), *: significant (p<0.05). 
 
 




3.2.3.5 Identification of organ-specific enriched genes 
    The original zebrafish transcriptome lists of the four organs contain many 
ribosomal protein genes and other housekeeping genes. To extract a more specific 
zebrafish transcriptome for each organ, lists of enriched genes in the swimbladder was 
generated using one sample t-test. The list efficiently excluded commonly expressed 
housekeeping genes and retained rarely expressed genes (e.g. those coding for 
transcription factor and signaling activity) if they were enriched in the organ.  
    The gene ontology slim classification of the organ-specific enriched gene lists 
showed more variations among different organs compared to the whole transcriptome 
(Figure 3-5). The brain showed enrichment only in genes located in the vesicle, 
correlating with its active vesicle transmission between synapses. The heart enriched 
genes showed significantly higher percentage of genes with transferase activity and 
located in the mitochondrion and ribosome, which suggests that the organ has very 
high level of protein and energy metabolic rate. Being the major immune response 
organ in teleosts, the head kidney exhibits very high percentage of genes involved in 
response to stimulus. Moreover, it also has higher percentage of genes with lipid and 
carbonhydrate binding function and electron carrier activity, suggesting the head 
kidney is an organ with unique functions and worth further exploring. 
 
Table 3-4 Number of enriched Unigene entries in each organ 
Organ Number of enriched genes  
Brain 1,732 
Heart 535 
Head kidney 684 
Swimbladder 888 
 












Figure 3-5. Gene ontology slim category classification of the zebrafish organ-specific enriched genes under Biological Process, 
Molecular Function and Cellular Component classifications. Slim classifications of the brain, heart, head kidney and swimbladder 
transcriptome are represented by blue, red, green and purple bars, respectively. Astrid is used to label significantly enriched categories 
in the organ (FDR<0.01). 




3.2.3 Functional analysis of the zebrafish swimbladder transcriptome 
3.2.3.1 Gene ontology slim classification of the swimbladder transcriptome 
    A total of 4,489 zebrafish Unigene clusters identified in the swimbladder was 
classified based on Gene ontology (GO). Comparing to the distribution of GO 
categories of the total ZGC database (9,530 Unigene clusters), the swimbladder has 
significantly more genes with unknown function in all the three classifications: 
Biological Process, Molecular Function, and Cellular Components, indicating the fact 
that the swimbladder is a less understood organ (Figure 3-6). Under the Biological 
Process classifications (Figure 3-6a), large proportions of genes are involved in 
housekeeping functions such as metabolic processes and biological regulation. In 
Molecular Function classification, the categories of nucleotide binding and transferase 
activity were significantly enriched in the swimbladder (Figure 3-6b). Based on 
Cellular Component classification in Figure 3-6c, genes function in the endoplasmic 
reticulum, Golgi apparatus, and endomembrane system are enriched in the 
swimbladder, suggesting the active synthesis and transportation of proteins. In 
particular, genes constituting the endosome are actively involved endocytosis to 
degrade or recycle extracellular components.  
    In Molecular Function classification, the categories of nucleotide binding and 
structural molecular activity were significantly enriched in the swimbladder, whereas 
in Cellular Component classification genes functioning in the endoplasmic reticulum 
was enriched in the swimbladder, suggesting the active synthesis and transportation of 
proteins. In particular, enriched categories under Molecular Function and Cellular 
Component together implicated the abundance of cytoskeleton genes in the 
swimbladder.  












Figure 3-6. Gene ontology slim enrichment in the swimbladder transcriptome.  
Biological process (a), molecular function (b), and cellular component (c) slim 
classifications of the total ZGC database entries and swimbladder transcriptome are 
represented by blue and red bars, respectively. Astrid is used to label significantly 










3.2.3.2 Comparison of Gene ontology classification and energy distribution of the 
swimbladder transcriptome 
    Then we further compared the Gene ontology classification and energy distribution 
of swimbladder under Molecular Function category. As shown in Figure 3-7, genes 
with ion binding functions are the most diversified group in the swimbladder, and this 
group occupies an even heavier proportion in the energy distribution, indicating these 
transcripts tend to have high expression levels. Similar categories include genes with 
protein and lipid binding functions. Together, these three categories constitute more 
than 50% of the swimbladder energy expenditure, which illustrates that the 
swimbladder invest much energy to maintain the structural stability. At the same time, 
there are a few categories which show high diversity but have low expression levels, 
including genes with hydrolase, transferase, transcription regulator, molecular 
transducer, and enzyme regulator activities, as well as genes which can bind to nucleic 
acids. These categories are crucial for maintaining basic metabolisms and performing 
specific functions for the swimbladder, although they are expressed at relatively lower 
levels. 





Figure 3-7. Gene ontology classification and energy distribution of the swimbladder transcriptome. Gene ontology classification (a) 
and energy distribution (b) are based on GO Slim classification of molecular functions. Genes without gene ontology information 
constitute 40% of the total swimbladder transcriptome and they were not included in the pie chart.  




3.2.3.3 Gene ontology enrichment analysis of the swimbladder transcriptome 
    A further detailed enrichment analysis of GO Fat terms was performed using the 
total swimbladder transcriptome to reveal unique features of the organ without 
consideration of the expression levels (Table 3-5). The term “binding” could be 
assigned to the largest group of all transcript entries (3,126 GenBank entries). The 
second largest group is genes with catalytic activity. The results of enriched functional 
groups in terms of cellular component and biological process together support the 
importance of protein modification and transportation in the swimbladder. From the 
results of enriched biological process and molecular function terms, we observed that 
small GTP signaling played an important role in the swimbladder. 
 
Table 3-5 Gene ontology enrichment analysis of the zebrafish swimbladder 
transcriptome 
 











GO:0006412~translation 170 3.11 1.55E-23 2.68E-20 
GO:0015031~protein transport 173 3.16 7.31E-17 1.89E-13 
GO:0045184~establishment of protein localization 173 3.16 7.31E-17 1.89E-13 
GO:0008104~protein localization 179 3.27 1.47E-15 2.50E-12 
GO:0030163~protein catabolic process 119 2.18 4.53E-12 7.85E-09 
GO:0006457~protein folding 73 1.34 9.80E-12 1.70E-08 
GO:0044265~cellular macromolecule catabolic process 119 2.18 4.24E-11 7.36E-08 
GO:0009057~macromolecule catabolic process 133 2.43 4.32E-11 7.49E-08 
GO:0044257~cellular protein catabolic process 108 1.98 1.02E-10 1.76E-07 
GO:0051603~proteolysis involved in cellular protein 
catabolic process 108 1.98 1.02E-10 1.76E-07 
GO:0043632~modification-dependent macromolecule 
catabolic process 100 1.83 1.14E-10 1.98E-07 
GO:0019941~modification-dependent protein 
catabolic process 100 1.83 1.14E-10 1.98E-07 
GO:0006396~RNA processing 109 1.99 3.69E-08 6.39E-05 
GO:0006886~intracellular protein transport 80 1.46 1.74E-07 3.02E-04 
GO:0046907~intracellular transport 102 1.87 2.06E-07 3.57E-04 
GO:0034613~cellular protein localization 81 1.48 2.39E-07 4.14E-04 
GO:0070727~cellular macromolecule localization 81 1.48 3.55E-07 6.15E-04 




GO:0006397~mRNA processing 53 0.97 2.18E-06 3.78E-03 
GO:0006413~translational initiation 25 0.46 4.79E-06 8.31E-03 
GO:0007264~small GTPase mediated signal 
transduction 102 1.87 8.05E-06 1.40E-02 
GO:0016071~mRNA metabolic process 55 1.01 1.73E-05 3.01E-02 
GO:0006605~protein targeting 30 0.55 3.04E-05 5.27E-02 













GO:0003735~structural constituent of ribosome 113 2.07 3.40E-26 5.41E-23 
GO:0003723~RNA binding 149 2.73 1.08E-11 1.72E-08 
GO:0005198~structural molecule activity 172 3.15 2.70E-11 4.30E-08 
GO:0051082~unfolded protein binding 45 0.82 1.66E-08 2.65E-05 
GO:0000166~nucleotide binding 701 
12.8
2 1.81E-08 2.88E-05 
GO:0003743~translation initiation factor activity 41 0.75 2.45E-08 3.90E-05 
GO:0019787~small conjugating protein ligase activity 44 0.80 1.07E-06 1.71E-03 
GO:0008135~translation factor activity, nucleic acid 
binding 53 0.97 1.50E-06 2.39E-03 














GO:0030529~ribonucleoprotein complex 199 3.64 7.10E-42 9.94E-39 
GO:0005840~ribosome 131 2.40 1.84E-29 2.57E-26 
GO:0043232~intracellular non-membrane-bounded 
organelle 360 6.58 1.10E-26 1.54E-23 
GO:0043228~non-membrane-bounded organelle 360 6.58 1.10E-26 1.54E-23 
GO:0031974~membrane-enclosed lumen 122 2.23 7.39E-09 1.03E-05 
GO:0070013~intracellular organelle lumen 114 2.09 6.77E-08 9.47E-05 
GO:0043233~organelle lumen 114 2.09 6.77E-08 9.47E-05 
GO:0005783~endoplasmic reticulum 122 2.23 7.86E-07 1.10E-03 
GO:0031975~envelope 101 1.85 2.49E-06 3.48E-03 
GO:0031967~organelle envelope 100 1.83 2.77E-06 3.88E-03 
GO:0031981~nuclear lumen 95 1.74 4.77E-06 6.67E-03 
GO:0005635~nuclear envelope 33 0.60 1.36E-05 1.90E-02 
GO:0033279~ribosomal subunit 21 0.38 1.47E-05 2.06E-02 
GO:0005730~nucleolus 36 0.66 6.54E-05 9.14E-02 
GO:0046930~pore complex 22 0.40 9.54E-05 1.33E-01 
GO:0005643~nuclear pore 22 0.40 9.54E-05 1.33E-01 
GO:0005739~mitochondrion 124 2.27 1.17E-04 1.64E-01 
 
  




3.2.3.4 Biological function analysis of the swimbladder transcriptome 
   We also explored the biological insights of the swimbladder transcriptome using 
Ingeniuty Pathway Analysis (IPA). The same ranked swimbladder transcriptome file 
as in GSEA pre-ranked analysis was used here, among which 1,767 Human gene 
symbols were identified in the database. Remarkably, connective tissue and skeletal 
and muscular system development and function are the two abundant specific features, 
correlating with the enriched gene sets identified by GSEA pre-ranked analysis 
(Figure 3-8). 
  






Figure 3-8. Biological insights analysis of the swimbladder transcriptome. 
‘Physiological System Development and Function’ categories were selected for this 
analysis Histograms are read with reference to ‘Percentage of Human Homologs 
Used in Analysis’ axis while solid and dashed lines are read with reference to ‘-Log P-
value’ axis. ‘Percentage of Human Homologs Used in Analysis’ refers to the 
percentage of the total 1,767 Human homolog gene symbols available in the 
Ingenuity database. Solid line represents the inverse logarithm (base 10) of the P-
value for each group of biological association, while the dashed line represents the 
significant threshold where the P-value = 0.05. Only the top 10 features with the 
highest percentage of human homologs involved and which are statistically 
significant are shown. 




3.2.4 Analyses of the zebrafish swimbladder enriched gene lists 
3.2.4.1 Functional analyses of the zebrafish swimbladder enriched gene lists 
    A detailed enrichment analysis of GO terms was performed to examine the 
functional distribution of the 888 enriched genes (Table 3-6). Genes located in the 
endoplastic reticulum and extracellular region were enriched in the list, which 
implicated the active protein modification and transportation in the swimbladder. The 
results of enriched functional group in terms of Biological Process and Molecular 








Table 3-6 Enrichment of Gene ontology terms in the swimbladder enriched genes 
 Term Count % PValue 
Biological 
Process 
GO:0001558~regulation of cell growth 12 1.20 1.56E-05 
GO:0040008~regulation of growth 12 1.20 6.05E-05 
GO:0048729~tissue morphogenesis 15 1.50 3.16E-03 
GO:0007242~intracellular signaling cascade 38 3.79 3.55E-03 
GO:0042074~cell migration involved in gastrulation 11 1.10 4.36E-03 
GO:0016477~cell migration 16 1.60 4.82E-03 
GO:0007264~small GTPase mediated signal transduction 22 2.20 5.40E-03 
GO:0051674~localization of cell 17 1.70 5.51E-03 
GO:0048870~cell motility 17 1.70 5.51E-03 
GO:0001667~ameboidal cell migration 13 1.30 6.30E-03 
GO:0051216~cartilage development 9 0.90 7.67E-03 
GO:0051169~nuclear transport 6 0.60 8.44E-03 
GO:0006913~nucleocytoplasmic transport 6 0.60 8.44E-03 
GO:0048598~embryonic morphogenesis 23 2.30 9.56E-03 
GO:0060026~convergent extension 9 0.90 9.67E-03 
Molecular 
Function 
GO:0005520~insulin-like growth factor binding 10 1.00 6.74E-06 
GO:0019838~growth factor binding 10 1.00 7.56E-05 
GO:0005525~GTP binding 34 3.39 3.01E-03 
GO:0032561~guanyl ribonucleotide binding 34 3.39 3.60E-03 
GO:0019001~guanyl nucleotide binding 34 3.39 3.91E-03 
Cellular 
Component 
GO:0005576~extracellular region 54 5.39 4.58E-08 
GO:0005578~proteinaceous extracellular matrix 16 1.60 1.20E-04 
GO:0031012~extracellular matrix 16 1.60 1.98E-04 
GO:0044421~extracellular region part 21 2.10 1.12E-03 
GO:0043235~receptor complex 6 0.60 5.00E-03 
GO:0005783~endoplasmic reticulum 24 2.40 7.78E-03 
The counts are presented in transcript entry counts. The percentage for each GO 
term represents the percentage of transcript entries in the GO term in the total 
transcript entries identified in the DAVID database. P-values represent a modified 
Fisher’s exact t-test, and FDR score was provided as a multiple testing correction 
method. Only GO terms with p-value<0.001 and FDR<0.05 were shown in the table. 
Refer to Supplementary Table 1 for all enriched GO terms with p-value<0.05. 
  




    We furthered examined the composition of these signaling molecules (Table 4-7). 
Among the 201 zebrafish Unigenes identified in the KEGG pathway database, 31 of 
them were involved in focal adhesion or extracellular matrix (ECM)-receptor 
interaction, suggesting the critical role of ECM in the swimbladder. Genes involved in 
adherens junction and tight junction were also enriched, which is essential for 
epithelial morphology and function. Particularly, genes involved in Hedgehog and 
TGF beta signaling pathways were enriched. Previous research in the lab has shown 
that Hedgehog signaling is critical for swimbladder specification and organization 
during embryogenesis (Winata et al., 2009). The current transcriptome data correlates 
with the early developmental mechanism, suggesting that Hedgehog pathway remains 
active in the adulthood stage and may be important to maintain swimbladder regular 
function. Furthermore, GSEA pre-ranked analysis produced similar results in a 
quantitative manner (Table 3-8).  
 
  




Table 3-7 KEGG pathway analysis of the swimbladder enriched gene list 
Term Count % PValue 
dre04510:Focal adhesion 29 2.89 3.22E-06 
dre04810:Regulation of actin cytoskeleton 24 2.40 9.11E-04 
dre04512:ECM-receptor interaction 11 1.10 1.73E-03 
dre04520:Adherens junction 12 1.20 8.45E-03 
dre04530:Tight junction 14 1.40 2.74E-02 
dre04340:Hedgehog signaling pathway 8 0.80 3.54E-02 
The counts are presented in Unigene cluster counts. The percentage for each GO 
term represents the percentage of Unigene clusters in the GO term in the total 
transcript entries identified in the DAVID database. P-values represent a modified 
Fisher’s exact t-test. Only GO terms with p-value<0.05 were shown in the table. 
 
Table 3-8 Enriched Canonical Pathways in the swimbladder transcriptome 
NAME SIZE NES NOM p-val 
HSA04512_ECM_RECEPTOR_INTERACTION 9 1.71 1.63E-02 
HSA04060_CYTOKINE_CYTOKINE_RECEPTOR_INTERACTION 8 1.68 3.03E-02 
HSA04340_HEDGEHOG_SIGNALING_PATHWAY 6 1.62 3.58E-02 
HSA04350_TGF_BETA_SIGNALING_PATHWAY 10 1.56 4.64E-02 
Gene sets that are statistically enriched with nominal p-value (NP) and false 
discovery rate (FDR) are shown. The sizes of the gene sets mean the number of the 
genes from the pre-defined canonical pathway database which are identified from 
the swimbladder transcriptome with RPKM > 10. Values of normalized enrichment 
score (NES) indicate the activities of the enriched gene sets. 
  




3.2.4.2 Top enriched genes in the swimbladder 
    In the list of top 50 transcribed genes (Table 3-9), the most abundant category was 
extracellular matrix (13 zebrafish Unigenes). Among them, three different 
glycoprotein genes were present: sparc, dcn and chad.  
    Sparc encodes a prototypic matricellular protein, which is conserved in a wide 
variety of evolutionarily diverse organisms (Kawasaki et al., 2004; Tanaka et al., 
2001). Sparc can bind calcium, hydroxyapatite, and multiple types of collagens 
(Giudici et al., 2008). In mammals, Sparc is highly expressed in many developing 
tissues, including heart, thymus, lung, and gut (Mundlos et al., 1992; Sage et al., 
1989). However, upon organ maturation, levels of Sparc decrease and remain 
relatively low in most adult tissues with the exception of those undergoing high rates 
of matrix production and proliferation such as bone, skin and gut epithelia. Moreover, 
there is robust elevation of Sparc expression upon injury, particularly those associated 
with excessive deposition of collagen (Bradshaw and Sage, 2001). Hence, expression 
patterns of Sparc are consistent with a critical role of this protein in collagen 
production and deposition, as collagen is also highly expressed in the swimbladder. 
    Dcn and chad belong to another glycoprotein family, the small leucine-rich repeat 
proteoglycan (SLRP) family. The SLRP family is found in a variety of extracellular 
matrix tissues, including bone, cartilage and tendon. Dcn is known to bind to different 
types of collagens (Kresse et al., 1994). It can be located in the extracellular cellular 
matrix (ECM) or in the cell membrane interacting with cell surface receptors. In 
muscles, Dcn located in the ECM function as components of it, regulating the matrix 
structure as well as modulating the bioavailability of several growth factors, including 
BMP4 and TGF-b (Brandan et al., 2008; Cabello-Verrugio and Brandan, 2007; Chen 




et al., 2004). Overexpression of Dcn can induce migration of fibroblasts. A number of 
the intracellular regulators and effectors involved in cell migration can be up-
regulated, including the focal adhesion proteins, and some of the small Rho GTPase 
such as RhoA, Rac1 and Cdc42 (Tufvesson and Westergren-Thorsson, 2003).  
    The second most abundant category in the top 50 transcribed genes list was 
cytoskeleton genes, especially those important for muscle contraction (acta2, tagln, 
cald1, mylka, tpm4, and myl6). The third most abundant category was membrane 
protein genes, including immune-related genes (epcam, caprin1b, rergl, cldnd, tspan4, 
sdc2, and aplp2). Bacterial and fungal infections of the swimbladder are occasionally 
reported in various fish species (Aho et al., 1988; Wada et al., 1993). Having an open 
swimbladder that connects to the gastro-intestinal tract, the zebrafish swimbladder is 
more vulnerable to infection than physoclistous fishes. Our observation indicated that 
the swimbladder had its own defensive mechanism by expressing high levels of 
surface recognition molecules. 
 
  




Table 3-9 Top 50 enriched Unigenes in the swimbladder with annotation 
 
UGCluster Gene Symbol Gene Name RPKM P value 
1 Dr.20277 acta2 Actin, alpha 2, smooth muscle, aorta 75742.5 1.17E-06 
2 Dr.82256 tagln Transgelin 7296.7 2.43E-05 
3 Dr.75554 sparc 
Secreted acidic cysteine rich 
glycoprotein 
3751.4 3.04E-06 
4 Dr.75575 col1a2 Collagen, type I, alpha 2 2351.1 1.94E-04 
5 Dr.76397 mmp2 Matrix metalloproteinase 2 2038.5 6.96E-05 
6 Dr.105413 tpm1 Tropomyosin 1 (alpha) 1903.5 1.90E-05 
7 Dr.76093 s100a10b S100 calcium binding protein A10b 1821.1 8.08E-03 
8 Dr.67796 icn Ictacalcin 1584.0 4.87E-03 
9 Dr.42794 ctgf Connective tissue growth factor 1537.3 6.25E-05 
10 Dr.24504 pabpc1a Poly A binding protein, cytoplasmic 1 a 1248.1 1.14E-03 
11 Dr.114623 cald1 Caldesmon 1 1226.2 5.84E-04 
12 Dr.79279 lum Lumican 1175.7 3.22E-05 
13 Dr.34240 fbp2 Fructose-1,6-bisphosphatase 2 1053.9 3.96E-06 
14 Dr.79127 stm Starmaker 1023.5 9.47E-03 
15 Dr.89765 zgc:103467 Myosin, light chain 9, regulatory 1014.0 1.90E-03 
16 Dr.122523 dap1b Death associated protein 1b 944.6 1.09E-02 
17 Dr.76351 dcn Decorin 839.7 2.12E-04 
18 Dr.77427 b2m Beta-2 microglobulin 798.2 1.41E-04 
19 Dr.7877 mylka Myosin, light chain kinase a 718.8 3.27E-04 
20 Dr.76950 tpm4 Topomyosin alpha-4 chain 699.1 7.02E-04 
21 Dr.88679 fhl2a Four and a half LIM domains 2a 693.6 5.34E-03 
22 Dr.43046 c1qtnf1 
C1q and tumor necrosis factor related 
protein 1 
682.7 1.05E-06 
23 Dr.155448 bactin2 Bactin2 661.0 2.56E-04 
24 Dr.86222 rergl RERG/RAS-like 651.3 1.82E-04 
25 Dr.80811 si:ch211-237l4.5 Si:ch211-237l4.5 628.6 2.24E-03 
26 Dr.80402 chad Chondroadherin 558.6 5.77E-06 
27 Dr.142266 itgb1b Integrin, beta 1b 536.1 7.00E-03 
28 Dr.105090 ckba Creatine kinase, brain a 480.9 3.89E-03 
29 Dr.110680 mxra8a Matrix-remodelling associated 8a 476.5 4.97E-05 
30 Dr.150732 sdc2 Syndecan 2 465.2 7.39E-04 
31 Dr.104772 LOC100332090 Thymosin, beta 4-like 453.5 1.15E-02 
32 Dr.78058 myh11 
Myosin, heavy polypeptide 11, smooth 
muscle 
448.5 2.10E-03 
33 Dr.33255 tpm3 Tropomyosin 3 428.3 1.37E-02 
34 Dr.81804 dkk3 Dickkopf homolog 3 (Xenopus laevis) 427.7 1.86E-04 
35 Dr.76952 actn4 Actinin, alpha 4 407.0 2.55E-03 
36 Dr.29018 cygb1 Cytoglobin 1 391.4 6.09E-05 
37 Dr.30646 nt5c2b 5'-nucleotidase, cytosolic IIb 389.2 2.50E-06 
38 Dr.560 fbln1 Fibulin 1 387.4 4.79E-05 
39 Dr.15501 cyr61 cystein-rich, angiogenic inducer, 61 365.6 2.04E-03 
40 Dr.75720 myl6 Myosin, light chain 6 356.6 1.38E-03 




41 Dr.80990 htra1b HtrA serine peptidase 1b 353.3 3.41E-04 
42 Dr.76054 tpm4 Tropomyosin 4 350.0 1.82E-03 
43 Dr.83404 csrp1a Cysteine and glycine-rich protein 1a 349.3 3.08E-06 
44 Dr.118039 tnmd tenomodulin 341.5 3.31E-06 
45 Dr.75641 cnn2 Calponin 2 339.9 3.35E-03 
46 Dr.104797 cdc42 Cell division cycle 42 319.7 1.00E-02 
47 Dr.26461 gpc1 Glypican 1 309.2 2.72E-03 
48 Dr.76307 cav1 Caveolin 1 292.7 1.51E-02 
49 Dr.94036 pthlh Parathyroid hormone-like hormone 270.1 1.15E-04 
50 Dr.11532 fbxo32 F-box protein 32 264.6 1.10E-02 
 
 




3.2.4.3 Top enriched transcription factors in the swimbladder 
    Next, we compiled the list of top transcription factors in the swimbladder 
transcriptome based on Gene ontology (Table 3-10).  
    One unique observation is that three genes from the hoxC cluster are enriched in 
the swimbladder, including hoxc8a, hoxc6a and hoxc4a. In order to confirm the 
expression and role of hoxC genes in developing swimbladder, we examined the 
expression of hoxc4a/6a/8a during zebrafish embryogenesis (Figure 3-9). The early 
expression pattern is consistent with previously reported results (Prince et al., 1998). 
Expression of these genes in the notochord all have clear anterior boundaries and 
follows the colinearity rule. Hoxc4a starts to express in the notochord at the position 
of hindbrain, while hoxc6a and hoxc8a have the anterior expression boundary at 
approximately somite 2 and 4 respectively. None of their expression domain has a 
clear posterior boundary. Expression of all three genes in the swimbladder 
primordium could be detected at 36 hpf. The expression of hoxc8a became very 
prominent in the swimbladder starting from 48 hpf and is persistent at least until 72 
hpf. Cross-section confirmed that hoxc8a was expressed strongly in the mesenchyme 
and relatively weakly in the mesothelium. Hoxc6a was expressed at a slightly lower 
level from 48 hpf to 72 hpf, and it was also expressed in the swimbladder 
mesenchyme and mesothelium. On the other hand, hoxc4a was expressed at a barely 
visible level in the swimbladder and likely also in the mesoderm, but the exact 
expression domain is too weak to be confirmed by cross-section. 
    Two closely related Forkhead homeobox genes, foxl1 and foxf1 were also on the 
top of the list of enriched transcription factors (Stankiewicz et al., 2009). Foxf1 was 
expressed in the swimbladder primordium as early as 36 hpf and the expression was 




persistent in the swimbladder until at least 72 hpf (Figure 3-10). At the same time, 
prominent expression was also observed along the alimentary tract. Cross-section 
confirmed that the expression of foxf1 was restricted to the mesenchyme layer in both 
the swimbladder and the alimentary tract (Figure 3-11). However, although the 
expression level of foxl1 is higher than foxf1 in the adult swimbladder as revealed by 
the RNA-seq data, expression of foxl1 was not identified in the developing 
swimbladder (data not shown). 
 





Gene Name RPKM P value* 
1 Dr.132201 hoxc8a Homeo box C8a 185.8 8.06E-05 
2 Dr.132203 hoxc6a Homeo box C6a 143.2 NA 
3 Dr.15390 foxl1 Forkhead box L1 108.0 1.45E-03 
4 Dr.89399 foxf1 Forkhead box F1 85.8 4.48E-04 
5 Dr.12437 tsc22d3 TSC22 domain family, member 3 74.2 4.84E-03 
6 Dr.155563 atf1 Activating transcription factor 1 63.0 4.85E-04 
7 Dr.81025 foxk1 Forkhead box K1 61.5 2.41E-02 
8 Dr.152531 foxq1l Forkhead box Q, like 46.6 NA 
9 Dr.139 tgif1 TGFB-induced factor homeobox 1 45.9 1.96E-02 
10 Dr.80310 stat6 
Signal transducer and activator of transcription 6, 
interleukin-4 induced 
44.6 1.33E-02 
11 Dr.82149 zhx3 Zinc fingers and homeoboxes 3 33.3 2.45E-02 
12 Dr.20916 isl2b Islet2b 28.0 NA 
13 Dr.510 hoxc4a Homeo box C4a 27.5 2.47E-03 
14 Dr.15663 cebpg CCAAT/enhancer binding protein (C/EBP), gamma 26.8 1.28E-02 
15 Dr.32618 hoxa3a Homeo box A3a 26.1 1.71E-03 
16 Dr.91917 mnx1 Motor neuron and pancreas homeobox 1 25.9 1.63E-03 
17 Dr.80606 creb3l2 
cAMP responsive element binding protein 3-like 
2 
22.4 3.49E-03 
18 Dr.8233 tbx2b T-box 2b 22.0 1.03E-02 
19 Dr.83529 hsf5 heat shock transcription factor family member 5 20.6 1.46E-03 
20 Dr.114796 foxm1l Forkhead box M1-like 17.0 7.81E-03 
*NA, P value not available because the transcripts were detected only in the 
swimbladder.   





Figure 3-9 Expression of hoxc4a, hoxc6a and hoxc8a in the developing swimbladder. 
(A, D, G, J) Expression of hoxc4a in the swimbladder at 36 hpf (A), 60 hpf (D) and 72 
hpf (G, J). Anterior boundary of hoxc4a expression is at the position of hindbrain. 
Expression of hoxc4a can be weakly detected in the swimbladder from 36 hpf to 72 
hpf. (B, E, H, K) Expression of hoxc6a in the swimbladder at 36 hpf (B), 60 hpf (E) and 
72 hpf (H, K). Hoxc6a’s most anterior expression domain in the notochord is at 
somite 2. The expression of hoxc6a can be clearly seen in the swimbladder from 36 
hpf to 72 hpf, and cross section shows that hoxc6a is expressed in the mesenchyme 
and mesothelium (L). (C, F, I, L) Expression of hoxc8a in the swimbladder at 36 hpf (C), 
60 hpf (F) and 72 hpf (I, L). The expression of hoxc8a can be detected in the 
swimbladder at 36 hpf, and become very prominent in the swimbladder from 48 hpf 
and is persistent until 72 hpf. Cross-section confirms that hoxc8a expresses in the 
mesenchyme and part of the mesothelium (L). A-I are in lateral view, and J-L are 
shown in cross section. Swimbladder is indicated by red dashed-line circles or red 
arrows. Numbers are used to mark the position of somite 1-4. 
  





Figure 3-10. Expression of foxf1 in zebrafish embryo at different developmental 
stages. (A, B) Foxf1 is bilaterally expressed in the lateral plate mesoderm at 18 
somites. (C, D) Foxf1 is expressed in the brain and the pharyngeal arches at 24 hpf. (E, 
F) Foxf1 is expressed is expressed in the pharyngeal arches and the swimbladder 
primordium at 36 hpf. (G, H) Foxf1 is expressed along the alimentary tract and in the 
swimbladder at 60 hpf (G) and 72 hpf (H). For whole mount embryos, A, C, E, G and H 
are lateral views, and D and F are ventral views. All embryos are positioned with 
head pointing to the left. B is cross section of the embryo shown in A. Red 
arrowheads point out the lateral plate mesoderm, and red arrows indicate the 
swimbladder. Numbers are used to mark the position of somite 1-5. 
 
  








Figure 3-11. Expression of foxf1 along the alimentary tract and in the swimbladder 
at 72 hpf. As shown in cross sections, foxf1 is expressed in the mesenchyme 
surrounding the mouth (B, C), pharynx (D), esophagus (E, F), pneumatic duct (E, F), 
swimbladder (G) and gut (G, H). Abbreviations: m, mouth; p, pharynx; pd, pneumatic 








3.2.5 Resemblance of swimbladder transcriptome to mammalian lung 
    In order to gain insight into molecular resemblance of fish swimbladder and 
mammalian lung, our swimbladder transcriptomic data were compared with the 
transcriptomic data from various human and mouse tissues based on microarray 
studies. The enriched gene list of each zebrafish tissue was used to represent its 
transcriptome. As shown in Table 3-11 and 3-12, based on normalized enrichment 
scores (NES), the zebrafish brain show high resemblance to the human fetal and adult 
brains as well as the cerebellum and hippocampus of mouse. Meanwhile, the zebrafish 
heart closely resembles the mammalian heart and skeletal muscle, indicating similar 
cellular constitutions of the two tissues and thus validating the methodology. Among 
all the endodermal organs compared, it is interesting to note that the zebrafish 
swimbladder has the highest and significant NES to both human and mouse lung, 
indicating that indeed the fish swimbladder has the highest resemblance with lung at 
the transcriptome level. 
    The leading edge gene list in the human lung contains both constitution of the ECM 
(LUM, FN1, COL1A2, CYR61 and SPARC) and regulators of the ECM (TFPI, 
MMP2, RNPEP and HPSE), indicating that the zebrafish swimbladder and human 
lung may have some similar ECM characteristics (Table 3-13). A few molecules 
belonging to the small GTPase signaling pathway are identified (TNFAIP1, RND3, 
ARHGAP29, RASL12 and MX1), suggesting that the small GTPase signaling 
pathway may play an important role in both organs. Besides, genes involved in 
MAPK (DUSP1), TGF (TGFBI), and BMP (BMP5) signaling pathways are also 
identified. Several transcription factors are present in the list, including TGIF1, 
FOXF2, FOXF1, AATF and PFDN1. Examination of the leading edge gene list in the 
mouse lung showed a similar profile (Table 3-14).  




    Interestingly, the zebrafish head kidney showed very significant correlation with 
the human kidney and bone marrow, and significant correlation with the mouse 
kidney. It also showed significant correlation with the human adrenal gland and 










































































3.02** 2.43** -1.36* -1.31** -1.66** -1.45** -1.92** -1.55** -1.84** -1.50** 
<0.001 <0.001 0.005 0.051 0.001 0.003 <0.001 0.001 <0.001 <0.001 
Heart 
-1.23 -1.68** 2.99** 2.70** 0.90 -1.53** -1.13 0.84 1.43* 1.44* 
0.091 <0.001 <0.001 <0.001 0.202 0.006 0.175 0.882 0.016 0.007 
Swim 
bladder 
-1.62* -1.52** -1.41** -1.27* 1.46* 1.51** 0.87 1.26 -0.93 1.09 
0.004 0.001 <0.001 0.036 0.020 0.005 1.000 0.166 0.666 0.270 
Head 
kidney 
-1.09 -0.77 -0.66 0.91 1.15 0.79 0.71 1.03 2.69** 2.27** 
0.251 0.984 0.999 0.704 0.180 0.906 0.992 0.572 <0.001 <0.001 
 
  














































































-1.58** -1.58** -1.75** -1.85** -1.95* -1.67* -1.22 -1.44** -1.90* -1.64* 
<0.001 0.002 <0.001 <0.001 <0.001 <0.001 0.142 0.007 <0.001 <0.001 
Heart 
0.83 0.86 0.80 1.31* -0.74 1.74* 1.53* -1.08 -1.56* -1.56** 
0.882 0.829 0.907 0.11 0.979 <0.001 0.004 0.248 <0.001 <0.001 
Swim 
Bladder 
0.86 -1.12 -1.18 1.15 1.78* 1.04 -1.13 -1.55** -0.91 -1.00 
1.000 0.261 0.096 0.214 <0.001 0.345 0.166 <0.001 0.756 0.458 
Head 
kidney 
1.05 -0.56 1.66* 0.96 -0.88 2.48** 1.41* 1.98** 1.52* 0.71 
1.000 1.000 0.001 0.561 1.000 <0.001 0.009 <0.001 0.004 0.983 
 
Each intersection of the two zebrafish and human organs was split into two cells. Upper cell shows NES, and lower cell shows the 
corresponding FDR. **: very significant (p<0.001), *: significant (p<0.05). 
 
  





































































2.51** 2.26** -1.81* -1.38** -1.66** -2.10** -1.11 -1.56** -1.53** 
<0.001 <0.001 <0.001 0.016 0.001 <0.001 0.364 <0.001 0.003 
Heart 
-1.41* -1.74** 3.08** 2.84** -1.51** 0.89 -0.68 1.00 0.81 
0.024 <0.001 <0.001 <0.001 0.002 0.790 0.994 0.47 0.907 
Swim 
bladder 
-1.30* -1.60** -1.01 -1.01 1.42* 1.03 0.92 -1.10 0.85 
0.027 0.001 0.402 0.403 0.013 0.734 1.000 0.204 1.000 
Head 
kidney 
-1.34* -1.14 0.68 0.99 -1.16 -1.09 0.56 3.01** 1.04 
0.032 0.127 0.994 0.495 0.133 0.253 1.000 <0.001 1.000 
 
  















































































-1.71** -1.82** -1.41** -1.21* -1.08 -1.38** -1.74** -1.17* -1.50** 
<0.001 <0.001 0.025 0.148 0.253 0.007 <0.001 0.090 <0.001 
Heart 
1.01 -0.74 -1.15 1.92** 1.20 -1.45** -1.71** -1.37* -1.92** 
0.44 0.983 0.127 <0.001 0.201 0.008 <0.001 0.032 <0.001 
Swim 
bladder 
-1.32* -0.86 1.65** -1.09 1.02 0.91 0.89 -1.28** 0.78 
0.03 1.000 0.002 0.218 0.430 0.684 0.741 0.045 0.901 
Head 
kidney 
2.02** 1.01 0.89 2.41** 1.20 1.39* 0.93 0.81 1.00 
<0.001 0.408 0.727 <0.001 0.201 0.028 1.000 0.875 0.986 
 
Each intersection of the two zebrafish and mouse organs was split into two cells. Upper cell shows NES, and lower cell shows the 
corresponding FDR. **: very significant (p<0.001), *: significant (p<0.05).




Table 3-13 List of GSEA leading edge genes between the zebrafish swimbladder and 
the human lung 
  UGCluster Symbol Name 
1 Hs.437322 TNFAIP6 Tumor necrosis factor, alpha-induced protein 6 
2 Hs.200738 SLC38A6 Solute carrier family 38, member 6 
3 Hs.494496 FBP1 Fructose-1,6-bisphosphatase 1 
4 Hs.74034 CAV1 Caveolin 1, caveolae protein, 22kDa 
5 Hs.517168 TAGLN2 Transgelin 2 
6 Hs.200804 SDCBP Syndecan binding protein (syntenin) 
7 Hs.406475 LUM Lumican 
8 Hs.494173 ANXA1 Annexin A1 
9 Hs.76686 GPX1 Glutathione peroxidase 1 
10 Hs.373550 TGIF1 TGFB-induced factor homeobox 1 
11 Hs.516578 TFPI Tissue factor pathway inhibitor  
12 Hs.446017 WSB1 WD repeat and SOCS box containing 1 
13 Hs.76090 TNFAIP1 Tumor necrosis factor, alpha-induced protein 1 (endothelial) 
14 Hs.203717 FN1 Fibronectin 1 
15 Hs.235069 RECQL RecQ protein-like (DNA helicase Q1-like) 
16 Hs.369397 TGFBI Transforming growth factor, beta-induced, 68kDa 
17 Hs.103755 RIPK2 Receptor-interacting serine-threonine kinase 2 
18 Hs.6838 RND3 Rho family GTPase 3 
19 Hs.17518 RSAD2 Radical S-adenosyl methionine domain containing 2 
20 Hs.496622 PLS3 Plastin 3 
21 Hs.380627 CMTM6 CKLF-like MARVEL transmembrane domain containing 6 
22 Hs.523004 PSAP Prosaposin 
23 Hs.145717 JMJD5 Jumonji domain containing 5 
24 Hs.490415 ZYX Zyxin 
25 Hs.513617 MMP2 Matrix metallopeptidase 2  
26 Hs.126550 VPS4B Vacuolar protein sorting 4 homolog B  
27 Hs.436142 PTPN13 Protein tyrosine phosphatase, non-receptor type 13  
28 Hs.234642 AQP3 Aquaporin 3 (Gill blood group) 
29 Hs.497391 RNPEP Arginyl aminopeptidase (aminopeptidase B) 
30 Hs.322901 UTP3 UTP3, small subunit (SSU) processome component, homolog  
31 Hs.309090 SRSF7 Serine/arginine-rich splicing factor 7 
32 Hs.483238 ARHGAP29 Rho GTPase activating protein 29 
33 Hs.108029 SH3BGRL SH3 domain binding glutamic acid-rich protein like 
34 Hs.59332 SPRED2 Sprouty-related, EVH1 domain containing 2 
35 Hs.484423 FOXF2 Forkhead box F2 
36 Hs.489142 COL1A2 Collagen, type I, alpha 2 
37 Hs.8867 CYR61 Cysteine-rich, angiogenic inducer, 61 
38 Hs.155591 FOXF1 Forkhead box F1 
39 Hs.171695 DUSP1 Dual specificity phosphatase 1 
40 Hs.529272 MARCH7 Membrane-associated ring finger (C3HC4) 7 
41 Hs.474010 PTTG1IP Pituitary tumor-transforming 1 interacting protein 
42 Hs.296648 BMP5 Bone morphogenetic protein 5 




43 Hs.9196 C9orf156 Chromosome 9 open reading frame 156 
44 Hs.79110 NCL Nucleolin 
45 Hs.406096 ZFAND5 Zinc finger, AN1-type domain 5 
46 Hs.195740 AATF Apoptosis antagonizing transcription factor 
47 Hs.120766 ZNF330 Zinc finger protein 330 
48 Hs.436037 MYOC Myocilin, trabecular meshwork inducible glucocorticoid response 
49 Hs.27018 RASL12 RAS-like, family 12 
50 Hs.527861 OS9 Osteosarcoma amplified 9, endoplasmic reticulum lectin 
51 Hs.180909 PRDX1 Peroxiredoxin 1 
52 Hs.44227 HPSE Heparanase 
53 Hs.25441 KPTN Kaptin (actin binding protein) 
54 Hs.426312 AMOTL2 Angiomotin like 2 
55 Hs.515371 CAPNS1 Calpain, small subunit 1 
56 Hs.111779 SPARC Secreted protein, acidic, cysteine-rich (osteonectin) 
57 Hs.497353 MED6 Mediator complex subunit 6 
58 Hs.517307 MX1 Myxovirus resistance 1, interferon-inducible protein p78 
59 Hs.483564 PFDN1 Prefoldin subunit 1 
60 Hs.497581 EIF2D Eukaryotic translation initiation factor 2D 
61 Hs.172865 CSTF1 Cleavage stimulation factor, 3' pre-RNA, subunit 1, 50kDa 
62 Hs.465305 TMEM51 Transmembrane protein 51 
63 Hs.353175 AGPAT4 1-acylglycerol-3-phosphate O-acyltransferase 4  
 
  




Table 3-14 List of leading edge genes between the zebrafish swimbladder and the 
mouse lung 
  UGCluster Symbol Name 
1 Mm.389894 Rras Harvey rat sarcoma oncogene, subgroup R 
2 Mm.28278 Cav1 Caveolin 1, caveolae protein 
3 Mm.260760 Sh3bgrl SH3-binding domain glutamic acid-rich protein like 
4 Mm.258746 
1190002N
15Rik RIKEN cDNA 1190002N15 gene 
5 Mm.66222 Cxadr Coxsackie virus and adenovirus receptor 
6 Mm.25760 Grem2 Gremlin 2 homolog, cysteine knot superfamily (Xenopus laevis) 
7 Mm.4266 Itm2b Integral membrane protein 2B 
8 Mm.157770 Cnn2 Calponin 2 
9 Mm.234266 Sdc2 Syndecan 2 
10 Mm.28777 Pls3 Plastin 3 (T-isoform) 
11 Mm.133825 Crip2 Cysteine rich protein 2 
12 Mm.2675 Pdgfa Platelet derived growth factor, alpha 
13 Mm.229287 Arhgap29 Rho GTPase activating protein 29 
14 Mm.157313 Mafk 
V-maf musculoaponeurotic fibrosarcoma oncogene family, 
protein K (avian) 
15 Mm.163 B2m Beta-2 microglobulin 
16 Mm.1231 Cyr61 Cysteine rich protein 61 
17 Mm.439922 
0610031J0
6Rik RIKEN cDNA 0610031J06 gene 
18 Mm.29990 Tmem208 Transmembrane protein 208 
19 Mm.21787 Hspb11 Heat shock protein family B (small), member 11 
20 Mm.9404 Nbl1 Neuroblastoma, suppression of tumorigenicity 1 
21 Mm.41562 Exosc7 Exosome component 7 
22 Mm.282719 Eya2 Eyes absent 2 homolog (Drosophila) 
23 Mm.282096 Elovl1 Elongation of very long chain fatty acids-like 1 
24 Mm.10153   Transcribed locus 
25 Mm.30246 Cd151 CD151 antigen 
26 Mm.255723 Mbnl1 Muscleblind-like 1 (Drosophila) 
27 Mm.42257 Tekt1 Tektin 1 
28 Mm.239041 Dusp1 Dual specificity phosphatase 1 
29 Mm.41998 Ppp4c Protein phosphatase 4, catalytic subunit 
30 Mm.125548 Foxf2 Forkhead box F2 
31 Mm.390287 Ctgf Connective tissue growth factor 
32 Mm.2820 Galk1 Galactokinase 1 
33 Mm.5068 Sorbs3 Sorbin and SH3 domain containing 3 
34 Mm.295124 Tpm4 Tropomyosin 4 
35 Mm.87720 Arfrp1 ADP-ribosylation factor related protein 1 
36 Mm.258923 Nucb1 Nucleobindin 1 
37 Mm.3941 Eif4e Eukaryotic translation initiation factor 4E 
38 Mm.275341 Ftsjd1 FtsJ methyltransferase domain containing 1 
39 Mm.274846 Ilk Integrin linked kinase 
40 Mm.172346 Tgfbr2 Transforming growth factor, beta receptor II 




41 Mm.156 Dok1 Docking protein 1 
42 Mm.2402 Mprip Myosin phosphatase Rho interacting protein 
43 Mm.57734 Lims1 LIM and senescent cell antigen-like domains 1 
44 Mm.247473 Sdcbp Syndecan binding protein 
45 Mm.248360 Anxa1 Annexin A1 
46 Mm.11112 Spns1 Spinster homolog 1 (Drosophila) 
47 Mm.266668 BC005537 CDNA sequence BC005537 
48 Mm.9075 Ephx1 Epoxide hydrolase 1, microsomal 
49 Mm.39095 Ntn1 Netrin 1 
50 Mm.290704 
C330007P
06Rik RIKEN cDNA C330007P06 gene 
51 Mm.207 Hoxb5 Homeobox B5 
52 Mm.150701 Psmg2 Proteasome (prosome, macropain) assembly chaperone 2 
53 Mm.120763 Mrpl33 Mitochondrial ribosomal protein L33 
54 Mm.273090 Cebpg CCAAT/enhancer binding protein (C/EBP), gamma 
55 Mm.30929 Prdx1 Peroxiredoxin 1 
56 Mm.433257 Dnm2 Dynamin 2 
57 Mm.27871 Mrto4 MRT4, mRNA turnover 4, homolog (S. cerevisiae) 
 
  





    In this study, I used RNA-seq to analyze the full transcriptome of the adult 
zebrafish swimbladder. I described the general characteristics of the swimbladder 
transcriptome, and identified the unique features of the organ. I also established the 
correlation between the zebrafish swimbladder and the mammalian lung, which 
provides molecular evidence to the evolutionary relationship of them.  
 
3.3.1 Epithelial tight junctions allow selective permeability of the swimbladder 
    The epithelium is the inner most layer of the swimbladder and is in direct contact 
with the gas inside. It has been shown by transmitted electron microscopy that the 
swimbladder epithelial cells are polarized even prior to inflation (Perlberg et al., 
2008). Tight junctions serve to form seals between epithelial cells, creating a 
selectively permeable barrier to intercellular diffusion. Consistent with this, our 
KEGG pathway analysis indicated that the tight junction pathway genes were indeed 
enriched in the swimbladder. Among the swimbladder enriched gene, the zebrafish 
homologs of cldn4/5/6/7/9 were identified, together with members of the Rho small 
GTPase subfamily including cdc42, rhoA and rab13. Claudins are transmembrane 
proteins which act in concert with other transmembrane and peripheral proteins to 
form the physical basis for tight junction. There are roughly two dozens of different 
claudins. In human airways, both bronchi and bronchioles express Claudin 1, 3, 4, 5 
and 7. Particularly, CLDN3/4/5 have been found to be co-expressed by type II 
alveolar epithelial cells (Wang et al., 2003). It has been revealed by 
immunofluorescence staining that CLDN4 is increasingly localized to the apical tight 
junction region, but with lower expression at the lateral region (Van Itallie et al., 




2001). In contrast, CLDN3 and 5 are localized exclusively in the apical-most region 
of the tight junctions. Altered Claudin expression pattern can change the paracellular 
permeability characteristics of the epithelium. For example, CLDN3 overexpression 
decreases solute permeability, whereas CLDN5 increases permeability (Coyne et al., 
2003). In summary, the expression of CLDN/cldn 4, 5 and 7 is conserved between the 
human lung and the zebrafish swimbladder.  
    However, cldn9, which is one of the highest expressed genes in the swimbladder, is 
not identified in the human lung. Interestingly, Cldn9 is the most highly expressed in 
the inner ear of all the Claudin family members (Nunes et al., 2006), and it is present 
in all of the major epithelial cell types that line the endolymphatic space. Analysis of 









 barrier and 
causes deafness. In contrast, a mutant zebrafish line with K
+
 channel defect shows 
both hearing defect and swimbladder over-inflation (Abbas and Whitfield, 2009), 
suggesting that K
+
 channel plays a very important role in regulating swimbladder 
volume. In the zebrafish, the larvae surface and swallow a bolus of air, which is 
passed down through the esophagus and the pneumatic duct to inflate their 
swimbladders (Goolish and Okutake, 1999). However, how the larvae and adult fish 
maintain and regulate the swimbladder volume is unclear and seems to be 
independent of surface contact. Based on these findings, we speculate that cldn9 is 




 barrier in the swimbladder and to regulate 
swimbladder volume. It is also interesting to note that the swimbladder has long been 
recognized to function for sound production and hearing (Ostrander et al., 2000). 
 
 




3.3.2 Smooth muscle regulation and ECM 
    It has been previously revealed by phalloidin labeling of muscle fibers revealed that 
smooth muscles are the major muscle constitution in the swimbladder and myocytes 
form thick bands along the ventral surface of the anterior chamber and bilaterally 
along the posterior chamber. In contrast, striated muscle fibers constitute a sphincter 
at the junction of the esophagus with the pneumatic duct (Finney et al., 2006). The 
abundance of muscle-related genes identified in the swimbladder transcriptome 
correlates with this feature. Besides, KEGG pathway and GSEA analysis showed 
critical role of interaction between the cells and surrounding extracellular matrix. 
    The viscoelasticity of smooth muscle is contributed by a complex extracellular 
matrix. The ECM is not only a supporting structure of the smooth muscles, but also a 
dynamic structure constantly turning over its contents. This explains the abundant 
ECM-relating transcripts and the active protein transportation process. The major 
protein constituting ECM are collagens, glycoproteins and proteoglycans. In our 
transcriptome data, we also observed these transcripts expressing at high levels in the 
swimbladder. Collagen I is the only type of collagen identified in the swimbladder 
transcriptome, and it is also the most abundant collagen in the human body. In 
mammalian tissues, type I collagen shows the highest expression in the 
cardiomyocytes and smooth muscles (Su et al., 2004).  
    Previously, it has been reported that human airway smooth muscle cells in culture 
can secrete various ECM proteins (Johnson et al., 2000; Panettieri et al., 1998). The 
ECM can store inflammatory mediators and growth factors, which can be released via 
the action of MMPs (matrix metalloproteinases) to modulate smooth muscle 
proliferative and synthetic capacity. The composition of the ECM can be regulated by 




the synthesis of new proteins, and by the action of MMPs and TIMPs (tissue inhibitor 
of metalloproteinases). In the swimbladder, mmp2 and timp2 are the only MMP and 
TIMP identified. Mmp2 functions to degrade type IV collagen, which is a major 
structural component of the basement membranes. The activity of Mmp2 is often 
associated with excessive extracellular turnover, which is consistent with our 
observations that sparc is the most abundant transcript in the swimbladder. 
Interestingly, TIMP2 has been shown to be able to directly bind and inhibit MMP2 
activity (Morgunova et al., 2002). Therefore, mmp2 and timp2 may function to 
balance the extracellular turnover rate in the swimbladder. 
 
3.3.3 Possible roles of hoxC family genes in the swimbladder 
    Hox genes are one of the master regulators of pattern formation during 
embryogenesis. They regulate pattern formation by coordinating cell proliferation, 
migration, adhesion and differentiation. Our data on the embryonic expression pattern 
of hoxC family members and the adult transcriptome data together suggest that the 
expression of embryonic Hox genes is persistent until adult stage. This is in consistent 
with the previous findings that hox genes might have an enduring role in maintaining 
positional identity throughout the lifetime of an organism (Chang et al., 2002; Rinn et 
al., 2006). As the expression of hoxc4a/6a/8a in developing swimbladder was 
identified, the function of these genes remains an open question; thus, it is worth 
further exploring their regulatory mechanisms in future studies. 
    In humans, HOXC6 mRNA is detected in both fetal and normal adult lung. On 
contrary, HOXC8 mRNA is present in the fetal lung, but absent from normal adult 
lung. Interestingly, HOXC8 is consistently up-regulated in emphysematous lungs, a 




disease in which the alveolar septum is disintegrated and the alveoli gradually lose the 
elasticity. However, the human lung has a different expression profile of Hox genes. 
In both human fetal and adult lungs, the most abundant expressed Hox genes are 
HOXA5, HOXB2 and HOXB5. Among these genes, only the homolog of HOXB5 is 
expressed in the zebrafish swimbladder at a relatively low level. It is mostly accepted 
that the swimbladder and lung were evolved from the same ancestral organ, namely 
the respiratory pharynx. The swimbladder arises from the dorsal part, while the lung 
originated from the ventral part. The different expression profiles of HOX/hox genes 
in the swimbladder and lung are consistent with this double origin theory. 
    In recent years, it becomes increasingly clear that hox genes have regulatory roles 
in the adult, likely involved in cell renewal and in the normal physiological changes 
that occur in the adult life (Wang et al., 2009a). The deregulated expression of hox 
genes in adulthood is associated with cancer development and malignant progression 
such as invasion and metastasis (Abate-Shen, 2002; Shah and Sukumar, 2010). 
Noticeably, HOXC cluster genes have been shown to be selectively overexpressed in 
prostate carcinoma and may play key roles in the acquisition of invasive and 
metastatic phenotypes of prostate cancer cells (Miller et al., 2003; Ramachandran et 
al., 2005). Both of Hoxc6 and Hoxc8 have been shown to be able to regulate the 
cross-talk between Wnt, BMP, and FGF signaling pathways by directly targeting a 
few important regulators in the pathways (Lei et al., 2006; Lei et al., 2005; McCabe et 
al., 2008). Thus, the expression of HoxC cluster genes in the swimbladder may not 
only serve to memorize the positional identity of epithelial cells, but also act as master 
regulator for adult swimbladder function, likely in cellular adhesion and mobility. 
 




3.3.4 Conserved expression of Foxf1 and putative function of foxf1 in 
swimbladder development 
    During mouse development, Foxf1 was firstly detected in the lateral plate 
mesoderm. Later, splanchnic Foxf1 expression persisted in mesenchyme surrounding 
the entire primitive gut and in organs derived from it, such as lung buds and liver 
capsule (Mahlapuu et al., 2001b). This specific expression of Foxf1 in the lateral plate 
mesoderm and later in its derivative, the viscereal mesoderm, is conserved in mouse, 
Xenopus and rainbow trout during embryonic development (Hidaka et al., 2004; 
Tseng et al., 2004). Examination of the mouse and Xenopus Foxf1 null embryos 
reveals that Foxf1 is required for mesodermal proliferation and differentiation. Here 
we showed that foxf1 is expressed in the lateral plate mesoderm and later along the 
alimentary tract, which might indicate a highly conserved function and regulatory 
mechanism of foxf1 in mesoderm and gut development.  
    The expression of foxf1 in the lateral plate mesoderm is restricted to the level of 
somite 3 to 5, which is the same with the position of swimbladder at a later stage. The 
signals from the lateral plate mesoderm have been shown to be critical for endodermal 
organ specification (Chung et al., 2008; Ober et al., 2006; Wendl et al., 2007). It is 
interesting to examine whether mesodermal cells from this region actually induce the 
specification of swimbladder endoderm and contribute to form the mesenchyme of the 
swimbladder. 
    Furthermore, in our intersection analysis of swimbladder- and lung-enriched genes, 
Foxf1 is identified in the intersecting gene list, which has been implicated in lung 
development. In mouse lung development, Foxf1 expression is restricted to the distal 
mesenchyme and the muscle layer of the bronchus (Costa et al., 2001). Severe lung 




malformations were observed in Foxf1
+/-
 mice, including narrowing of the esophagus 
and trachea, TEF/EA, abnormalities of intrinsic pulmonary vasculature and lung 
lobation (Kalinichenko et al., 2001; Lim et al., 2002; Mahlapuu et al., 2001a). 
Expression of a number of genes critical for lung morphogenesis and function were 
also reduced. It has been suggested that Foxf1 acts downstream in the Shh pathway 
during lung organogenesis, gut development, and vasculogenesis (Astorga and 
Carlsson, 2007; Mahlapuu et al., 2001a; Ormestad et al., 2006). During lung 
branching morphogenesis, Shh and Foxf1 are expressed in complementary domains 
(Sato et al., 2008). Foxf1 expression can be upregulated by Shh. Indeed, Foxf1 is 
downregulated in Shh null lung mesenchyme and the repression of Foxf1 by Shh can 
be partially released by removing Gli3 (Li et al., 2004). Analysis of non-coding 
sequences surrounding Foxf1 identified conserved Gli binding sites, which are 
identical among mammalian, bird, fish, and amphibian species (Madison et al., 2009). 
These results provide compelling evidence that Foxf1 is the effecter of the Hh 
signaling pathway mediated by Gli. Further detailed analysis of foxf1 during 
swimbladder development may provide evidence to the homology between the 
zebrafish swimbladder and the mammalian lung from the view of embryonic 
development. And it could also help to decipher the function of Hedgehog signaling 
pathway during zebrafish endodermal organ development. 
 
3.3.5 Evolutionary insights between the fish swimbladder and mammalian lung 
    Epithelial cells of air-breathing organs of vertebrates are covered with a thin layer 
surfactant, which reduces and modifies surface tension at the air-liquid interphase. 
Surfactant consists of mixtures of lipids and surfactant proteins (SPs). In humans, four 




surfactant proteins have been identified: SP-A, SP-B, SP-C, and SP-D. These four 
proteins belong to three different superfamilies. Both SP-A and SP-D are collectins, 
and they are known to play a role in innate immune defense of the lungs by binding a 
wide array of pathogens, including viruses, bacteria, and fungi, and facilitating their 
uptake by immune cells. Both of them are rooted by the MBL (Mannose binding 
lectin) sequence (Hughes, 2007). Homologs of SP-A has been identified in the 
swimbladder of goldfish by western and northern blot analyses (Sullivan et al., 1998). 
We also identified a zebrafish homolog in this family, lman2 (lectin,manose binding2), 
expressed in the swimbladder, which was confirmed by real-time qRT-PCR (Figure 2). 
SP-B, which is highly hydrophobic, belongs to the superfamily of saposin-like 
proteins, a diverse group of lipid-interacting proteins. We identified prosaposin 
(Dr.75922) transcripts in the zebrafish swimbladder at intermediate abundance (78.9 
RPKM), and it is also enriched in the swimbladder. SP-C belongs to the 
chondromodulin I (CHM1) family. One of the zebrafish homolog from the gene 
family, tenomodulin (Dr.118039, 341.47 RPKM) is highly transcribed and enriched in 
the swimbladder. Taken together, the homologs of all four human SPs have been 
identified in the zebrafish swimbladder transcriptome, further supporting the 
evolutionary relationship of the fish swimbladder and mammalian lung. In human 
lung, SP-A is the most dominant surfactant protein expressing (Ballard et al., 2003). 
However, in the zebrafish swimbladder transcriptome, homologs of SP-B and SP-C 
are highly expressed surfactant-related genes. Since both of them are hydrophobic, the 
higher expressing level may due to the fact that the fraction of lipid (mainly 
cholesterol) in the swimbladder is higher than in lung surfactant of mammals (Orgeig 
et al., 2003). In contrast to lung surfactant, swimbladder surfactant mainly acts as an 




antiglue to facilitate reopening of the swimbladder after a collapse or partial collapse, 
and it may prevent edema (Daniels et al., 1995).  
    Gas gland cells of physostome have been shown to produce surfactant in vivo and 
in culture (Prem et al., 2000). Lamellar bodies are also observed in the apical region 
of these cells. No anatomical evidence for a gas gland was found in the zebrafish 
swimbladder in previous study (Finney et al., 2006). However, many species of 
physostomes that are known to secrete gas into their swimbladders do not have a 
morphologically identifiable gas gland, and it has been proposed that the gas-secreting 
cells may be scattered singly or in small groups in the wall of the swimbladder in 
these species (Fange, 1976; Morris and Albright, 1979).Immunohistochemistry 
staining suggested the presence of gas-secreting cells in the zebrafish swimbladder by 
showing nerve terminal concentration of autonomic nerve terminals (Finney et al., 
2006).  
    Another clue of the evolutionary homology is the parathyroid hormone-related 
protein (PTHrP). Ligand-receptor signaling involving PTHrP is crucial for the 
development and proper functioning of lungs in all vertebrates studied. Its expression 
correlates with lung maturation, homeostasis, and repair as well as alveolar size, 
septal thickness and composition of the matrix (Torday and Rehan, 2004). It is 
expressed throughout vertebrate phylogeny, beginning with its expression in the fish 
swimbladder as an adaption to gravity. The zebrafish swimbladder transcriptome 









In this chapter, I focused on the transcriptome profile of the zebrafish 
swimbladder employing the RNA-seq technology and multiple bioinformatic tools. 
The main findings include the followings: 
1. Top enriched genes in the swimbladder were identified, which provides a general 
and complete picture of the swimbladder transcriptome. 
2. Top enriched transcription factors in the swimbladder were examined from the 
swimbladder transcriptome. Interestingly, several consecutive hoxc gene 
transcripts are enriched and expression of these genes have been confirmed in 
developing swimbladder. Differential expression profiles of Hox genes in the 
swimbladder and the lung may help to explain the double origin theory of the two 
organs. 
3. The functional implications of the swimbladder transcriptome indicate two 
important features of the swimbladder, connective tissue as well as muscular 
system development and functions, which provide molecular foundation of the 
physiological function of the swimbladder. 
4. The correlation of the fish swimbladder and the mammalian lung was established 
using integrative bioinformatic analysis, and similar molecular constitutions were 
identified in several aspects, which provide molecular insights in the evolutionary 
relationship of the two organs.  
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